data_4cyk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4cyk _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.521 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 7.7 p-90 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.789 0.328 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -63.33 -38.06 89.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.051 0.453 . . . . 0.0 110.875 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -67.76 -13.73 62.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.358 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.06 -3.91 28.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.698 0.285 . . . . 0.0 111.14 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.479 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 4.8 mt -124.29 116.19 27.08 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.741 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 131.74 21.81 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.573 2.182 . . . . 0.0 112.787 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.37 136.86 55.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.735 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 mtt85 -52.92 -25.95 13.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.34 . . . . 0.0 110.576 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -63.53 -52.94 59.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.366 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.413 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 13.7 mm -67.26 -31.12 51.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.632 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -79.01 -40.81 30.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.324 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.458 HG21 ' CD1' ' A' ' 20' ' ' TYR . 1.9 mp -96.38 -54.6 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.458 ' CD1' HG21 ' A' ' 19' ' ' ILE . 2.7 m-85 -85.24 -12.21 53.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.038 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 68.4 8.34 55.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.529 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.427 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 10.1 p90 -160.27 143.9 13.92 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.47 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 36.7 t -120.71 80.93 1.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.57 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -22.23 30.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.921 0.391 . . . . 0.0 110.525 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.9 -3.38 58.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.952 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.34 -36.88 61.8 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.805 0.336 . . . . 0.0 110.4 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -65.94 -15.47 63.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.494 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.533 ' C ' ' H ' ' A' ' 30' ' ' CYS . 48.5 mt-10 -95.9 179.17 5.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.558 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.45 24.32 0.08 OUTLIER Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.727 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.533 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.9 t -66.34 127.31 93.22 Favored Pre-proline 0 C--O 1.231 0.088 0 CA-C-N 117.819 0.809 . . . . 0.0 110.597 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 92.1 Cg_endo -80.96 152.43 18.93 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.352 2.035 . . . . 0.0 112.541 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.555 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 26.2 m-85 107.5 154.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.965 0.906 . . . . 0.0 111.066 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -84.45 96.54 9.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.419 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.47 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 4.7 m80 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.703 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.521 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.0 p-90 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.848 0.356 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -63.06 -38.43 91.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.023 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -67.59 -13.04 61.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.399 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -101.65 -4.09 27.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.756 0.312 . . . . 0.0 111.25 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.476 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 3.9 mt -124.35 107.86 29.68 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.942 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.6 130.63 32.3 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.497 2.131 . . . . 0.0 112.386 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.2 t -66.46 136.77 56.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.8 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.9 mtt85 -53.15 -24.14 9.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.71 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.417 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.1 m-80 -60.48 -52.95 63.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.113 0.482 . . . . 0.0 110.094 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.433 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.2 mm -71.34 -29.75 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.015 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 m -78.72 -38.32 39.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.007 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.502 HG21 ' CD1' ' A' ' 20' ' ' TYR . 2.9 mp -99.3 -54.73 6.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.934 0.397 . . . . 0.0 111.709 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.502 ' CD1' HG21 ' A' ' 19' ' ' ILE . 3.6 m-85 -85.48 -13.62 48.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.946 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 72.5 5.65 64.02 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.659 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CD1' ' HG3' ' A' ' 24' ' ' LYS . 14.2 p90 -160.26 143.97 13.97 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.482 0.182 . . . . 0.0 110.513 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.49 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 46.1 t -120.82 79.39 1.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.49 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.424 ' HG3' ' CD1' ' A' ' 22' ' ' TYR . 45.5 mttm -56.37 -21.7 26.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.838 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.59 1.96 52.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.187 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -55.49 -37.15 67.45 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.773 0.321 . . . . 0.0 110.274 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -15.86 63.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.372 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.562 ' C ' ' H ' ' A' ' 30' ' ' CYS . 1.5 mt-10 -93.19 179.36 5.44 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.0 19.73 0.05 OUTLIER Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.929 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.562 ' H ' ' C ' ' A' ' 28' ' ' GLU . 2.4 t -66.2 123.59 85.7 Favored Pre-proline 0 C--O 1.232 0.138 0 CA-C-N 117.824 0.812 . . . . 0.0 110.858 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.559 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 95.1 Cg_endo -79.85 153.78 22.78 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.282 1.988 . . . . 0.0 112.331 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.559 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 27.2 m-85 107.38 155.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.985 0.914 . . . . 0.0 111.133 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.405 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 14.5 tptt -85.77 97.51 10.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.38 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.49 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 3.1 m80 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.782 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.55 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 13.8 p-90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.912 0.387 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.55 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.35 -34.49 76.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.181 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.6 ttmt -67.15 -17.2 64.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.477 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -100.42 -1.6 35.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.581 0.229 . . . . 0.0 111.269 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.492 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 16.6 mt -124.24 109.9 29.03 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.202 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.04 130.61 31.43 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.483 2.122 . . . . 0.0 112.216 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.3 t -68.02 137.02 54.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.881 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -52.78 -22.97 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.584 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -61.66 -57.04 13.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.041 0.448 . . . . 0.0 110.128 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.423 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.2 mm -67.66 -29.17 44.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.841 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.2 m -78.82 -41.55 29.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.197 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.488 HG21 ' CD2' ' A' ' 20' ' ' TYR . 2.2 mt -97.02 -54.54 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.925 0.393 . . . . 0.0 111.867 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.488 ' CD2' HG21 ' A' ' 19' ' ' ILE . 3.3 m-85 -85.47 -12.1 52.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.971 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.93 6.81 57.65 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.284 -0.96 . . . . 0.0 111.782 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -160.27 143.24 13.51 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.575 0.226 . . . . 0.0 110.53 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.479 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 17.6 t -120.85 80.22 1.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.565 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.22 -22.61 30.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.501 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -2.59 56.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.927 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.3 tm-20 -53.7 -34.17 57.91 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.758 0.313 . . . . 0.0 110.432 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.19 -11.86 61.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.691 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -99.11 179.05 4.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.671 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.78 25.79 0.11 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.742 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.525 ' H ' ' C ' ' A' ' 28' ' ' GLU . 6.3 t -66.33 133.03 94.42 Favored Pre-proline 0 N--CA 1.457 -0.077 0 CA-C-N 117.599 0.699 . . . . 0.0 110.714 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 95.3 Cg_endo -82.05 148.14 15.1 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.363 2.042 . . . . 0.0 112.326 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.555 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 26.2 m-85 108.53 154.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.951 0.901 . . . . 0.0 110.91 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 47.3 tptt -87.09 99.99 12.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.443 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.479 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 2.2 m80 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.654 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.531 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.0 p-90 . . . . . 0 N--CA 1.461 0.087 0 CA-C-O 120.796 0.332 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.531 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -63.23 -38.76 92.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.174 0.511 . . . . 0.0 110.893 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.415 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -68.46 -13.37 62.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.356 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.39 -3.31 31.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.781 0.324 . . . . 0.0 111.021 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.516 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 5.8 mt -124.35 109.17 29.09 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.54 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.66 130.62 23.87 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.644 2.229 . . . . 0.0 112.914 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.2 t -65.9 136.87 56.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.716 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -52.77 -25.36 11.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.837 0.351 . . . . 0.0 110.684 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -63.42 -53.43 52.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.172 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.427 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 10.9 mm -68.32 -29.31 43.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.554 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.8 m -78.95 -40.67 31.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.112 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.476 HG21 ' CD1' ' A' ' 20' ' ' TYR . 1.6 mp -96.85 -54.64 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 111.934 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.476 ' CD1' HG21 ' A' ' 19' ' ' ILE . 2.9 m-85 -85.32 -13.11 50.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.949 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.9 6.96 61.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.098 -1.048 . . . . 0.0 111.614 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.423 ' CE1' ' HG3' ' A' ' 24' ' ' LYS . 9.2 p90 -160.19 143.3 13.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.599 0.238 . . . . 0.0 110.45 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.47 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 36.0 t -120.67 80.55 1.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.387 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.423 ' HG3' ' CE1' ' A' ' 22' ' ' TYR . 5.8 mtmm -56.22 -22.11 27.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.771 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.75 10.17 27.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.423 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -59.12 -34.52 72.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.876 0.369 . . . . 0.0 110.124 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -69.48 -12.64 61.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.565 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.566 ' C ' ' H ' ' A' ' 30' ' ' CYS . 2.0 mt-10 -94.12 179.39 5.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.69 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.74 14.47 0.02 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.746 -0.74 . . . . 0.0 114.109 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.566 ' H ' ' C ' ' A' ' 28' ' ' GLU . 1.5 t -66.26 114.51 17.24 Favored Pre-proline 0 C--O 1.23 0.075 0 CA-C-N 118.028 0.914 . . . . 0.0 110.632 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 74.1 Cg_endo -75.67 158.65 39.48 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.279 1.986 . . . . 0.0 112.158 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.555 ' CB ' ' O ' ' A' ' 31' ' ' PRO . 28.0 m-85 105.68 154.28 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.95 0.9 . . . . 0.0 111.06 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.415 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 23.6 tptp -82.13 96.33 7.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.609 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.47 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 9.0 m80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.827 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.553 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 15.7 p-90 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.948 0.404 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.553 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.17 -35.12 77.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.135 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.412 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 1.2 ttmt -67.32 -18.74 65.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.214 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.69 -2.02 42.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.133 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.542 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 53.6 mt -124.2 126.37 25.56 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.94 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.39 130.58 13.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.526 2.151 . . . . 0.0 112.511 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t -67.18 136.84 55.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.782 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.3 mtp85 -52.81 -25.43 11.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.935 0.398 . . . . 0.0 110.5 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.43 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 5.0 m120 -63.71 -55.22 24.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.413 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 mm -64.87 -30.47 50.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.603 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.0 m -78.93 -43.27 25.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.561 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.501 HG21 ' CD2' ' A' ' 20' ' ' TYR . 2.1 mp -95.39 -53.42 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.501 ' CD2' HG21 ' A' ' 19' ' ' ILE . 3.0 m-85 -85.19 -12.08 53.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.944 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.96 7.82 51.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.203 -0.998 . . . . 0.0 111.657 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.411 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 10.2 p90 -160.3 143.12 13.39 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.46 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 34.5 t -120.7 80.15 1.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.698 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -56.4 -22.06 29.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.585 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -83.51 -5.37 59.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.076 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -53.61 -36.24 61.78 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 120.812 0.339 . . . . 0.0 110.383 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -15.79 63.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.294 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 30' ' ' CYS . 70.0 mt-10 -97.75 179.04 4.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.457 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.92 28.73 0.11 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.746 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.514 ' H ' ' C ' ' A' ' 28' ' ' GLU . 6.1 t -66.43 134.09 94.48 Favored Pre-proline 0 CA--C 1.528 0.097 0 CA-C-N 117.764 0.782 . . . . 0.0 110.628 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.553 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 89.5 Cg_endo -82.37 147.86 14.42 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.258 1.972 . . . . 0.0 112.338 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.553 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 26.5 m-85 107.81 155.61 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.978 0.911 . . . . 0.0 111.035 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.412 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -88.02 100.57 13.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.468 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.483 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.338 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.556 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 14.3 p-90 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.0 0.428 . . . . 0.0 111.441 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.556 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.34 -33.48 74.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.323 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -67.5 -17.88 64.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.457 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.39 -1.03 39.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.192 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.515 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 9.4 mt -124.34 103.64 32.32 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.075 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.89 130.58 35.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.479 2.119 . . . . 0.0 112.366 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.7 t -65.48 136.73 56.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.881 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -52.88 -25.61 12.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.613 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -63.78 -52.98 57.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.121 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.422 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 14.5 mm -67.01 -31.23 52.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.522 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.4 m -78.97 -39.99 32.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.334 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.461 HG21 ' CD2' ' A' ' 20' ' ' TYR . 4.1 mt -96.69 -54.68 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.461 ' CD2' HG21 ' A' ' 19' ' ' ILE . 2.6 m-85 -85.47 -12.56 51.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.996 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.18 7.11 59.29 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.596 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.405 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 11.7 p90 -160.19 143.25 13.64 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.61 0.243 . . . . 0.0 110.57 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.477 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 35.6 t -120.86 80.2 1.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.805 0.336 . . . . 0.0 110.281 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.2 -23.21 34.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.775 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 3.82 45.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -55.23 -36.15 65.69 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.818 0.342 . . . . 0.0 110.384 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -68.11 -13.2 62.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.407 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.555 ' C ' ' H ' ' A' ' 30' ' ' CYS . 3.7 mm-40 -94.38 179.14 5.39 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.592 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.09 20.24 0.06 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.798 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.555 ' H ' ' C ' ' A' ' 28' ' ' GLU . 2.6 t -66.32 121.17 75.42 Favored Pre-proline 0 C--O 1.231 0.086 0 CA-C-N 117.747 0.774 . . . . 0.0 110.769 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 72.6 Cg_endo -77.72 153.28 29.78 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.293 1.995 . . . . 0.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.555 ' CB ' ' O ' ' A' ' 31' ' ' PRO . 25.9 m-85 108.33 153.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.006 0.923 . . . . 0.0 111.104 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -85.1 96.66 9.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.339 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.477 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 3.8 m80 . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.672 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.555 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 16.3 p-90 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.939 0.399 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.555 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.79 -34.97 78.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.202 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -67.39 -13.73 62.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.549 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -105.88 0.85 26.27 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.42 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.495 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 11.7 mt -124.48 110.77 28.21 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 120.682 0.277 . . . . 0.0 111.121 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.03 130.67 33.51 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.562 2.174 . . . . 0.0 112.376 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.1 t -72.61 136.68 45.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.939 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.42 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 27.4 ptt180 -53.47 -21.5 6.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.07 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.425 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.0 OUTLIER -61.65 -57.24 12.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.056 0.455 . . . . 0.0 110.513 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.44 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -71.25 -25.83 25.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.773 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' A' ' 15' ' ' ARG . 2.0 m -78.87 -42.88 26.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.536 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.496 HG21 ' CD1' ' A' ' 20' ' ' TYR . 1.5 mp -96.44 -53.03 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 111.786 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.496 ' CD1' HG21 ' A' ' 19' ' ' ILE . 3.6 m-85 -85.28 -15.08 44.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.937 -178.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 72.85 5.5 64.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.81 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -160.33 142.36 12.82 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.482 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 7.1 t -120.85 78.6 1.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.603 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.4 -22.63 32.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.576 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.8 -2.14 53.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.112 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.494 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.7 tm-20 -53.54 -35.78 61.1 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.799 0.333 . . . . 0.0 110.449 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -68.51 -13.03 62.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.771 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.52 ' C ' ' H ' ' A' ' 30' ' ' CYS . 9.6 mp0 -98.4 179.06 4.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.689 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.23 27.47 0.1 OUTLIER Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.765 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.52 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.7 t -66.45 134.88 94.56 Favored Pre-proline 0 C--O 1.231 0.083 0 CA-C-N 117.752 0.776 . . . . 0.0 110.6 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.557 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 88.5 Cg_endo -82.4 146.31 13.77 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.35 2.034 . . . . 0.0 112.083 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.557 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 27.6 m-85 106.56 157.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.839 0.856 . . . . 0.0 111.004 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -88.47 105.78 17.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.599 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.494 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.561 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.53 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 7.4 p-90 . . . . . 0 N--CA 1.461 0.105 0 CA-C-O 120.798 0.333 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.53 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -63.54 -38.44 91.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.046 0.45 . . . . 0.0 110.709 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.428 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -68.12 -14.2 62.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.31 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.24 -3.42 31.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.728 0.299 . . . . 0.0 110.968 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.578 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 63.8 mt -124.36 113.51 27.66 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.786 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.95 130.64 22.11 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.54 2.16 . . . . 0.0 112.756 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.3 t -67.81 136.93 54.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.662 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -22.8 6.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.786 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.423 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.3 m-80 -61.71 -57.03 13.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.032 0.444 . . . . 0.0 110.117 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.425 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.3 mm -66.73 -28.3 42.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.741 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -78.9 -43.06 25.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.227 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.528 HG21 ' CD1' ' A' ' 20' ' ' TYR . 1.4 mp -95.99 -54.08 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.863 0.363 . . . . 0.0 111.844 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.528 ' CD1' HG21 ' A' ' 19' ' ' ILE . 3.3 m-85 -85.17 -12.65 52.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.904 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.88 5.44 57.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.804 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -160.29 143.32 13.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.47 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 32.2 t -120.78 79.7 1.53 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.824 0.345 . . . . 0.0 110.647 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -56.34 -22.6 31.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.455 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.36 -1.47 53.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.064 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 1.3 tm-20 -52.95 -37.75 61.35 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.857 0.361 . . . . 0.0 110.485 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.51 -13.59 61.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.625 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.553 ' C ' ' H ' ' A' ' 30' ' ' CYS . 12.7 mt-10 -95.07 179.19 5.3 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.655 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.87 19.55 0.06 OUTLIER Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.776 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.553 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.0 t -66.28 124.22 87.45 Favored Pre-proline 0 C--O 1.232 0.133 0 CA-C-N 117.9 0.85 . . . . 0.0 110.823 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 88.5 Cg_endo -79.36 154.64 24.7 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.311 2.008 . . . . 0.0 112.295 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CE1' ' HB ' ' A' ' 12' ' ' ILE . 26.4 m-85 106.89 153.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.988 0.915 . . . . 0.0 111.029 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.428 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 11.3 tptt -84.28 96.34 8.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.242 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.47 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 5.3 m80 . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.688 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.527 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 18.3 p-90 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.035 0.445 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.527 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.15 -35.09 77.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.216 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.427 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -67.11 -18.46 65.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -96.01 -5.02 42.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.653 0.263 . . . . 0.0 111.242 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.464 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 6.3 mt -124.26 126.31 25.55 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.47 130.65 13.0 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.583 2.189 . . . . 0.0 112.725 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.414 ' HA ' ' CD1' ' A' ' 32' ' ' PHE . 49.7 t -63.36 136.79 57.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.791 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.2 mtp85 -53.02 -25.85 13.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.914 0.387 . . . . 0.0 110.287 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.435 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 3.7 m120 -64.66 -52.92 54.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.328 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.3 mm -67.21 -30.7 50.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.618 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 m -78.97 -44.92 21.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.379 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.632 HG23 ' CD1' ' A' ' 20' ' ' TYR . 2.0 mp -95.59 -49.79 12.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.632 ' CD1' HG23 ' A' ' 19' ' ' ILE . 4.3 m-85 -85.06 -15.47 43.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.523 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.62 7.21 60.76 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.345 -0.931 . . . . 0.0 111.481 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -160.56 143.72 13.36 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 122.39 0.276 . . . . 0.0 110.501 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.481 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 30.4 t -120.99 80.48 1.64 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.754 0.311 . . . . 0.0 110.266 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.19 -22.77 31.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.821 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.02 4.18 49.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.1 tm-20 -55.92 -32.5 63.84 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.852 0.358 . . . . 0.0 110.191 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -71.55 -11.04 60.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.615 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.531 ' C ' ' H ' ' A' ' 30' ' ' CYS . 2.6 mt-10 -98.53 179.06 4.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.773 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.06 24.59 0.09 OUTLIER Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.859 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.531 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.5 t -66.41 132.11 94.28 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 117.763 0.781 . . . . 0.0 110.654 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.557 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 88.1 Cg_endo -82.49 148.65 14.46 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.435 2.09 . . . . 0.0 112.663 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.557 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 26.1 m-85 109.06 154.37 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.094 0.957 . . . . 0.0 111.091 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.427 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 2.9 tppt? -86.35 98.01 10.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.243 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.481 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 2.9 m80 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.579 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.525 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.4 p-90 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.879 0.371 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.525 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -63.94 -38.41 91.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.095 0.474 . . . . 0.0 110.842 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -68.07 -12.19 60.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.408 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.08 -3.5 25.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.677 0.275 . . . . 0.0 111.103 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.497 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 9.0 mt -124.19 108.15 29.91 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.143 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.86 130.55 33.38 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.411 2.074 . . . . 0.0 112.348 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.5 t -66.44 136.82 56.27 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.817 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -53.02 -23.58 7.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.803 0.335 . . . . 0.0 110.624 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -61.06 -54.08 49.13 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 110.297 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.405 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.7 mm -70.99 -29.16 35.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.765 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -78.74 -38.93 37.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.944 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.463 HG21 ' CD1' ' A' ' 20' ' ' TYR . 5.9 mt -99.84 -54.7 6.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.863 0.363 . . . . 0.0 111.963 -178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.463 ' CD1' HG21 ' A' ' 19' ' ' ILE . 3.8 m-85 -85.58 -11.98 52.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.003 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.18 7.33 59.72 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.722 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -160.3 146.87 15.69 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.491 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 34.1 t -120.9 80.45 1.64 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.753 0.311 . . . . 0.0 110.684 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -56.37 -21.97 28.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.704 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 -2.99 58.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.067 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.443 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.7 tm-20 -53.65 -35.82 61.43 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.765 0.316 . . . . 0.0 110.365 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.11 -16.04 63.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.391 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 30' ' ' CYS . 15.3 mt-10 -96.83 179.15 5.06 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.56 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 27.4 0.1 OUTLIER Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.754 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.523 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.5 t -66.51 130.07 94.14 Favored Pre-proline 0 C--O 1.231 0.129 0 CA-C-N 117.738 0.769 . . . . 0.0 110.603 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.56 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 92.8 Cg_endo -81.13 150.12 17.64 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.382 2.055 . . . . 0.0 112.42 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.56 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 26.6 m-85 107.51 156.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.995 0.918 . . . . 0.0 111.042 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.437 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 7.4 tptp -87.14 100.06 12.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.445 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.491 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 2.0 m80 . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.673 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.506 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 7.9 p-90 . . . . . 0 N--CA 1.461 0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.506 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.52 -40.58 97.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.013 0.435 . . . . 0.0 110.889 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.41 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 2.7 ttmt -67.7 -13.41 62.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.24 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -99.31 -5.56 29.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.64 0.257 . . . . 0.0 111.092 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.477 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 2.5 mp -124.24 117.0 26.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.645 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.92 130.55 19.35 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.48 2.12 . . . . 0.0 112.779 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.98 136.7 56.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.652 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.02 -21.99 5.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.752 0.31 . . . . 0.0 110.737 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -62.37 -56.75 15.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.917 0.389 . . . . 0.0 110.117 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.415 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.9 mm -67.72 -28.18 40.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.774 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 m -78.81 -42.76 26.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.167 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.529 HG21 ' CD1' ' A' ' 20' ' ' TYR . 1.6 mp -96.61 -54.22 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.357 . . . . 0.0 111.872 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.529 ' CD1' HG21 ' A' ' 19' ' ' ILE . 3.5 m-85 -85.28 -12.09 53.22 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.058 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.12 6.56 57.38 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.731 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -160.23 144.47 14.34 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.569 0.223 . . . . 0.0 110.445 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.478 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 26.7 t -120.82 80.74 1.67 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.754 0.311 . . . . 0.0 110.657 178.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -22.83 31.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.482 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -1.45 56.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.996 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.438 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 3.3 tm-20 -53.75 -35.25 61.04 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.813 0.34 . . . . 0.0 110.45 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 mtpp -68.84 -13.06 62.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.58 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.54 ' C ' ' H ' ' A' ' 30' ' ' CYS . 16.4 mm-40 -96.53 179.17 5.09 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.655 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.2 22.51 0.08 OUTLIER Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.858 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.54 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.2 t -66.38 128.78 94.03 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 117.735 0.767 . . . . 0.0 110.636 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 90.0 Cg_endo -81.87 152.39 16.86 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.44 2.094 . . . . 0.0 112.592 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.558 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 26.7 m-85 107.48 154.08 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.079 0.952 . . . . 0.0 111.07 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.41 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -84.38 96.53 9.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.295 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.478 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 5.3 m80 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.793 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.505 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 7.9 p-90 . . . . . 0 N--CA 1.461 0.088 0 CA-C-O 120.805 0.336 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.505 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.45 -39.71 94.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.972 0.415 . . . . 0.0 110.995 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.434 ' CG ' ' HB2' ' A' ' 33' ' ' LYS . 1.1 ttmm -67.16 -13.43 61.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.325 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.81 -7.02 25.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.711 0.291 . . . . 0.0 111.225 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.453 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 2.6 mp -124.19 124.41 25.88 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.899 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -73.06 130.97 16.09 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.675 2.25 . . . . 0.0 112.712 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -65.81 136.67 56.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.826 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -53.23 -22.23 6.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.667 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.423 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.6 m-80 -61.67 -57.07 13.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.939 0.4 . . . . 0.0 110.251 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mm -66.97 -28.98 44.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.883 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 m -78.83 -42.35 27.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.247 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.509 HG21 ' CD2' ' A' ' 20' ' ' TYR . 2.1 mp -96.84 -54.43 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.952 0.406 . . . . 0.0 111.921 -178.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.509 ' CD2' HG21 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.27 -11.32 55.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.109 -178.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.14 6.67 54.45 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.731 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -160.23 145.49 14.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.536 0.207 . . . . 0.0 110.467 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.468 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 27.8 t -120.86 80.39 1.63 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.84 0.353 . . . . 0.0 110.537 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -56.35 -21.77 26.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.33 -0.91 57.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.247 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -54.26 -36.35 63.5 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.808 0.337 . . . . 0.0 110.38 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -66.53 -14.91 62.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.509 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.531 ' C ' ' H ' ' A' ' 30' ' ' CYS . 4.9 mt-10 -96.21 179.12 5.16 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.433 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.92 26.05 0.09 OUTLIER Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.535 -0.841 . . . . 0.0 113.749 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.531 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.7 t -66.31 134.08 94.6 Favored Pre-proline 0 C--O 1.231 0.124 0 CA-C-N 117.717 0.758 . . . . 0.0 110.539 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 88.9 Cg_endo -83.46 148.14 12.73 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.455 2.103 . . . . 0.0 112.627 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.558 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 25.9 m-85 108.97 154.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.1 0.96 . . . . 0.0 111.1 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.434 ' HB2' ' CG ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -87.55 96.46 10.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.129 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.468 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 2.0 m80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.631 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.521 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.8 p-90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -64.72 -36.0 82.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.075 0.464 . . . . 0.0 110.651 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.636 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -68.39 -13.89 62.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.288 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -102.3 -1.97 29.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.748 0.308 . . . . 0.0 110.852 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.55 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 65.1 mt -124.57 116.6 26.58 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.833 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.84 130.51 20.62 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.45 2.1 . . . . 0.0 112.596 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.4 t -66.73 137.05 56.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.852 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.433 ' HB3' HD12 ' A' ' 19' ' ' ILE . 72.1 mtt180 -52.97 -22.41 5.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.74 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.41 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.8 m-80 -63.58 -57.15 11.03 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 110.372 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.404 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.2 mm -65.52 -27.72 42.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.496 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.411 HG23 HD11 ' A' ' 19' ' ' ILE . 18.0 m -78.91 -44.78 21.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.192 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.511 HG21 ' CD1' ' A' ' 20' ' ' TYR . 2.3 mp -95.36 -54.62 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.965 0.412 . . . . 0.0 111.99 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.511 ' CD1' HG21 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.32 -9.98 56.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.028 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 66.83 7.48 42.67 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.279 -0.963 . . . . 0.0 111.81 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 10.2 p90 -160.35 144.17 13.96 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.47 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 35.1 t -120.81 80.26 1.61 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.777 0.323 . . . . 0.0 110.543 178.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.38 -22.76 33.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.68 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.59 -2.91 58.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.051 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -54.06 -36.08 62.73 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.885 0.374 . . . . 0.0 110.266 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -65.83 -15.79 63.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.41 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 30' ' ' CYS . 33.5 mt-10 -96.65 179.14 5.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.561 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.37 25.72 0.08 OUTLIER Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.888 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.527 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.8 t -66.34 130.31 94.21 Favored Pre-proline 0 CA--C 1.527 0.069 0 CA-C-N 117.874 0.837 . . . . 0.0 110.622 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 96.6 Cg_endo -79.87 150.73 21.17 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.32 2.013 . . . . 0.0 112.379 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.55 ' CE2' ' HB ' ' A' ' 12' ' ' ILE . 26.6 m-85 106.55 154.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.957 0.903 . . . . 0.0 111.105 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.636 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -87.73 96.56 10.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.228 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.47 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 1.9 m80 . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.658 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.52 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 7.6 p-90 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.852 0.358 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.52 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.87 -39.87 95.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.082 0.468 . . . . 0.0 110.96 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.52 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -67.77 -12.27 60.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.414 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -101.64 -5.01 25.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.676 0.274 . . . . 0.0 111.163 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.484 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 8.2 mt -124.32 123.72 25.88 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.829 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.08 130.72 16.96 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.496 2.131 . . . . 0.0 112.692 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.22 137.0 55.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.927 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.9 mtt85 -53.09 -22.29 5.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.806 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.427 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.6 m-80 -62.86 -57.04 12.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 110.228 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.408 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.1 mm -66.1 -27.65 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.546 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.7 m -78.9 -45.77 19.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.205 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.517 HG21 ' CD2' ' A' ' 20' ' ' TYR . 2.2 mp -94.11 -54.39 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.935 0.398 . . . . 0.0 111.939 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.517 ' CD2' HG21 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.2 -11.34 55.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.998 -178.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 68.9 6.23 50.89 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.808 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -160.34 143.36 13.47 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.469 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 25.6 t -120.76 79.9 1.56 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.734 0.302 . . . . 0.0 110.5 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -56.21 -23.26 34.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.698 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.39 -1.06 52.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.0 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.452 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -53.51 -36.19 61.47 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.847 0.356 . . . . 0.0 110.393 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -68.54 -12.84 61.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.668 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.531 ' C ' ' H ' ' A' ' 30' ' ' CYS . 7.4 mt-10 -96.94 179.04 5.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 25.49 0.09 OUTLIER Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.708 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.531 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.1 t -66.31 133.21 94.47 Favored Pre-proline 0 C--O 1.231 0.108 0 CA-C-N 117.766 0.783 . . . . 0.0 110.687 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.56 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 87.2 Cg_endo -82.84 147.51 13.46 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.404 2.069 . . . . 0.0 112.258 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.56 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 26.7 m-85 108.01 156.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.011 0.924 . . . . 0.0 110.969 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 6.2 tmmm? -88.52 105.48 17.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.076 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.491 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 1.6 m80 . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.569 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.517 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.0 p-90 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.817 0.341 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.517 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.82 -39.54 94.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.076 0.465 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.411 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 2.2 ttmt -67.77 -13.48 62.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.293 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.94 -5.29 28.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.675 0.274 . . . . 0.0 111.122 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.483 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 2.5 mp -124.17 117.08 27.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.707 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.0 130.49 19.14 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.568 2.179 . . . . 0.0 112.774 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.9 t -65.29 136.91 57.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.641 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.9 mtm105 -53.12 -23.18 7.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 0.0 110.629 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.412 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.4 m-80 -61.53 -55.29 32.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.939 0.4 . . . . 0.0 110.199 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.411 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.8 mm -69.29 -28.37 38.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.834 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 m -78.77 -42.21 28.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.053 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.519 HG21 ' CD1' ' A' ' 20' ' ' TYR . 1.4 mp -97.02 -54.12 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 111.872 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.519 ' CD1' HG21 ' A' ' 19' ' ' ILE . 3.5 m-85 -85.37 -12.25 52.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.001 -178.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.45 6.11 57.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.874 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -160.28 144.79 14.46 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.53 0.205 . . . . 0.0 110.475 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.477 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 41.2 t -120.99 79.88 1.57 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.813 0.34 . . . . 0.0 110.674 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -56.4 -21.37 24.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.752 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.16 -1.12 57.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.341 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -53.72 -36.81 62.66 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.856 0.36 . . . . 0.0 110.42 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -65.69 -15.39 62.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.332 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.545 ' C ' ' H ' ' A' ' 30' ' ' CYS . 9.3 mm-40 -94.1 179.34 5.35 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.516 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.36 21.28 0.06 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.833 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.545 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.4 t -66.22 127.45 93.25 Favored Pre-proline 0 C--O 1.231 0.098 0 CA-C-N 117.901 0.85 . . . . 0.0 110.723 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 87.3 Cg_endo -82.08 152.97 16.56 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.43 2.087 . . . . 0.0 112.512 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.558 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 27.0 m-85 107.77 154.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.942 0.897 . . . . 0.0 111.128 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.411 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 17.4 tptp -85.23 96.41 9.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.262 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.477 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 3.9 m80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.681 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.548 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 13.0 p-90 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.012 0.434 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.548 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.32 -33.5 74.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.244 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -67.17 -19.47 65.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.356 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -98.32 -0.59 43.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.167 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.537 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 81.4 mt -124.36 103.79 32.15 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.057 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.59 130.5 35.67 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.428 2.085 . . . . 0.0 112.161 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.5 t -65.6 136.65 56.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.815 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -53.16 -25.6 14.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.337 . . . . 0.0 110.514 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.415 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 5.5 m120 -63.12 -53.23 56.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.31 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.413 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 13.1 mm -67.15 -30.59 49.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.612 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 m -78.98 -41.46 29.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.251 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.467 HG21 ' CD2' ' A' ' 20' ' ' TYR . 1.6 mp -96.34 -54.3 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.925 0.393 . . . . 0.0 111.949 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.467 ' CD2' HG21 ' A' ' 19' ' ' ILE . 2.8 m-85 -85.24 -12.33 52.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.036 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.38 7.47 57.64 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.676 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 22' ' ' TYR . 9.0 p90 -160.29 143.87 13.86 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 120.609 0.242 . . . . 0.0 110.468 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.471 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 36.8 t -120.65 80.76 1.67 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.791 0.329 . . . . 0.0 110.27 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -22.06 27.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.103 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.76 2.13 55.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.171 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -55.0 -36.55 65.54 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.857 0.36 . . . . 0.0 110.301 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -66.54 -14.41 62.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.419 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.548 ' C ' ' H ' ' A' ' 30' ' ' CYS . 4.9 mm-40 -94.42 179.19 5.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.602 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.82 22.05 0.07 OUTLIER Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.752 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.548 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.4 t -66.38 123.74 86.29 Favored Pre-proline 0 CA--C 1.527 0.073 0 CA-C-N 117.82 0.81 . . . . 0.0 110.687 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 71.8 Cg_endo -77.62 151.7 28.88 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.195 1.93 . . . . 0.0 112.249 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.551 ' CB ' ' O ' ' A' ' 31' ' ' PRO . 25.6 m-85 109.45 153.02 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.062 0.945 . . . . 0.0 111.049 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -86.49 96.47 10.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.247 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.471 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 3.2 m80 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.084 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.528 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.0 p-90 . . . . . 0 N--CA 1.461 0.111 0 CA-C-O 120.808 0.337 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.528 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -63.34 -37.73 88.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 0.0 110.842 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -67.92 -13.59 62.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.419 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.47 -3.6 28.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 111.14 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.492 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 6.7 mt -124.19 116.35 27.18 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.765 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 131.6 21.66 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.655 2.237 . . . . 0.0 112.859 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.1 t -67.12 136.81 55.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.777 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.3 mtt-85 -52.93 -25.6 12.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 0.0 110.568 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.427 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 5.1 m120 -64.36 -52.78 56.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.289 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.405 HD12 ' HB3' ' A' ' 34' ' ' HIS . 14.9 mm -67.77 -31.27 51.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.613 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.1 m -78.92 -40.8 31.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.426 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.635 HG23 ' CD1' ' A' ' 20' ' ' TYR . 3.1 mp -98.43 -51.47 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.635 ' CD1' HG23 ' A' ' 19' ' ' ILE . 3.2 m-85 -85.14 -14.87 45.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.439 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.38 7.41 63.91 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.472 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -160.48 144.54 13.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.443 0.297 . . . . 0.0 110.344 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.481 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 27.3 t -120.77 80.71 1.66 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.349 178.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.19 -22.7 30.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.846 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 9.27 32.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.454 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -58.79 -36.4 74.39 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.9 0.381 . . . . 0.0 110.202 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -68.65 -12.94 61.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.593 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.566 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.3 OUTLIER -93.91 179.28 5.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.33 19.53 0.05 OUTLIER Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.846 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.566 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.0 t -66.3 124.38 87.91 Favored Pre-proline 0 C--O 1.231 0.124 0 CA-C-N 117.885 0.843 . . . . 0.0 110.619 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.553 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 98.2 Cg_endo -80.0 153.6 22.26 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.357 2.038 . . . . 0.0 112.445 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.553 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 26.8 m-85 107.31 153.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.03 0.932 . . . . 0.0 111.0 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -84.46 96.42 9.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.359 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.481 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 4.3 m80 . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.68 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.523 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 7.7 p-90 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.824 0.345 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.523 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -63.3 -38.59 91.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.085 0.469 . . . . 0.0 110.821 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 1.5 tmmt? -67.58 -13.03 61.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.45 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -102.02 -3.99 26.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.723 0.296 . . . . 0.0 111.245 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.467 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 4.8 mt -124.29 122.37 26.02 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.871 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.79 130.68 17.24 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.64 2.227 . . . . 0.0 112.8 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.3 t -67.2 137.05 55.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.925 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.9 mtt85 -52.81 -24.85 9.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.69 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.42 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 6.1 m120 -63.41 -55.47 24.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.979 0.418 . . . . 0.0 110.325 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.411 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 10.0 mm -65.49 -29.26 46.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.6 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.1 m -78.93 -42.47 26.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.361 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.487 HG21 ' CD1' ' A' ' 20' ' ' TYR . 1.7 mp -96.17 -53.93 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.487 ' CD1' HG21 ' A' ' 19' ' ' ILE . 3.0 m-85 -85.15 -12.52 52.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.902 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.63 6.78 56.59 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.768 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -160.26 142.01 12.67 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.464 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 35.0 t -120.77 79.11 1.45 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.672 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.0 tptt -56.74 -20.43 22.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.827 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -85.19 -2.74 58.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.337 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.411 ' CG ' ' HB2' ' A' ' 34' ' ' HIS . 14.8 tt0 -53.9 -36.42 62.68 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.778 0.323 . . . . 0.0 110.381 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.54 -15.79 63.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.051 0.453 . . . . 0.0 110.273 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.537 ' C ' ' H ' ' A' ' 30' ' ' CYS . 10.2 mt-10 -95.13 179.14 5.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.479 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.12 23.96 0.08 OUTLIER Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.889 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.537 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.6 t -66.27 132.6 94.44 Favored Pre-proline 0 C--O 1.231 0.128 0 CA-C-N 117.868 0.834 . . . . 0.0 110.718 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.554 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 86.3 Cg_endo -83.41 149.31 13.09 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.41 2.073 . . . . 0.0 112.451 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.554 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 26.3 m-85 107.99 155.18 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.989 0.916 . . . . 0.0 111.0 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.418 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 12.6 tptt -87.54 97.6 10.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.391 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.464 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 1.4 m80 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.531 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.552 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 16.9 p-90 . . . . . 0 N--CA 1.46 0.058 0 CA-C-O 121.033 0.444 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.552 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.43 -34.37 76.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.194 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.435 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.5 ttmt -67.32 -17.64 64.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.394 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.39 -1.04 39.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.613 0.244 . . . . 0.0 111.287 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.51 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 8.3 mt -124.33 105.53 30.99 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.686 0.279 . . . . 0.0 111.168 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.74 130.58 33.74 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.573 2.182 . . . . 0.0 112.439 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.9 t -67.69 136.96 55.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.836 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -53.04 -23.29 7.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.774 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.402 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.1 m-80 -61.11 -54.96 38.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.081 0.467 . . . . 0.0 110.116 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.438 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.1 mm -69.25 -28.5 38.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.881 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 m -78.86 -41.36 30.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.021 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.517 HG21 ' CD2' ' A' ' 20' ' ' TYR . 1.8 mp -97.06 -54.6 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.915 0.388 . . . . 0.0 111.738 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.517 ' CD2' HG21 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.25 -13.08 50.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.963 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 71.86 5.43 61.26 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.746 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -160.27 142.98 13.34 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.617 0.246 . . . . 0.0 110.53 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.481 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 37.5 t -120.82 79.53 1.51 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.459 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.42 -22.04 29.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.717 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.52 -1.66 56.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.401 ' CG ' ' HB2' ' A' ' 34' ' ' HIS . 14.2 tt0 -54.06 -35.55 62.15 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 120.727 0.299 . . . . 0.0 110.389 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.92 -15.95 63.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.421 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.548 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -95.19 179.35 5.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.561 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.48 21.11 0.05 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.653 -0.785 . . . . 0.0 114.133 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.548 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.8 t -66.2 124.25 87.46 Favored Pre-proline 0 C--O 1.231 0.111 0 CA-C-N 117.976 0.888 . . . . 0.0 110.598 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 86.3 Cg_endo -78.89 151.1 24.12 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.302 2.001 . . . . 0.0 112.471 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.55 ' CB ' ' O ' ' A' ' 31' ' ' PRO . 26.0 m-85 108.46 154.82 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.041 0.936 . . . . 0.0 111.034 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.435 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 15.9 tptt -86.0 99.55 11.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.293 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.481 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 3.0 m80 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.731 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.513 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 7.2 p-90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.864 0.364 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.513 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.8 -38.0 88.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.04 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.425 ' CG ' ' HB2' ' A' ' 33' ' ' LYS . 1.8 ttmt -67.24 -14.99 63.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.348 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -100.33 -3.47 31.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.646 0.26 . . . . 0.0 111.134 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.513 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 55.5 mt -124.3 126.69 25.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.11 132.31 13.86 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.633 2.222 . . . . 0.0 112.907 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.0 t -70.65 136.85 49.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.641 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.3 mtp85 -53.21 -22.56 6.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.0 110.835 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.422 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.5 m-80 -61.68 -55.74 27.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.016 0.436 . . . . 0.0 110.185 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.411 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.9 mm -68.44 -28.82 41.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.836 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.5 m -78.64 -42.58 28.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.178 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.507 HG21 ' CD2' ' A' ' 20' ' ' TYR . 1.7 mp -96.57 -54.31 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.41 . . . . 0.0 111.863 -178.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.507 ' CD2' HG21 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.28 -12.06 53.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.063 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.93 6.31 55.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.163 -1.017 . . . . 0.0 111.759 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -160.18 146.6 15.72 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.48 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 21.8 t -120.8 81.05 1.71 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.575 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.3 -22.37 29.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.667 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.88 2.04 54.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.016 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.46 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -55.05 -35.16 64.19 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.806 0.336 . . . . 0.0 110.427 179.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -11.09 60.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.718 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.541 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -97.26 179.04 5.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.665 179.402 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.45 23.28 0.08 OUTLIER Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.81 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.541 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.5 t -66.36 131.35 94.26 Favored Pre-proline 0 C--O 1.23 0.054 0 CA-C-N 117.75 0.775 . . . . 0.0 110.714 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.556 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 94.8 Cg_endo -81.52 148.9 16.39 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.398 2.065 . . . . 0.0 112.25 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.556 ' CB ' ' O ' ' A' ' 31' ' ' PRO . 25.5 m-85 109.16 154.77 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.062 0.945 . . . . 0.0 111.056 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.425 ' HB2' ' CG ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -87.18 98.79 11.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.269 179.637 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.48 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 2.1 m80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.633 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.889 0.376 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -104.2 -30.87 9.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.926 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.18 123.42 32.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.934 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.28 107.6 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.452 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 2.3 t30 -73.76 138.28 76.87 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.179 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -42.8 -25.08 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.523 2.149 . . . . 0.0 112.864 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -58.71 -23.89 60.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.283 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.521 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 7.7 p-90 -76.05 -52.07 10.95 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.789 0.328 . . . . 0.0 111.109 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -63.33 -38.06 89.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.051 0.453 . . . . 0.0 110.875 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -67.76 -13.73 62.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.358 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.06 -3.91 28.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.698 0.285 . . . . 0.0 111.14 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.479 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 4.8 mt -124.29 116.19 27.08 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.741 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 131.74 21.81 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.573 2.182 . . . . 0.0 112.787 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.37 136.86 55.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.735 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 mtt85 -52.92 -25.95 13.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.34 . . . . 0.0 110.576 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -63.53 -52.94 59.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.366 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.413 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 13.7 mm -67.26 -31.12 51.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.632 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -79.01 -40.81 30.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.324 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.458 HG21 ' CD1' ' A' ' 20' ' ' TYR . 1.9 mp -96.38 -54.6 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.458 ' CD1' HG21 ' A' ' 19' ' ' ILE . 2.7 m-85 -85.24 -12.21 53.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.038 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 68.4 8.34 55.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.529 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.427 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 10.1 p90 -160.27 143.9 13.92 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.7 t -120.71 80.93 1.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.57 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -22.23 30.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.921 0.391 . . . . 0.0 110.525 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.9 -3.38 58.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.952 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.34 -36.88 61.8 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.805 0.336 . . . . 0.0 110.4 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -65.94 -15.47 63.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.494 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.533 ' C ' ' H ' ' A' ' 30' ' ' CYS . 48.5 mt-10 -95.9 179.17 5.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.558 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.45 24.32 0.08 OUTLIER Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.727 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.533 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.9 t -66.34 127.31 93.22 Favored Pre-proline 0 C--O 1.231 0.088 0 CA-C-N 117.819 0.809 . . . . 0.0 110.597 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 92.1 Cg_endo -80.96 152.43 18.93 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.352 2.035 . . . . 0.0 112.541 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.555 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 26.2 m-85 107.5 154.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.965 0.906 . . . . 0.0 111.066 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -84.45 96.54 9.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.419 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.436 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 4.7 m80 -90.07 79.02 6.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.703 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -95.43 110.71 22.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.863 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -118.82 31.73 6.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -117.29 -60.22 1.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.4 m -83.67 86.25 7.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -67.88 111.58 4.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.53 173.68 11.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.075 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.838 0.351 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.4 -70.68 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.06 113.18 10.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.86 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.41 ' HB ' ' CD1' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -124.77 111.6 28.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.026 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.437 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -76.07 136.15 69.71 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.278 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -42.72 -24.98 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.695 2.263 . . . . 0.0 113.009 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.2 p30 -64.1 -16.17 61.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.428 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.521 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.0 p-90 -78.9 -51.95 8.96 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.848 0.356 . . . . 0.0 111.057 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -63.06 -38.43 91.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.023 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -67.59 -13.04 61.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.399 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -101.65 -4.09 27.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.756 0.312 . . . . 0.0 111.25 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.476 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 3.9 mt -124.35 107.86 29.68 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.942 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.6 130.63 32.3 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.497 2.131 . . . . 0.0 112.386 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.2 t -66.46 136.77 56.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.8 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.9 mtt85 -53.15 -24.14 9.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.71 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.417 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.1 m-80 -60.48 -52.95 63.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.113 0.482 . . . . 0.0 110.094 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.433 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.2 mm -71.34 -29.75 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.015 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 m -78.72 -38.32 39.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.007 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.502 HG21 ' CD1' ' A' ' 20' ' ' TYR . 2.9 mp -99.3 -54.73 6.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.934 0.397 . . . . 0.0 111.709 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.502 ' CD1' HG21 ' A' ' 19' ' ' ILE . 3.6 m-85 -85.48 -13.62 48.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.946 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 72.5 5.65 64.02 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.659 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CD1' ' HG3' ' A' ' 24' ' ' LYS . 14.2 p90 -160.26 143.97 13.97 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.482 0.182 . . . . 0.0 110.513 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.1 t -120.82 79.39 1.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.49 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' HG3' ' CD1' ' A' ' 22' ' ' TYR . 45.5 mttm -56.37 -21.7 26.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.838 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.59 1.96 52.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.187 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -55.49 -37.15 67.45 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.773 0.321 . . . . 0.0 110.274 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -15.86 63.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.372 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.562 ' C ' ' H ' ' A' ' 30' ' ' CYS . 1.5 mt-10 -93.19 179.36 5.44 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.0 19.73 0.05 OUTLIER Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.929 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.562 ' H ' ' C ' ' A' ' 28' ' ' GLU . 2.4 t -66.2 123.59 85.7 Favored Pre-proline 0 C--O 1.232 0.138 0 CA-C-N 117.824 0.812 . . . . 0.0 110.858 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.559 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 95.1 Cg_endo -79.85 153.78 22.78 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.282 1.988 . . . . 0.0 112.331 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.559 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 27.2 m-85 107.38 155.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.985 0.914 . . . . 0.0 111.133 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.405 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 14.5 tptt -85.77 97.51 10.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.38 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.447 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 3.1 m80 -92.17 79.03 5.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.782 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.8 t -68.24 105.21 2.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.929 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -136.27 -175.16 3.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.833 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -67.67 -36.13 80.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 90.2 m 61.21 153.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.821 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 m 61.09 102.98 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.801 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.46 143.85 34.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.206 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.933 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ptp . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.896 0.379 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -104.22 41.56 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.14 90.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.569 HG12 ' HB3' ' A' ' 8' ' ' TRP . 11.4 tt -139.17 163.08 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.024 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.572 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 5.3 m-20 -90.64 138.38 26.65 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.013 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -42.72 -27.53 0.87 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.801 2.334 . . . . 0.0 113.299 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -61.95 -16.96 55.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.73 0.3 . . . . 0.0 110.969 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.572 ' HD1' ' O ' ' A' ' 5' ' ' ASN . 13.8 p-90 -70.44 -51.47 29.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.381 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.55 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.35 -34.49 76.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.181 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.6 ttmt -67.15 -17.2 64.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.477 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -100.42 -1.6 35.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.581 0.229 . . . . 0.0 111.269 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.492 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 16.6 mt -124.24 109.9 29.03 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.202 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.04 130.61 31.43 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.483 2.122 . . . . 0.0 112.216 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.3 t -68.02 137.02 54.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.881 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -52.78 -22.97 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.584 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -61.66 -57.04 13.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.041 0.448 . . . . 0.0 110.128 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.423 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.2 mm -67.66 -29.17 44.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.841 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.2 m -78.82 -41.55 29.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.197 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.488 HG21 ' CD2' ' A' ' 20' ' ' TYR . 2.2 mt -97.02 -54.54 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.925 0.393 . . . . 0.0 111.867 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.488 ' CD2' HG21 ' A' ' 19' ' ' ILE . 3.3 m-85 -85.47 -12.1 52.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.971 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.93 6.81 57.65 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.284 -0.96 . . . . 0.0 111.782 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -160.27 143.24 13.51 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.575 0.226 . . . . 0.0 110.53 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 17.6 t -120.85 80.22 1.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.565 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.22 -22.61 30.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.501 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -2.59 56.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.927 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.3 tm-20 -53.7 -34.17 57.91 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.758 0.313 . . . . 0.0 110.432 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.19 -11.86 61.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.691 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -99.11 179.05 4.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.671 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.78 25.79 0.11 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.742 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.525 ' H ' ' C ' ' A' ' 28' ' ' GLU . 6.3 t -66.33 133.03 94.42 Favored Pre-proline 0 N--CA 1.457 -0.077 0 CA-C-N 117.599 0.699 . . . . 0.0 110.714 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 95.3 Cg_endo -82.05 148.14 15.1 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.363 2.042 . . . . 0.0 112.326 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.555 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 26.2 m-85 108.53 154.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.951 0.901 . . . . 0.0 110.91 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 47.3 tptt -87.09 99.99 12.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.443 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.473 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 2.2 m80 -95.63 79.0 3.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.654 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.4 p -77.11 128.57 34.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.49 176.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -143.64 -48.0 0.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.17 86.1 4.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.7 -43.5 2.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.89 -46.99 5.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.104 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.846 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.89 0.376 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -125.77 -42.93 1.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.948 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -85.98 145.65 27.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.988 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.413 ' HB ' ' CD1' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -116.8 101.36 12.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.455 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 16.7 t-20 -72.03 139.16 82.27 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.213 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -42.76 -24.77 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.54 2.16 . . . . 0.0 112.856 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -61.32 -24.82 66.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.311 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.531 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.0 p-90 -71.93 -52.23 18.23 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.796 0.332 . . . . 0.0 110.97 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.531 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -63.23 -38.76 92.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.174 0.511 . . . . 0.0 110.893 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.415 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -68.46 -13.37 62.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.356 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.39 -3.31 31.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.781 0.324 . . . . 0.0 111.021 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.516 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 5.8 mt -124.35 109.17 29.09 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.54 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.66 130.62 23.87 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.644 2.229 . . . . 0.0 112.914 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.2 t -65.9 136.87 56.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.716 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -52.77 -25.36 11.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.837 0.351 . . . . 0.0 110.684 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -63.42 -53.43 52.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.172 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.427 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 10.9 mm -68.32 -29.31 43.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.554 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.8 m -78.95 -40.67 31.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.112 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.476 HG21 ' CD1' ' A' ' 20' ' ' TYR . 1.6 mp -96.85 -54.64 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 111.934 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.476 ' CD1' HG21 ' A' ' 19' ' ' ILE . 2.9 m-85 -85.32 -13.11 50.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.949 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.9 6.96 61.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.098 -1.048 . . . . 0.0 111.614 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.423 ' CE1' ' HG3' ' A' ' 24' ' ' LYS . 9.2 p90 -160.19 143.3 13.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.599 0.238 . . . . 0.0 110.45 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.0 t -120.67 80.55 1.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.387 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.423 ' HG3' ' CE1' ' A' ' 22' ' ' TYR . 5.8 mtmm -56.22 -22.11 27.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.771 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.75 10.17 27.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.423 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -59.12 -34.52 72.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.876 0.369 . . . . 0.0 110.124 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -69.48 -12.64 61.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.565 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.566 ' C ' ' H ' ' A' ' 30' ' ' CYS . 2.0 mt-10 -94.12 179.39 5.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.69 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.74 14.47 0.02 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.746 -0.74 . . . . 0.0 114.109 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.566 ' H ' ' C ' ' A' ' 28' ' ' GLU . 1.5 t -66.26 114.51 17.24 Favored Pre-proline 0 C--O 1.23 0.075 0 CA-C-N 118.028 0.914 . . . . 0.0 110.632 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 74.1 Cg_endo -75.67 158.65 39.48 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.279 1.986 . . . . 0.0 112.158 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.555 ' CB ' ' O ' ' A' ' 31' ' ' PRO . 28.0 m-85 105.68 154.28 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.95 0.9 . . . . 0.0 111.06 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.415 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 23.6 tptp -82.13 96.33 7.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.609 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.438 ' ND1' ' O ' ' A' ' 32' ' ' PHE . 9.0 m80 -89.25 79.3 7.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.827 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.95 160.65 17.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -98.12 33.28 2.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -143.14 -171.83 3.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.4 m -130.83 125.57 34.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 t -123.22 -43.69 2.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.16 140.43 49.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.153 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mtt . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.742 0.306 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -120.52 -41.13 2.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.34 101.7 9.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.582 HG12 ' HB3' ' A' ' 8' ' ' TRP . 14.8 tt -152.69 163.78 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.988 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.568 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -93.19 137.43 23.62 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.683 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -42.3 -28.2 0.88 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.112 2.542 . . . . 0.0 113.069 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -60.38 -19.12 54.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.935 0.397 . . . . 0.0 110.564 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.582 ' HB3' HG12 ' A' ' 4' ' ' ILE . 15.7 p-90 -65.34 -51.21 62.09 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.349 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.553 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.17 -35.12 77.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.135 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.412 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 1.2 ttmt -67.32 -18.74 65.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.214 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.69 -2.02 42.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.133 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.542 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 53.6 mt -124.2 126.37 25.56 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.94 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.39 130.58 13.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.526 2.151 . . . . 0.0 112.511 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t -67.18 136.84 55.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.782 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.3 mtp85 -52.81 -25.43 11.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.935 0.398 . . . . 0.0 110.5 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.43 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 5.0 m120 -63.71 -55.22 24.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.413 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 mm -64.87 -30.47 50.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.603 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.0 m -78.93 -43.27 25.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.561 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.501 HG21 ' CD2' ' A' ' 20' ' ' TYR . 2.1 mp -95.39 -53.42 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.501 ' CD2' HG21 ' A' ' 19' ' ' ILE . 3.0 m-85 -85.19 -12.08 53.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.944 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.96 7.82 51.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.203 -0.998 . . . . 0.0 111.657 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.411 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 10.2 p90 -160.3 143.12 13.39 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.5 t -120.7 80.15 1.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.698 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -56.4 -22.06 29.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.585 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -83.51 -5.37 59.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.076 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -53.61 -36.24 61.78 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 120.812 0.339 . . . . 0.0 110.383 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -15.79 63.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.294 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 30' ' ' CYS . 70.0 mt-10 -97.75 179.04 4.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.457 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.92 28.73 0.11 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.746 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.514 ' H ' ' C ' ' A' ' 28' ' ' GLU . 6.1 t -66.43 134.09 94.48 Favored Pre-proline 0 CA--C 1.528 0.097 0 CA-C-N 117.764 0.782 . . . . 0.0 110.628 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.553 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 89.5 Cg_endo -82.37 147.86 14.42 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.258 1.972 . . . . 0.0 112.338 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.553 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 26.5 m-85 107.81 155.61 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.978 0.911 . . . . 0.0 111.035 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.412 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -88.02 100.57 13.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.468 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.483 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 1.0 OUTLIER -98.26 78.85 2.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.338 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.3 m -123.28 156.0 36.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.138 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 59.98 161.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.934 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -118.19 92.09 3.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.21 32.49 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.845 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.93 122.94 4.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.899 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.83 -48.16 4.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.094 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.889 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.757 0.313 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -165.96 -43.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 109.07 17.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.762 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.594 HG12 ' HB3' ' A' ' 8' ' ' TRP . 14.3 tt -132.78 163.75 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.968 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.565 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 1.6 m-20 -91.86 137.53 25.32 Favored Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.941 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -42.62 -27.86 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.929 2.419 . . . . 0.0 113.284 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -64.44 -14.68 58.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.717 0.294 . . . . 0.0 110.967 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.594 ' HB3' HG12 ' A' ' 4' ' ' ILE . 14.3 p-90 -68.95 -51.27 41.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.0 0.428 . . . . 0.0 111.441 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.556 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.34 -33.48 74.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.323 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -67.5 -17.88 64.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.457 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.39 -1.03 39.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.192 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.515 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 9.4 mt -124.34 103.64 32.32 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.075 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.89 130.58 35.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.479 2.119 . . . . 0.0 112.366 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.7 t -65.48 136.73 56.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.881 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -52.88 -25.61 12.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.613 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -63.78 -52.98 57.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.121 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.422 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 14.5 mm -67.01 -31.23 52.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.522 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.4 m -78.97 -39.99 32.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.334 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.461 HG21 ' CD2' ' A' ' 20' ' ' TYR . 4.1 mt -96.69 -54.68 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.461 ' CD2' HG21 ' A' ' 19' ' ' ILE . 2.6 m-85 -85.47 -12.56 51.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.996 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.18 7.11 59.29 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.596 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.405 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 11.7 p90 -160.19 143.25 13.64 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.61 0.243 . . . . 0.0 110.57 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.6 t -120.86 80.2 1.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.805 0.336 . . . . 0.0 110.281 178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.2 -23.21 34.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.775 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 3.82 45.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -55.23 -36.15 65.69 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.818 0.342 . . . . 0.0 110.384 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -68.11 -13.2 62.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.407 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.555 ' C ' ' H ' ' A' ' 30' ' ' CYS . 3.7 mm-40 -94.38 179.14 5.39 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.592 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.09 20.24 0.06 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.798 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.555 ' H ' ' C ' ' A' ' 28' ' ' GLU . 2.6 t -66.32 121.17 75.42 Favored Pre-proline 0 C--O 1.231 0.086 0 CA-C-N 117.747 0.774 . . . . 0.0 110.769 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 72.6 Cg_endo -77.72 153.28 29.78 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.293 1.995 . . . . 0.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.555 ' CB ' ' O ' ' A' ' 31' ' ' PRO . 25.9 m-85 108.33 153.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.006 0.923 . . . . 0.0 111.104 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -85.1 96.66 9.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.339 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.47 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 3.8 m80 -89.56 79.03 6.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.672 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.1 p -72.33 159.6 33.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -118.31 42.51 2.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -107.9 142.26 38.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.24 160.35 40.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.839 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.9 101.1 9.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.6 157.53 24.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.135 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.7 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.951 179.892 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.824 0.345 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -126.96 68.93 1.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -73.1 95.25 2.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.82 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.537 HG12 ' HB3' ' A' ' 8' ' ' TRP . 9.5 tt -105.66 161.59 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.606 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 4.7 t-20 -90.75 136.71 27.55 Favored Pre-proline 0 N--CA 1.461 0.116 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.771 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -42.04 -25.99 0.45 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.087 2.525 . . . . 0.0 113.115 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.54 -18.34 51.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.769 0.318 . . . . 0.0 110.686 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.606 ' HD1' ' O ' ' A' ' 5' ' ' ASN . 16.3 p-90 -71.13 -51.64 23.87 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.232 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.555 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.79 -34.97 78.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.202 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -67.39 -13.73 62.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.549 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -105.88 0.85 26.27 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.42 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.495 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 11.7 mt -124.48 110.77 28.21 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 120.682 0.277 . . . . 0.0 111.121 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.03 130.67 33.51 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.562 2.174 . . . . 0.0 112.376 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.1 t -72.61 136.68 45.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.939 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.42 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 27.4 ptt180 -53.47 -21.5 6.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.07 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.425 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.0 OUTLIER -61.65 -57.24 12.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.056 0.455 . . . . 0.0 110.513 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.44 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -71.25 -25.83 25.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.773 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' A' ' 15' ' ' ARG . 2.0 m -78.87 -42.88 26.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.536 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.496 HG21 ' CD1' ' A' ' 20' ' ' TYR . 1.5 mp -96.44 -53.03 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 111.786 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.496 ' CD1' HG21 ' A' ' 19' ' ' ILE . 3.6 m-85 -85.28 -15.08 44.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.937 -178.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 72.85 5.5 64.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.81 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -160.33 142.36 12.82 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.1 t -120.85 78.6 1.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.603 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.4 -22.63 32.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.576 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.8 -2.14 53.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.112 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.494 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.7 tm-20 -53.54 -35.78 61.1 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.799 0.333 . . . . 0.0 110.449 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -68.51 -13.03 62.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.771 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.52 ' C ' ' H ' ' A' ' 30' ' ' CYS . 9.6 mp0 -98.4 179.06 4.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.689 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.23 27.47 0.1 OUTLIER Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.765 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.52 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.7 t -66.45 134.88 94.56 Favored Pre-proline 0 C--O 1.231 0.083 0 CA-C-N 117.752 0.776 . . . . 0.0 110.6 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.557 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 88.5 Cg_endo -82.4 146.31 13.77 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.35 2.034 . . . . 0.0 112.083 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.557 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 27.6 m-85 106.56 157.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.839 0.856 . . . . 0.0 111.004 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -88.47 105.78 17.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.599 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.494 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 0.8 OUTLIER -105.13 79.08 1.45 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.561 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -110.89 145.32 38.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -170.59 1.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.833 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -85.2 103.27 14.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.5 m -84.85 89.33 7.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.26 -48.17 2.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.27 32.21 3.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.081 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.948 179.982 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ptp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.849 0.357 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -175.56 -40.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.2 pttm -99.01 116.53 31.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.943 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.424 HG23 ' CG ' ' A' ' 8' ' ' TRP . 0.4 OUTLIER -127.99 101.9 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.031 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -76.77 142.61 70.08 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.229 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -42.93 -24.55 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.557 2.171 . . . . 0.0 112.981 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -65.56 -22.44 66.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.523 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.53 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 7.4 p-90 -68.19 -52.17 37.38 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.798 0.333 . . . . 0.0 110.997 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.53 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -63.54 -38.44 91.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.046 0.45 . . . . 0.0 110.709 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.428 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -68.12 -14.2 62.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.31 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.24 -3.42 31.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.728 0.299 . . . . 0.0 110.968 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.578 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 63.8 mt -124.36 113.51 27.66 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.786 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.95 130.64 22.11 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.54 2.16 . . . . 0.0 112.756 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.3 t -67.81 136.93 54.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.662 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -22.8 6.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.786 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.423 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.3 m-80 -61.71 -57.03 13.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.032 0.444 . . . . 0.0 110.117 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.425 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.3 mm -66.73 -28.3 42.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.741 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -78.9 -43.06 25.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.227 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.528 HG21 ' CD1' ' A' ' 20' ' ' TYR . 1.4 mp -95.99 -54.08 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.863 0.363 . . . . 0.0 111.844 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.528 ' CD1' HG21 ' A' ' 19' ' ' ILE . 3.3 m-85 -85.17 -12.65 52.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.904 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.88 5.44 57.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.804 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -160.29 143.32 13.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 32.2 t -120.78 79.7 1.53 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.824 0.345 . . . . 0.0 110.647 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -56.34 -22.6 31.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.455 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.36 -1.47 53.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.064 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 1.3 tm-20 -52.95 -37.75 61.35 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.857 0.361 . . . . 0.0 110.485 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.51 -13.59 61.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.625 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.553 ' C ' ' H ' ' A' ' 30' ' ' CYS . 12.7 mt-10 -95.07 179.19 5.3 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.655 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.87 19.55 0.06 OUTLIER Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.776 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.553 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.0 t -66.28 124.22 87.45 Favored Pre-proline 0 C--O 1.232 0.133 0 CA-C-N 117.9 0.85 . . . . 0.0 110.823 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 88.5 Cg_endo -79.36 154.64 24.7 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.311 2.008 . . . . 0.0 112.295 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CE1' ' HB ' ' A' ' 12' ' ' ILE . 26.4 m-85 106.89 153.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.988 0.915 . . . . 0.0 111.029 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.428 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 11.3 tptt -84.28 96.34 8.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.242 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.43 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 5.3 m80 -89.86 79.08 6.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.688 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.9 p -89.05 100.6 13.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.46 -27.92 9.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -56.98 101.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.94 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.0 m -163.88 78.94 0.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.2 t -62.75 152.86 34.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 59.78 81.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.099 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mtp . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.858 0.361 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -108.75 27.4 9.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.38 112.99 2.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.65 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.49 ' CG1' ' HB3' ' A' ' 8' ' ' TRP . 8.2 tp -152.62 154.57 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.226 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.64 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 1.5 m-20 -91.17 145.04 30.8 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.628 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -41.79 -23.73 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.185 2.59 . . . . 0.0 113.229 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.39 -21.74 26.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.666 0.269 . . . . 0.0 110.738 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.64 ' HD1' ' O ' ' A' ' 5' ' ' ASN . 18.3 p-90 -77.63 -49.76 13.9 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.035 0.445 . . . . 0.0 111.268 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.527 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.15 -35.09 77.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.216 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.427 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -67.11 -18.46 65.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -96.01 -5.02 42.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.653 0.263 . . . . 0.0 111.242 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.464 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 6.3 mt -124.26 126.31 25.55 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.47 130.65 13.0 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.583 2.189 . . . . 0.0 112.725 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.414 ' HA ' ' CD1' ' A' ' 32' ' ' PHE . 49.7 t -63.36 136.79 57.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.791 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.2 mtp85 -53.02 -25.85 13.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.914 0.387 . . . . 0.0 110.287 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.435 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 3.7 m120 -64.66 -52.92 54.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.328 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.3 mm -67.21 -30.7 50.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.618 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 m -78.97 -44.92 21.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.379 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.632 HG23 ' CD1' ' A' ' 20' ' ' TYR . 2.0 mp -95.59 -49.79 12.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.632 ' CD1' HG23 ' A' ' 19' ' ' ILE . 4.3 m-85 -85.06 -15.47 43.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.523 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.62 7.21 60.76 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.345 -0.931 . . . . 0.0 111.481 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -160.56 143.72 13.36 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 122.39 0.276 . . . . 0.0 110.501 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.4 t -120.99 80.48 1.64 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.754 0.311 . . . . 0.0 110.266 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.19 -22.77 31.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.821 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.02 4.18 49.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.1 tm-20 -55.92 -32.5 63.84 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.852 0.358 . . . . 0.0 110.191 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -71.55 -11.04 60.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.615 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.531 ' C ' ' H ' ' A' ' 30' ' ' CYS . 2.6 mt-10 -98.53 179.06 4.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.773 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.06 24.59 0.09 OUTLIER Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.859 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.531 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.5 t -66.41 132.11 94.28 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 117.763 0.781 . . . . 0.0 110.654 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.557 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 88.1 Cg_endo -82.49 148.65 14.46 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.435 2.09 . . . . 0.0 112.663 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.557 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 26.1 m-85 109.06 154.37 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.094 0.957 . . . . 0.0 111.091 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.427 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 2.9 tppt? -86.35 98.01 10.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.243 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.467 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 2.9 m80 -91.42 78.84 5.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.579 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -91.73 126.58 36.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.835 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -62.08 -175.77 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -108.84 -29.26 8.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.977 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.25 176.13 10.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.0 p -108.51 119.51 39.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.24 31.19 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.126 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 42.0 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.925 -179.98 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttt . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.805 0.336 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.4 -77.98 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.832 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -77.14 119.92 21.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.931 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.41 HG23 ' CG ' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -131.49 105.92 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.062 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -78.61 140.69 59.66 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.027 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.12 -24.27 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.613 2.209 . . . . 0.0 113.114 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -16.34 62.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.831 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.525 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.4 p-90 -67.25 -52.07 45.44 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.879 0.371 . . . . 0.0 110.919 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.525 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -63.94 -38.41 91.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.095 0.474 . . . . 0.0 110.842 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -68.07 -12.19 60.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.408 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.08 -3.5 25.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.677 0.275 . . . . 0.0 111.103 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.497 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 9.0 mt -124.19 108.15 29.91 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.143 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.86 130.55 33.38 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.411 2.074 . . . . 0.0 112.348 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.5 t -66.44 136.82 56.27 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.817 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -53.02 -23.58 7.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.803 0.335 . . . . 0.0 110.624 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -61.06 -54.08 49.13 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 110.297 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.405 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.7 mm -70.99 -29.16 35.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.765 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -78.74 -38.93 37.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.944 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.463 HG21 ' CD1' ' A' ' 20' ' ' TYR . 5.9 mt -99.84 -54.7 6.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.863 0.363 . . . . 0.0 111.963 -178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.463 ' CD1' HG21 ' A' ' 19' ' ' ILE . 3.8 m-85 -85.58 -11.98 52.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.003 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.18 7.33 59.72 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.722 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -160.3 146.87 15.69 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.1 t -120.9 80.45 1.64 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.753 0.311 . . . . 0.0 110.684 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -56.37 -21.97 28.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.704 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 -2.99 58.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.067 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.443 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.7 tm-20 -53.65 -35.82 61.43 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.765 0.316 . . . . 0.0 110.365 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.11 -16.04 63.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.391 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 30' ' ' CYS . 15.3 mt-10 -96.83 179.15 5.06 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.56 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 27.4 0.1 OUTLIER Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.754 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.523 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.5 t -66.51 130.07 94.14 Favored Pre-proline 0 C--O 1.231 0.129 0 CA-C-N 117.738 0.769 . . . . 0.0 110.603 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.56 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 92.8 Cg_endo -81.13 150.12 17.64 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.382 2.055 . . . . 0.0 112.42 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.56 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 26.6 m-85 107.51 156.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.995 0.918 . . . . 0.0 111.042 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.437 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 7.4 tptp -87.14 100.06 12.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.445 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.466 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 2.0 m80 -96.35 78.99 3.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.673 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.7 p -117.6 106.22 12.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -164.42 150.24 10.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -136.8 104.66 5.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.27 83.76 3.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.783 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.2 p -140.93 -67.69 0.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.72 173.35 11.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.97 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 mtm . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.793 0.33 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -107.76 -31.67 7.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 mttm -89.8 123.07 33.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.419 HG21 ' CG ' ' A' ' 8' ' ' TRP . 0.2 OUTLIER -144.5 102.06 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.428 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 8.1 m-20 -76.41 145.12 75.4 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.244 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -42.82 -24.76 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.526 2.15 . . . . 0.0 112.83 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.91 -26.35 67.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.321 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.506 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 7.9 p-90 -69.54 -51.91 31.15 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.814 0.34 . . . . 0.0 110.933 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.506 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.52 -40.58 97.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.013 0.435 . . . . 0.0 110.889 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.41 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 2.7 ttmt -67.7 -13.41 62.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.24 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -99.31 -5.56 29.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.64 0.257 . . . . 0.0 111.092 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.477 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 2.5 mp -124.24 117.0 26.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.645 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.92 130.55 19.35 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.48 2.12 . . . . 0.0 112.779 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.98 136.7 56.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.652 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.02 -21.99 5.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.752 0.31 . . . . 0.0 110.737 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -62.37 -56.75 15.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.917 0.389 . . . . 0.0 110.117 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.415 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.9 mm -67.72 -28.18 40.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.774 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 m -78.81 -42.76 26.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.167 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.529 HG21 ' CD1' ' A' ' 20' ' ' TYR . 1.6 mp -96.61 -54.22 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.357 . . . . 0.0 111.872 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.529 ' CD1' HG21 ' A' ' 19' ' ' ILE . 3.5 m-85 -85.28 -12.09 53.22 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.058 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.12 6.56 57.38 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.731 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -160.23 144.47 14.34 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.569 0.223 . . . . 0.0 110.445 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.7 t -120.82 80.74 1.67 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.754 0.311 . . . . 0.0 110.657 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -22.83 31.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.482 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -1.45 56.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.996 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.438 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 3.3 tm-20 -53.75 -35.25 61.04 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.813 0.34 . . . . 0.0 110.45 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 mtpp -68.84 -13.06 62.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.58 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.54 ' C ' ' H ' ' A' ' 30' ' ' CYS . 16.4 mm-40 -96.53 179.17 5.09 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.655 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.2 22.51 0.08 OUTLIER Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.858 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.54 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.2 t -66.38 128.78 94.03 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 117.735 0.767 . . . . 0.0 110.636 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 90.0 Cg_endo -81.87 152.39 16.86 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.44 2.094 . . . . 0.0 112.592 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.558 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 26.7 m-85 107.48 154.08 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.079 0.952 . . . . 0.0 111.07 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.41 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -84.38 96.53 9.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.295 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.438 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 5.3 m80 -89.87 79.12 6.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.793 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.5 p -123.52 104.78 9.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -130.66 -48.85 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -110.24 174.65 5.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.58 -178.72 5.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.39 152.58 24.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.904 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.96 164.45 30.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.88 -179.956 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.804 0.335 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -98.19 -34.78 10.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -100.75 110.04 22.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.401 ' HB ' ' CD1' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -131.1 105.97 11.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.035 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.444 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 6.7 t30 -74.49 139.83 75.06 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.297 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -42.69 -24.89 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.55 2.167 . . . . 0.0 112.918 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -24.09 64.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.295 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.505 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 7.9 p-90 -73.71 -51.76 15.51 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.805 0.336 . . . . 0.0 111.133 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.505 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.45 -39.71 94.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.972 0.415 . . . . 0.0 110.995 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.434 ' CG ' ' HB2' ' A' ' 33' ' ' LYS . 1.1 ttmm -67.16 -13.43 61.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.325 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.81 -7.02 25.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.711 0.291 . . . . 0.0 111.225 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.453 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 2.6 mp -124.19 124.41 25.88 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.899 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -73.06 130.97 16.09 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.675 2.25 . . . . 0.0 112.712 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -65.81 136.67 56.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.826 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -53.23 -22.23 6.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.667 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.423 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.6 m-80 -61.67 -57.07 13.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.939 0.4 . . . . 0.0 110.251 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mm -66.97 -28.98 44.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.883 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 m -78.83 -42.35 27.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.247 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.509 HG21 ' CD2' ' A' ' 20' ' ' TYR . 2.1 mp -96.84 -54.43 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.952 0.406 . . . . 0.0 111.921 -178.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.509 ' CD2' HG21 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.27 -11.32 55.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.109 -178.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.14 6.67 54.45 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.731 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -160.23 145.49 14.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.536 0.207 . . . . 0.0 110.467 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.8 t -120.86 80.39 1.63 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.84 0.353 . . . . 0.0 110.537 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -56.35 -21.77 26.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.33 -0.91 57.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.247 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -54.26 -36.35 63.5 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.808 0.337 . . . . 0.0 110.38 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -66.53 -14.91 62.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.509 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.531 ' C ' ' H ' ' A' ' 30' ' ' CYS . 4.9 mt-10 -96.21 179.12 5.16 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.433 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.92 26.05 0.09 OUTLIER Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.535 -0.841 . . . . 0.0 113.749 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.531 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.7 t -66.31 134.08 94.6 Favored Pre-proline 0 C--O 1.231 0.124 0 CA-C-N 117.717 0.758 . . . . 0.0 110.539 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 88.9 Cg_endo -83.46 148.14 12.73 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.455 2.103 . . . . 0.0 112.627 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.558 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 25.9 m-85 108.97 154.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.1 0.96 . . . . 0.0 111.1 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.434 ' HB2' ' CG ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -87.55 96.46 10.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.129 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.459 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 2.0 m80 -90.9 78.91 5.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.631 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -89.19 100.96 13.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.68 88.2 3.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -108.15 111.07 22.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.952 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.58 96.31 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.942 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.89 37.59 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.915 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.19 31.58 4.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.129 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.908 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.803 0.335 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -110.69 -48.71 3.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.827 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -93.36 96.13 9.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.719 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.74 106.29 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.969 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.406 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -79.29 147.53 68.97 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.207 179.417 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -42.88 -24.18 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.604 2.203 . . . . 0.0 112.862 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.25 -27.01 69.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.441 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.521 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.8 p-90 -64.77 -52.04 59.03 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -64.72 -36.0 82.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.075 0.464 . . . . 0.0 110.651 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.636 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -68.39 -13.89 62.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.288 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -102.3 -1.97 29.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.748 0.308 . . . . 0.0 110.852 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.55 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 65.1 mt -124.57 116.6 26.58 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.833 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.84 130.51 20.62 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.45 2.1 . . . . 0.0 112.596 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.4 t -66.73 137.05 56.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.852 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.433 ' HB3' HD12 ' A' ' 19' ' ' ILE . 72.1 mtt180 -52.97 -22.41 5.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.74 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.41 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.8 m-80 -63.58 -57.15 11.03 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 110.372 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.404 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.2 mm -65.52 -27.72 42.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.496 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.411 HG23 HD11 ' A' ' 19' ' ' ILE . 18.0 m -78.91 -44.78 21.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.192 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.511 HG21 ' CD1' ' A' ' 20' ' ' TYR . 2.3 mp -95.36 -54.62 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.965 0.412 . . . . 0.0 111.99 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.511 ' CD1' HG21 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.32 -9.98 56.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.028 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 66.83 7.48 42.67 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.279 -0.963 . . . . 0.0 111.81 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 10.2 p90 -160.35 144.17 13.96 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.1 t -120.81 80.26 1.61 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.777 0.323 . . . . 0.0 110.543 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.38 -22.76 33.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.68 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.59 -2.91 58.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.051 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -54.06 -36.08 62.73 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.885 0.374 . . . . 0.0 110.266 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -65.83 -15.79 63.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.41 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 30' ' ' CYS . 33.5 mt-10 -96.65 179.14 5.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.561 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.37 25.72 0.08 OUTLIER Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.888 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.527 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.8 t -66.34 130.31 94.21 Favored Pre-proline 0 CA--C 1.527 0.069 0 CA-C-N 117.874 0.837 . . . . 0.0 110.622 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 96.6 Cg_endo -79.87 150.73 21.17 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.32 2.013 . . . . 0.0 112.379 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.55 ' CE2' ' HB ' ' A' ' 12' ' ' ILE . 26.6 m-85 106.55 154.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.957 0.903 . . . . 0.0 111.105 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.636 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -87.73 96.56 10.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.228 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.459 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 1.9 m80 -91.29 79.19 5.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.658 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.0 m -59.55 156.23 13.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.913 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.95 102.98 4.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.935 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -62.75 -31.71 72.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.827 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.11 86.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -110.18 -54.21 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.946 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.92 -70.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.069 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.926 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.76 0.314 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -142.19 -46.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.872 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.57 127.4 41.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.783 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.417 HG23 ' CG ' ' A' ' 8' ' ' TRP . 0.2 OUTLIER -120.9 113.35 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.033 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.24 144.31 50.17 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.288 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -42.99 -24.99 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.607 2.205 . . . . 0.0 112.948 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -66.18 -20.04 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.567 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.52 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 7.6 p-90 -67.92 -52.05 40.77 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.852 0.358 . . . . 0.0 111.035 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.52 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.87 -39.87 95.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.082 0.468 . . . . 0.0 110.96 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.52 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -67.77 -12.27 60.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.414 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -101.64 -5.01 25.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.676 0.274 . . . . 0.0 111.163 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.484 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 8.2 mt -124.32 123.72 25.88 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.829 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.08 130.72 16.96 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.496 2.131 . . . . 0.0 112.692 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.22 137.0 55.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.927 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.9 mtt85 -53.09 -22.29 5.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.806 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.427 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.6 m-80 -62.86 -57.04 12.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 110.228 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.408 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.1 mm -66.1 -27.65 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.546 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.7 m -78.9 -45.77 19.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.205 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.517 HG21 ' CD2' ' A' ' 20' ' ' TYR . 2.2 mp -94.11 -54.39 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.935 0.398 . . . . 0.0 111.939 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.517 ' CD2' HG21 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.2 -11.34 55.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.998 -178.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 68.9 6.23 50.89 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.808 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -160.34 143.36 13.47 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.6 t -120.76 79.9 1.56 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.734 0.302 . . . . 0.0 110.5 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -56.21 -23.26 34.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.698 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.39 -1.06 52.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.0 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.452 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -53.51 -36.19 61.47 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.847 0.356 . . . . 0.0 110.393 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -68.54 -12.84 61.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.668 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.531 ' C ' ' H ' ' A' ' 30' ' ' CYS . 7.4 mt-10 -96.94 179.04 5.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 25.49 0.09 OUTLIER Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.708 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.531 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.1 t -66.31 133.21 94.47 Favored Pre-proline 0 C--O 1.231 0.108 0 CA-C-N 117.766 0.783 . . . . 0.0 110.687 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.56 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 87.2 Cg_endo -82.84 147.51 13.46 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.404 2.069 . . . . 0.0 112.258 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.56 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 26.7 m-85 108.01 156.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.011 0.924 . . . . 0.0 110.969 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 6.2 tmmm? -88.52 105.48 17.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.076 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.491 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 1.6 m80 -101.63 78.81 1.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.569 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.5 p -59.76 134.25 56.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -97.08 110.77 23.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.6 t30 62.39 121.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.028 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 m -109.91 150.14 28.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.8 p -122.03 -43.38 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.81 120.2 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.949 179.984 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttm . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.831 0.348 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -63.19 -39.06 93.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -84.47 108.09 17.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.727 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.415 HG23 ' CG ' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -126.51 120.94 57.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.186 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -80.74 139.52 50.57 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.998 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -42.98 -24.81 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.503 2.135 . . . . 0.0 113.013 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.65 -20.77 66.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.599 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.517 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.0 p-90 -66.34 -51.91 52.42 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.817 0.341 . . . . 0.0 110.996 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.517 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.82 -39.54 94.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.076 0.465 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.411 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 2.2 ttmt -67.77 -13.48 62.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.293 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.94 -5.29 28.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.675 0.274 . . . . 0.0 111.122 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.483 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 2.5 mp -124.17 117.08 27.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.707 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.0 130.49 19.14 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.568 2.179 . . . . 0.0 112.774 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.9 t -65.29 136.91 57.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.641 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.9 mtm105 -53.12 -23.18 7.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 0.0 110.629 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.412 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.4 m-80 -61.53 -55.29 32.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.939 0.4 . . . . 0.0 110.199 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.411 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.8 mm -69.29 -28.37 38.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.834 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 m -78.77 -42.21 28.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.053 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.519 HG21 ' CD1' ' A' ' 20' ' ' TYR . 1.4 mp -97.02 -54.12 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 111.872 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.519 ' CD1' HG21 ' A' ' 19' ' ' ILE . 3.5 m-85 -85.37 -12.25 52.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.001 -178.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.45 6.11 57.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.874 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -160.28 144.79 14.46 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.53 0.205 . . . . 0.0 110.475 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.2 t -120.99 79.88 1.57 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.813 0.34 . . . . 0.0 110.674 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -56.4 -21.37 24.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.752 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.16 -1.12 57.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.341 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -53.72 -36.81 62.66 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.856 0.36 . . . . 0.0 110.42 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -65.69 -15.39 62.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.332 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.545 ' C ' ' H ' ' A' ' 30' ' ' CYS . 9.3 mm-40 -94.1 179.34 5.35 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.516 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.36 21.28 0.06 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.833 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.545 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.4 t -66.22 127.45 93.25 Favored Pre-proline 0 C--O 1.231 0.098 0 CA-C-N 117.901 0.85 . . . . 0.0 110.723 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 87.3 Cg_endo -82.08 152.97 16.56 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.43 2.087 . . . . 0.0 112.512 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.558 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 27.0 m-85 107.77 154.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.942 0.897 . . . . 0.0 111.128 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.411 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 17.4 tptp -85.23 96.41 9.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.262 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.444 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 3.9 m80 -89.82 79.08 6.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.681 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.71 145.54 29.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.25 152.67 32.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.951 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.57 115.72 4.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 t -112.92 154.88 25.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.983 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 m -63.63 -19.09 64.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.147 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 67.84 95.22 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.872 0.368 . . . . 0.0 111.134 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.3 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.87 -179.969 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mtm . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.828 0.347 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -137.81 -47.58 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.29 124.94 49.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.658 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.492 ' CG1' ' HB3' ' A' ' 8' ' ' TRP . 7.9 tp -123.12 154.54 28.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.16 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.602 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 2.6 t-20 -87.98 141.78 31.65 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.928 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -42.49 -25.73 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.738 2.292 . . . . 0.0 113.247 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -58.35 -20.41 43.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.793 0.33 . . . . 0.0 110.765 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.602 ' HD1' ' O ' ' A' ' 5' ' ' ASN . 13.0 p-90 -74.29 -51.11 16.21 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.012 0.434 . . . . 0.0 111.295 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.548 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.32 -33.5 74.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.244 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -67.17 -19.47 65.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.356 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -98.32 -0.59 43.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.167 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.537 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 81.4 mt -124.36 103.79 32.15 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.057 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.59 130.5 35.67 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.428 2.085 . . . . 0.0 112.161 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.5 t -65.6 136.65 56.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.815 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -53.16 -25.6 14.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.337 . . . . 0.0 110.514 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.415 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 5.5 m120 -63.12 -53.23 56.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.31 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.413 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 13.1 mm -67.15 -30.59 49.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.612 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 m -78.98 -41.46 29.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.251 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.467 HG21 ' CD2' ' A' ' 20' ' ' TYR . 1.6 mp -96.34 -54.3 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.925 0.393 . . . . 0.0 111.949 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.467 ' CD2' HG21 ' A' ' 19' ' ' ILE . 2.8 m-85 -85.24 -12.33 52.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.036 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.38 7.47 57.64 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.676 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 22' ' ' TYR . 9.0 p90 -160.29 143.87 13.86 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 120.609 0.242 . . . . 0.0 110.468 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.8 t -120.65 80.76 1.67 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.791 0.329 . . . . 0.0 110.27 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -22.06 27.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.103 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.76 2.13 55.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.171 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -55.0 -36.55 65.54 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.857 0.36 . . . . 0.0 110.301 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -66.54 -14.41 62.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.419 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.548 ' C ' ' H ' ' A' ' 30' ' ' CYS . 4.9 mm-40 -94.42 179.19 5.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.602 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.82 22.05 0.07 OUTLIER Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.752 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.548 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.4 t -66.38 123.74 86.29 Favored Pre-proline 0 CA--C 1.527 0.073 0 CA-C-N 117.82 0.81 . . . . 0.0 110.687 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 71.8 Cg_endo -77.62 151.7 28.88 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.195 1.93 . . . . 0.0 112.249 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.551 ' CB ' ' O ' ' A' ' 31' ' ' PRO . 25.6 m-85 109.45 153.02 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.062 0.945 . . . . 0.0 111.049 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -86.49 96.47 10.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.247 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.458 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 3.2 m80 -89.94 79.16 6.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.084 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.4 p -112.89 119.39 37.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.773 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -94.51 -56.94 2.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -152.3 58.98 0.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.9 m -123.68 33.03 5.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 t -157.38 145.96 19.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.09 167.86 10.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.7 p . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.895 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 mtp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.849 0.357 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -64.73 -31.02 72.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -99.55 100.63 11.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.411 ' HB ' ' NE1' ' A' ' 8' ' ' TRP . 0.2 OUTLIER -136.42 106.73 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.69 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.462 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 83.0 m-20 -72.89 138.72 79.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.385 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -42.68 -24.69 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.522 2.148 . . . . 0.0 112.887 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -57.92 -23.44 53.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.214 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.528 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.0 p-90 -78.87 -51.99 8.93 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 120.808 0.337 . . . . 0.0 110.951 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.528 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -63.34 -37.73 88.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 0.0 110.842 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -67.92 -13.59 62.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.419 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.47 -3.6 28.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 111.14 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.492 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 6.7 mt -124.19 116.35 27.18 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.765 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 131.6 21.66 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.655 2.237 . . . . 0.0 112.859 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.1 t -67.12 136.81 55.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.777 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.3 mtt-85 -52.93 -25.6 12.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 0.0 110.568 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.427 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 5.1 m120 -64.36 -52.78 56.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.289 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.405 HD12 ' HB3' ' A' ' 34' ' ' HIS . 14.9 mm -67.77 -31.27 51.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.613 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.1 m -78.92 -40.8 31.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.426 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.635 HG23 ' CD1' ' A' ' 20' ' ' TYR . 3.1 mp -98.43 -51.47 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.635 ' CD1' HG23 ' A' ' 19' ' ' ILE . 3.2 m-85 -85.14 -14.87 45.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.439 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.38 7.41 63.91 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.472 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -160.48 144.54 13.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.443 0.297 . . . . 0.0 110.344 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.3 t -120.77 80.71 1.66 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.349 178.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.19 -22.7 30.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.846 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 9.27 32.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.454 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -58.79 -36.4 74.39 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.9 0.381 . . . . 0.0 110.202 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -68.65 -12.94 61.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.593 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.566 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.3 OUTLIER -93.91 179.28 5.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.33 19.53 0.05 OUTLIER Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.846 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.566 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.0 t -66.3 124.38 87.91 Favored Pre-proline 0 C--O 1.231 0.124 0 CA-C-N 117.885 0.843 . . . . 0.0 110.619 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.553 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 98.2 Cg_endo -80.0 153.6 22.26 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.357 2.038 . . . . 0.0 112.445 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.553 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 26.8 m-85 107.31 153.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.03 0.932 . . . . 0.0 111.0 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -84.46 96.42 9.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.359 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.454 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 4.3 m80 -90.11 79.07 6.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.68 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -74.84 159.19 32.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.868 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 t0 61.43 162.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.39 154.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.33 -67.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.828 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.68 103.18 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.43 -173.28 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.026 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.887 -179.983 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 mtm . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.781 0.324 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -176.72 -39.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.43 94.46 7.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' A' ' 8' ' ' TRP . 0.3 OUTLIER -131.87 118.57 38.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.976 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -78.19 136.24 61.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.232 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -42.83 -24.93 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.627 2.218 . . . . 0.0 113.018 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -67.35 -14.63 63.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.717 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.523 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 7.7 p-90 -75.57 -52.06 11.47 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.824 0.345 . . . . 0.0 111.151 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.523 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -63.3 -38.59 91.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.085 0.469 . . . . 0.0 110.821 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 1.5 tmmt? -67.58 -13.03 61.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.45 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -102.02 -3.99 26.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.723 0.296 . . . . 0.0 111.245 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.467 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 4.8 mt -124.29 122.37 26.02 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.871 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.79 130.68 17.24 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.64 2.227 . . . . 0.0 112.8 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.3 t -67.2 137.05 55.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.925 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.9 mtt85 -52.81 -24.85 9.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.69 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.42 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 6.1 m120 -63.41 -55.47 24.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.979 0.418 . . . . 0.0 110.325 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.411 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 10.0 mm -65.49 -29.26 46.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.6 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.1 m -78.93 -42.47 26.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.361 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.487 HG21 ' CD1' ' A' ' 20' ' ' TYR . 1.7 mp -96.17 -53.93 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.487 ' CD1' HG21 ' A' ' 19' ' ' ILE . 3.0 m-85 -85.15 -12.52 52.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.902 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.63 6.78 56.59 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.768 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -160.26 142.01 12.67 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.0 t -120.77 79.11 1.45 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.672 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.0 tptt -56.74 -20.43 22.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.827 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -85.19 -2.74 58.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.337 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.411 ' CG ' ' HB2' ' A' ' 34' ' ' HIS . 14.8 tt0 -53.9 -36.42 62.68 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.778 0.323 . . . . 0.0 110.381 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.54 -15.79 63.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.051 0.453 . . . . 0.0 110.273 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.537 ' C ' ' H ' ' A' ' 30' ' ' CYS . 10.2 mt-10 -95.13 179.14 5.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.479 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.12 23.96 0.08 OUTLIER Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.889 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.537 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.6 t -66.27 132.6 94.44 Favored Pre-proline 0 C--O 1.231 0.128 0 CA-C-N 117.868 0.834 . . . . 0.0 110.718 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.554 ' O ' ' HB2' ' A' ' 32' ' ' PHE . 86.3 Cg_endo -83.41 149.31 13.09 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.41 2.073 . . . . 0.0 112.451 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.554 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 26.3 m-85 107.99 155.18 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.989 0.916 . . . . 0.0 111.0 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 12.6 tptt -87.54 97.6 10.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.391 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.464 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 1.4 m80 -94.26 79.05 3.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.531 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 85.3 p -88.04 111.37 21.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.975 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.04 74.54 0.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -173.25 147.13 1.5 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.91 65.89 6.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.7 m -73.26 155.4 39.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.818 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.35 -47.01 7.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.085 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.906 179.954 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.811 0.338 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.54 -47.32 0.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -79.95 103.43 9.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.723 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.495 ' CG1' ' HB3' ' A' ' 8' ' ' TRP . 8.4 tp -139.06 154.72 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.163 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.633 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 1.2 t30 -89.65 140.59 28.12 Favored Pre-proline 0 C--N 1.333 -0.14 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.497 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -41.94 -24.48 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.094 2.529 . . . . 0.0 113.192 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -58.86 -20.31 49.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.821 0.343 . . . . 0.0 110.728 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.633 ' HD1' ' O ' ' A' ' 5' ' ' ASN . 16.9 p-90 -73.63 -51.09 17.97 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-O 121.033 0.444 . . . . 0.0 111.226 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.552 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.43 -34.37 76.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.194 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.435 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.5 ttmt -67.32 -17.64 64.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.394 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.39 -1.04 39.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.613 0.244 . . . . 0.0 111.287 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.51 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 8.3 mt -124.33 105.53 30.99 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.686 0.279 . . . . 0.0 111.168 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.74 130.58 33.74 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.573 2.182 . . . . 0.0 112.439 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.9 t -67.69 136.96 55.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.836 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -53.04 -23.29 7.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.774 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.402 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.1 m-80 -61.11 -54.96 38.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.081 0.467 . . . . 0.0 110.116 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.438 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.1 mm -69.25 -28.5 38.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.881 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 m -78.86 -41.36 30.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.021 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.517 HG21 ' CD2' ' A' ' 20' ' ' TYR . 1.8 mp -97.06 -54.6 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.915 0.388 . . . . 0.0 111.738 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.517 ' CD2' HG21 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.25 -13.08 50.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.963 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 71.86 5.43 61.26 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.746 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -160.27 142.98 13.34 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.617 0.246 . . . . 0.0 110.53 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 37.5 t -120.82 79.53 1.51 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.459 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.42 -22.04 29.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.717 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.52 -1.66 56.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.401 ' CG ' ' HB2' ' A' ' 34' ' ' HIS . 14.2 tt0 -54.06 -35.55 62.15 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 120.727 0.299 . . . . 0.0 110.389 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.92 -15.95 63.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.421 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.548 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -95.19 179.35 5.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.561 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.48 21.11 0.05 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.653 -0.785 . . . . 0.0 114.133 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.548 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.8 t -66.2 124.25 87.46 Favored Pre-proline 0 C--O 1.231 0.111 0 CA-C-N 117.976 0.888 . . . . 0.0 110.598 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 86.3 Cg_endo -78.89 151.1 24.12 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.302 2.001 . . . . 0.0 112.471 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.55 ' CB ' ' O ' ' A' ' 31' ' ' PRO . 26.0 m-85 108.46 154.82 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.041 0.936 . . . . 0.0 111.034 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.435 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 15.9 tptt -86.0 99.55 11.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.293 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.461 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 3.0 m80 -93.96 79.07 4.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.731 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.3 151.4 26.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.903 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.03 159.4 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -126.04 -56.31 1.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.2 m -152.49 153.34 33.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.88 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.79 82.53 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.876 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.96 152.3 7.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.013 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.906 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.815 0.341 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -99.68 -35.16 9.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -89.7 118.07 29.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.2 107.59 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.979 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.426 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -75.67 142.27 73.55 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.314 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -42.84 -25.28 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.58 2.187 . . . . 0.0 112.845 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -59.33 -25.56 64.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.211 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.513 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 7.2 p-90 -72.29 -51.86 18.9 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.864 0.364 . . . . 0.0 110.891 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.513 ' N ' ' CG ' ' A' ' 8' ' ' TRP . . . -62.8 -38.0 88.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.04 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.425 ' CG ' ' HB2' ' A' ' 33' ' ' LYS . 1.8 ttmt -67.24 -14.99 63.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.348 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -100.33 -3.47 31.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.646 0.26 . . . . 0.0 111.134 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.513 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 55.5 mt -124.3 126.69 25.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.11 132.31 13.86 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.633 2.222 . . . . 0.0 112.907 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.0 t -70.65 136.85 49.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.641 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.3 mtp85 -53.21 -22.56 6.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.0 110.835 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.422 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.5 m-80 -61.68 -55.74 27.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.016 0.436 . . . . 0.0 110.185 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.411 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.9 mm -68.44 -28.82 41.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.836 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.5 m -78.64 -42.58 28.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.178 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.507 HG21 ' CD2' ' A' ' 20' ' ' TYR . 1.7 mp -96.57 -54.31 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.41 . . . . 0.0 111.863 -178.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.507 ' CD2' HG21 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.28 -12.06 53.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.063 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.93 6.31 55.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.163 -1.017 . . . . 0.0 111.759 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -160.18 146.6 15.72 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 21.8 t -120.8 81.05 1.71 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.575 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.3 -22.37 29.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.667 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.88 2.04 54.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.016 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.46 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -55.05 -35.16 64.19 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.806 0.336 . . . . 0.0 110.427 179.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -11.09 60.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.718 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.541 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -97.26 179.04 5.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.665 179.402 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.45 23.28 0.08 OUTLIER Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.81 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.541 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.5 t -66.36 131.35 94.26 Favored Pre-proline 0 C--O 1.23 0.054 0 CA-C-N 117.75 0.775 . . . . 0.0 110.714 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.556 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 94.8 Cg_endo -81.52 148.9 16.39 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.398 2.065 . . . . 0.0 112.25 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.556 ' CB ' ' O ' ' A' ' 31' ' ' PRO . 25.5 m-85 109.16 154.77 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.062 0.945 . . . . 0.0 111.056 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.425 ' HB2' ' CG ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -87.18 98.79 11.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.269 179.637 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.46 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 2.1 m80 -95.07 79.0 3.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.633 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -97.58 150.2 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.57 79.1 9.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.022 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -93.47 178.83 5.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.4 m -94.2 143.12 26.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.843 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 m -101.27 34.28 2.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.93 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.67 107.1 19.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.315 -0.85 . . . . 0.0 110.956 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.534 ' O ' HD12 ' A' ' 12' ' ' ILE . 7.7 p-90 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.789 0.328 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.715 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.33 -38.06 89.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.051 0.453 . . . . 0.0 110.875 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -67.76 -13.73 62.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.358 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.06 -3.91 28.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.698 0.285 . . . . 0.0 111.14 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 8' ' ' TRP . 4.8 mt -124.29 116.19 27.08 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.741 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 131.74 21.81 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.573 2.182 . . . . 0.0 112.787 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.37 136.86 55.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.735 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 mtt85 -52.92 -25.95 13.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.34 . . . . 0.0 110.576 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.403 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 5.7 m120 -63.53 -52.94 59.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.366 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 34' ' ' HIS . 13.7 mm -67.26 -31.12 51.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.632 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -79.01 -40.81 30.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.324 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.702 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.9 mp -96.38 -54.6 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.702 ' CD1' HG22 ' A' ' 19' ' ' ILE . 2.7 m-85 -85.24 -12.21 53.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.038 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 68.4 8.34 55.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.529 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.427 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 10.1 p90 -160.27 143.9 13.92 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.47 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 36.7 t -120.71 80.93 1.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.57 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -22.23 30.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.921 0.391 . . . . 0.0 110.525 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.9 -3.38 58.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.952 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.424 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -53.34 -36.88 61.8 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.805 0.336 . . . . 0.0 110.4 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -65.94 -15.47 63.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.494 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 30' ' ' CYS . 48.5 mt-10 -95.9 179.17 5.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.558 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.45 24.32 0.08 OUTLIER Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.727 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.502 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.9 t -66.34 127.31 93.22 Favored Pre-proline 0 C--O 1.231 0.088 0 CA-C-N 117.819 0.809 . . . . 0.0 110.597 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 92.1 Cg_endo -80.96 152.43 18.93 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.352 2.035 . . . . 0.0 112.541 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.715 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.2 m-85 107.5 154.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.965 0.906 . . . . 0.0 111.066 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -84.45 96.54 9.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.419 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.47 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 4.7 m80 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.703 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.611 ' O ' HD12 ' A' ' 12' ' ' ILE . 8.0 p-90 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.848 0.356 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.72 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.06 -38.43 91.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.023 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.415 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -67.59 -13.04 61.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.399 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -101.65 -4.09 27.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.756 0.312 . . . . 0.0 111.25 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 8' ' ' TRP . 3.9 mt -124.35 107.86 29.68 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.942 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.6 130.63 32.3 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.497 2.131 . . . . 0.0 112.386 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.2 t -66.46 136.77 56.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.8 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.44 ' HB3' HD13 ' A' ' 19' ' ' ILE . 13.9 mtt85 -53.15 -24.14 9.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.71 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.432 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.1 m-80 -60.48 -52.95 63.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.113 0.482 . . . . 0.0 110.094 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.433 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.2 mm -71.34 -29.75 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.015 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.599 HG22 HD12 ' A' ' 19' ' ' ILE . 1.6 m -78.72 -38.32 39.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.007 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.717 HG22 ' CD1' ' A' ' 20' ' ' TYR . 2.9 mp -99.3 -54.73 6.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.934 0.397 . . . . 0.0 111.709 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.717 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.6 m-85 -85.48 -13.62 48.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.946 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 72.5 5.65 64.02 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.659 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.427 ' CD1' ' HG3' ' A' ' 24' ' ' LYS . 14.2 p90 -160.26 143.97 13.97 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.482 0.182 . . . . 0.0 110.513 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.49 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 46.1 t -120.82 79.39 1.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.49 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.427 ' HG3' ' CD1' ' A' ' 22' ' ' TYR . 45.5 mttm -56.37 -21.7 26.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.838 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.59 1.96 52.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.187 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -55.49 -37.15 67.45 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.773 0.321 . . . . 0.0 110.274 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -15.86 63.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.372 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.532 ' C ' ' H ' ' A' ' 30' ' ' CYS . 1.5 mt-10 -93.19 179.36 5.44 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.0 19.73 0.05 OUTLIER Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.929 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.532 ' H ' ' C ' ' A' ' 28' ' ' GLU . 2.4 t -66.2 123.59 85.7 Favored Pre-proline 0 C--O 1.232 0.138 0 CA-C-N 117.824 0.812 . . . . 0.0 110.858 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.554 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 95.1 Cg_endo -79.85 153.78 22.78 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.282 1.988 . . . . 0.0 112.331 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.72 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 27.2 m-85 107.38 155.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.985 0.914 . . . . 0.0 111.133 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.415 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 14.5 tptt -85.77 97.51 10.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.38 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.49 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 3.1 m80 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.782 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.55 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 13.8 p-90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.912 0.387 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.756 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.35 -34.49 76.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.181 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.6 ttmt -67.15 -17.2 64.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.477 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -100.42 -1.6 35.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.581 0.229 . . . . 0.0 111.269 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.503 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 16.6 mt -124.24 109.9 29.03 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.202 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.04 130.61 31.43 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.483 2.122 . . . . 0.0 112.216 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.3 t -68.02 137.02 54.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.881 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -52.78 -22.97 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.584 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -61.66 -57.04 13.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.041 0.448 . . . . 0.0 110.128 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.424 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.2 mm -67.66 -29.17 44.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.841 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.2 m -78.82 -41.55 29.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.197 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.76 HG22 ' CD2' ' A' ' 20' ' ' TYR . 2.2 mt -97.02 -54.54 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.925 0.393 . . . . 0.0 111.867 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.76 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.3 m-85 -85.47 -12.1 52.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.971 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.93 6.81 57.65 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.284 -0.96 . . . . 0.0 111.782 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -160.27 143.24 13.51 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.575 0.226 . . . . 0.0 110.53 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.479 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 17.6 t -120.85 80.22 1.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.565 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.22 -22.61 30.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.501 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -2.59 56.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.927 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.3 tm-20 -53.7 -34.17 57.91 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.758 0.313 . . . . 0.0 110.432 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.19 -11.86 61.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.691 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -99.11 179.05 4.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.671 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.78 25.79 0.11 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.742 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.496 ' H ' ' C ' ' A' ' 28' ' ' GLU . 6.3 t -66.33 133.03 94.42 Favored Pre-proline 0 N--CA 1.457 -0.077 0 CA-C-N 117.599 0.699 . . . . 0.0 110.714 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 95.3 Cg_endo -82.05 148.14 15.1 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.363 2.042 . . . . 0.0 112.326 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.756 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.2 m-85 108.53 154.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.951 0.901 . . . . 0.0 110.91 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 47.3 tptt -87.09 99.99 12.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.443 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.479 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 2.2 m80 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.654 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.531 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.0 p-90 . . . . . 0 N--CA 1.461 0.087 0 CA-C-O 120.796 0.332 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.71 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.23 -38.76 92.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.174 0.511 . . . . 0.0 110.893 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.439 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -68.46 -13.37 62.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.356 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.39 -3.31 31.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.781 0.324 . . . . 0.0 111.021 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.529 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 5.8 mt -124.35 109.17 29.09 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.54 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.66 130.62 23.87 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.644 2.229 . . . . 0.0 112.914 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.439 ' SG ' ' ND2' ' A' ' 16' ' ' ASN . 48.2 t -65.9 136.87 56.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.716 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -52.77 -25.36 11.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.837 0.351 . . . . 0.0 110.684 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.439 ' ND2' ' SG ' ' A' ' 14' ' ' CYS . 2.5 m-80 -63.42 -53.43 52.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.172 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.424 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 10.9 mm -68.32 -29.31 43.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.554 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.8 m -78.95 -40.67 31.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.112 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.746 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.6 mp -96.85 -54.64 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 111.934 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.746 ' CD1' HG22 ' A' ' 19' ' ' ILE . 2.9 m-85 -85.32 -13.11 50.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.949 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.9 6.96 61.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.098 -1.048 . . . . 0.0 111.614 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.42 ' CE1' ' HG3' ' A' ' 24' ' ' LYS . 9.2 p90 -160.19 143.3 13.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.599 0.238 . . . . 0.0 110.45 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.47 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 36.0 t -120.67 80.55 1.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.387 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.42 ' HG3' ' CE1' ' A' ' 22' ' ' TYR . 5.8 mtmm -56.22 -22.11 27.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.771 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.75 10.17 27.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -59.12 -34.52 72.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.876 0.369 . . . . 0.0 110.124 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -69.48 -12.64 61.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.565 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.526 ' C ' ' H ' ' A' ' 30' ' ' CYS . 2.0 mt-10 -94.12 179.39 5.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.69 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.74 14.47 0.02 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.746 -0.74 . . . . 0.0 114.109 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.526 ' H ' ' C ' ' A' ' 28' ' ' GLU . 1.5 t -66.26 114.51 17.24 Favored Pre-proline 0 C--O 1.23 0.075 0 CA-C-N 118.028 0.914 . . . . 0.0 110.632 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 74.1 Cg_endo -75.67 158.65 39.48 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.279 1.986 . . . . 0.0 112.158 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.71 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 28.0 m-85 105.68 154.28 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.95 0.9 . . . . 0.0 111.06 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 23.6 tptp -82.13 96.33 7.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.609 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.47 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 9.0 m80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.827 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.591 ' CE3' HD12 ' A' ' 12' ' ' ILE . 15.7 p-90 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.948 0.404 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.747 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.17 -35.12 77.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.135 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.2 ttmt -67.32 -18.74 65.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.214 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.69 -2.02 42.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.133 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.591 HD12 ' CE3' ' A' ' 8' ' ' TRP . 53.6 mt -124.2 126.37 25.56 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.94 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.39 130.58 13.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.526 2.151 . . . . 0.0 112.511 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.431 ' HG ' ' H ' ' A' ' 16' ' ' ASN . 45.6 t -67.18 136.84 55.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.782 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.487 ' HB3' HD13 ' A' ' 19' ' ' ILE . 21.3 mtp85 -52.81 -25.43 11.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.935 0.398 . . . . 0.0 110.5 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.447 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 5.0 m120 -63.71 -55.22 24.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.413 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 mm -64.87 -30.47 50.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.603 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.0 m -78.93 -43.27 25.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.561 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.725 HG22 ' CD2' ' A' ' 20' ' ' TYR . 2.1 mp -95.39 -53.42 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.725 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.0 m-85 -85.19 -12.08 53.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.944 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.96 7.82 51.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.203 -0.998 . . . . 0.0 111.657 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.411 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 10.2 p90 -160.3 143.12 13.39 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.46 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 34.5 t -120.7 80.15 1.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.698 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -56.4 -22.06 29.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.585 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -83.51 -5.37 59.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.076 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.4 ' CG ' ' HB2' ' A' ' 34' ' ' HIS . 22.0 tt0 -53.61 -36.24 61.78 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 120.812 0.339 . . . . 0.0 110.383 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -15.79 63.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.294 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.478 ' C ' ' H ' ' A' ' 30' ' ' CYS . 70.0 mt-10 -97.75 179.04 4.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.457 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.92 28.73 0.11 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.746 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.478 ' H ' ' C ' ' A' ' 28' ' ' GLU . 6.1 t -66.43 134.09 94.48 Favored Pre-proline 0 CA--C 1.528 0.097 0 CA-C-N 117.764 0.782 . . . . 0.0 110.628 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 89.5 Cg_endo -82.37 147.86 14.42 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.258 1.972 . . . . 0.0 112.338 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.747 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.5 m-85 107.81 155.61 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.978 0.911 . . . . 0.0 111.035 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -88.02 100.57 13.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.468 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.483 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.338 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.556 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 14.3 p-90 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.0 0.428 . . . . 0.0 111.441 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.762 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.34 -33.48 74.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.323 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -67.5 -17.88 64.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.457 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.39 -1.03 39.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.192 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.525 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 9.4 mt -124.34 103.64 32.32 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.075 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.89 130.58 35.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.479 2.119 . . . . 0.0 112.366 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.7 t -65.48 136.73 56.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.881 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.574 ' HB3' HD12 ' A' ' 19' ' ' ILE . 36.1 mtt180 -52.88 -25.61 12.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.613 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -63.78 -52.98 57.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.121 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' A' ' 34' ' ' HIS . 14.5 mm -67.01 -31.23 52.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.522 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.4 m -78.97 -39.99 32.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.334 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.721 HG22 ' CD2' ' A' ' 20' ' ' TYR . 4.1 mt -96.69 -54.68 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.721 ' CD2' HG22 ' A' ' 19' ' ' ILE . 2.6 m-85 -85.47 -12.56 51.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.996 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.18 7.11 59.29 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.596 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.405 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 11.7 p90 -160.19 143.25 13.64 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.61 0.243 . . . . 0.0 110.57 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.477 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 35.6 t -120.86 80.2 1.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.805 0.336 . . . . 0.0 110.281 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.2 -23.21 34.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.775 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 3.82 45.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.487 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -55.23 -36.15 65.69 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.818 0.342 . . . . 0.0 110.384 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -68.11 -13.2 62.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.407 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' A' ' 30' ' ' CYS . 3.7 mm-40 -94.38 179.14 5.39 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.592 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.09 20.24 0.06 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.798 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.525 ' H ' ' C ' ' A' ' 28' ' ' GLU . 2.6 t -66.32 121.17 75.42 Favored Pre-proline 0 C--O 1.231 0.086 0 CA-C-N 117.747 0.774 . . . . 0.0 110.769 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 72.6 Cg_endo -77.72 153.28 29.78 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.293 1.995 . . . . 0.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.762 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 25.9 m-85 108.33 153.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.006 0.923 . . . . 0.0 111.104 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -85.1 96.66 9.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.339 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.487 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 3.8 m80 . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.672 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.555 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 16.3 p-90 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.939 0.399 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.779 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.79 -34.97 78.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.202 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -67.39 -13.73 62.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.549 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -105.88 0.85 26.27 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.42 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.506 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 11.7 mt -124.48 110.77 28.21 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 120.682 0.277 . . . . 0.0 111.121 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.03 130.67 33.51 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.562 2.174 . . . . 0.0 112.376 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.1 t -72.61 136.68 45.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.939 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.627 ' HB2' HD13 ' A' ' 19' ' ' ILE . 27.4 ptt180 -53.47 -21.5 6.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.07 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.439 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.0 OUTLIER -61.65 -57.24 12.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.056 0.455 . . . . 0.0 110.513 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.666 HD11 ' HB3' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -71.25 -25.83 25.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.773 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.414 ' HB ' ' HA ' ' A' ' 15' ' ' ARG . 2.0 m -78.87 -42.88 26.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.536 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.77 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.5 mp -96.44 -53.03 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 111.786 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.77 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.6 m-85 -85.28 -15.08 44.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.937 -178.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 72.85 5.5 64.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.81 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -160.33 142.36 12.82 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.482 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 7.1 t -120.85 78.6 1.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.603 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.4 -22.63 32.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.576 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.8 -2.14 53.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.112 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.521 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.7 tm-20 -53.54 -35.78 61.1 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.799 0.333 . . . . 0.0 110.449 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -68.51 -13.03 62.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.771 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.49 ' C ' ' H ' ' A' ' 30' ' ' CYS . 9.6 mp0 -98.4 179.06 4.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.689 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.23 27.47 0.1 OUTLIER Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.765 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.49 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.7 t -66.45 134.88 94.56 Favored Pre-proline 0 C--O 1.231 0.083 0 CA-C-N 117.752 0.776 . . . . 0.0 110.6 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.554 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 88.5 Cg_endo -82.4 146.31 13.77 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.35 2.034 . . . . 0.0 112.083 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.779 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 27.6 m-85 106.56 157.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.839 0.856 . . . . 0.0 111.004 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -88.47 105.78 17.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.599 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.666 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.561 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.671 ' CE3' HD12 ' A' ' 12' ' ' ILE . 7.4 p-90 . . . . . 0 N--CA 1.461 0.105 0 CA-C-O 120.798 0.333 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.699 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.54 -38.44 91.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.046 0.45 . . . . 0.0 110.709 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -68.12 -14.2 62.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.31 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.24 -3.42 31.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.728 0.299 . . . . 0.0 110.968 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.671 HD12 ' CE3' ' A' ' 8' ' ' TRP . 63.8 mt -124.36 113.51 27.66 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.786 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.95 130.64 22.11 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.54 2.16 . . . . 0.0 112.756 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.3 t -67.81 136.93 54.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.662 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.446 ' HB2' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -53.04 -22.8 6.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.786 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.44 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.3 m-80 -61.71 -57.03 13.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.032 0.444 . . . . 0.0 110.117 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.425 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.3 mm -66.73 -28.3 42.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.741 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -78.9 -43.06 25.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.227 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.786 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.4 mp -95.99 -54.08 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.863 0.363 . . . . 0.0 111.844 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.786 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.3 m-85 -85.17 -12.65 52.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.904 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.88 5.44 57.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.804 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -160.29 143.32 13.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.47 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 32.2 t -120.78 79.7 1.53 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.824 0.345 . . . . 0.0 110.647 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -56.34 -22.6 31.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.455 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.36 -1.47 53.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.064 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 1.3 tm-20 -52.95 -37.75 61.35 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.857 0.361 . . . . 0.0 110.485 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.51 -13.59 61.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.625 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 30' ' ' CYS . 12.7 mt-10 -95.07 179.19 5.3 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.655 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.87 19.55 0.06 OUTLIER Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.776 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.523 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.0 t -66.28 124.22 87.45 Favored Pre-proline 0 C--O 1.232 0.133 0 CA-C-N 117.9 0.85 . . . . 0.0 110.823 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 88.5 Cg_endo -79.36 154.64 24.7 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.311 2.008 . . . . 0.0 112.295 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.699 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.4 m-85 106.89 153.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.988 0.915 . . . . 0.0 111.029 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 11.3 tptt -84.28 96.34 8.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.242 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.47 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 5.3 m80 . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.688 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.527 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 18.3 p-90 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.035 0.445 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.748 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.15 -35.09 77.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.216 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.439 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -67.11 -18.46 65.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -96.01 -5.02 42.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.653 0.263 . . . . 0.0 111.242 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.474 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 6.3 mt -124.26 126.31 25.55 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.47 130.65 13.0 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.583 2.189 . . . . 0.0 112.725 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.422 ' HA ' ' CD1' ' A' ' 32' ' ' PHE . 49.7 t -63.36 136.79 57.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.791 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.2 mtp85 -53.02 -25.85 13.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.914 0.387 . . . . 0.0 110.287 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.45 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 3.7 m120 -64.66 -52.92 54.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.328 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 23' ' ' CYS . 17.3 mm -67.21 -30.7 50.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.618 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 m -78.97 -44.92 21.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.379 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.529 HG22 ' CD1' ' A' ' 20' ' ' TYR . 2.0 mp -95.59 -49.79 12.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.529 ' CD1' HG22 ' A' ' 19' ' ' ILE . 4.3 m-85 -85.06 -15.47 43.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.523 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.62 7.21 60.76 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.345 -0.931 . . . . 0.0 111.481 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -160.56 143.72 13.36 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 122.39 0.276 . . . . 0.0 110.501 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.481 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 30.4 t -120.99 80.48 1.64 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.754 0.311 . . . . 0.0 110.266 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.19 -22.77 31.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.821 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.02 4.18 49.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.1 tm-20 -55.92 -32.5 63.84 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.852 0.358 . . . . 0.0 110.191 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -71.55 -11.04 60.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.615 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 30' ' ' CYS . 2.6 mt-10 -98.53 179.06 4.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.773 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.06 24.59 0.09 OUTLIER Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.859 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.501 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.5 t -66.41 132.11 94.28 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 117.763 0.781 . . . . 0.0 110.654 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 88.1 Cg_endo -82.49 148.65 14.46 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.435 2.09 . . . . 0.0 112.663 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.748 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.1 m-85 109.06 154.37 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.094 0.957 . . . . 0.0 111.091 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.439 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 2.9 tppt? -86.35 98.01 10.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.243 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.481 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 2.9 m80 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.579 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.525 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.4 p-90 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.879 0.371 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.695 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.94 -38.41 91.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.095 0.474 . . . . 0.0 110.842 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -68.07 -12.19 60.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.408 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.08 -3.5 25.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.677 0.275 . . . . 0.0 111.103 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.509 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 9.0 mt -124.19 108.15 29.91 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.143 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.86 130.55 33.38 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.411 2.074 . . . . 0.0 112.348 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.5 t -66.44 136.82 56.27 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.817 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.726 ' HB3' HD12 ' A' ' 19' ' ' ILE . 2.3 mmp_? -53.02 -23.58 7.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.803 0.335 . . . . 0.0 110.624 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.402 ' OD1' ' HA ' ' A' ' 23' ' ' CYS . 1.2 m-80 -61.06 -54.08 49.13 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 110.297 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' A' ' 23' ' ' CYS . 4.7 mm -70.99 -29.16 35.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.765 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -78.74 -38.93 37.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.944 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.748 HG22 ' CD1' ' A' ' 20' ' ' TYR . 5.9 mt -99.84 -54.7 6.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.863 0.363 . . . . 0.0 111.963 -178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.748 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.8 m-85 -85.58 -11.98 52.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.003 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.18 7.33 59.72 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.722 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -160.3 146.87 15.69 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.491 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 34.1 t -120.9 80.45 1.64 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.753 0.311 . . . . 0.0 110.684 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -56.37 -21.97 28.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.704 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 -2.99 58.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.067 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.7 tm-20 -53.65 -35.82 61.43 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.765 0.316 . . . . 0.0 110.365 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.11 -16.04 63.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.391 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.493 ' C ' ' H ' ' A' ' 30' ' ' CYS . 15.3 mt-10 -96.83 179.15 5.06 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.56 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 27.4 0.1 OUTLIER Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.754 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.493 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.5 t -66.51 130.07 94.14 Favored Pre-proline 0 C--O 1.231 0.129 0 CA-C-N 117.738 0.769 . . . . 0.0 110.603 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 92.8 Cg_endo -81.13 150.12 17.64 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.382 2.055 . . . . 0.0 112.42 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.695 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.6 m-85 107.51 156.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.995 0.918 . . . . 0.0 111.042 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.466 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 7.4 tptp -87.14 100.06 12.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.445 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.491 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 2.0 m80 . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.673 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.881 ' O ' HD12 ' A' ' 12' ' ' ILE . 7.9 p-90 . . . . . 0 N--CA 1.461 0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.641 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.52 -40.58 97.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.013 0.435 . . . . 0.0 110.889 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.446 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 2.7 ttmt -67.7 -13.41 62.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.24 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -99.31 -5.56 29.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.64 0.257 . . . . 0.0 111.092 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.881 HD12 ' O ' ' A' ' 8' ' ' TRP . 2.5 mp -124.24 117.0 26.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.645 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.92 130.55 19.35 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.48 2.12 . . . . 0.0 112.779 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.98 136.7 56.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.652 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.44 ' HB2' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -53.02 -21.99 5.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.752 0.31 . . . . 0.0 110.737 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -62.37 -56.75 15.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.917 0.389 . . . . 0.0 110.117 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.416 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.9 mm -67.72 -28.18 40.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.774 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 m -78.81 -42.76 26.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.167 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.785 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.6 mp -96.61 -54.22 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.357 . . . . 0.0 111.872 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.785 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.5 m-85 -85.28 -12.09 53.22 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.058 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.12 6.56 57.38 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.731 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -160.23 144.47 14.34 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.569 0.223 . . . . 0.0 110.445 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.478 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 26.7 t -120.82 80.74 1.67 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.754 0.311 . . . . 0.0 110.657 178.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -22.83 31.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.482 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -1.45 56.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.996 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 3.3 tm-20 -53.75 -35.25 61.04 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.813 0.34 . . . . 0.0 110.45 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 mtpp -68.84 -13.06 62.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.58 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 30' ' ' CYS . 16.4 mm-40 -96.53 179.17 5.09 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.655 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.2 22.51 0.08 OUTLIER Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.858 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.51 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.2 t -66.38 128.78 94.03 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 117.735 0.767 . . . . 0.0 110.636 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 90.0 Cg_endo -81.87 152.39 16.86 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.44 2.094 . . . . 0.0 112.592 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.641 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.7 m-85 107.48 154.08 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.079 0.952 . . . . 0.0 111.07 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -84.38 96.53 9.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.295 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.478 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 5.3 m80 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.793 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.877 ' O ' HD12 ' A' ' 12' ' ' ILE . 7.9 p-90 . . . . . 0 N--CA 1.461 0.088 0 CA-C-O 120.805 0.336 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.75 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.45 -39.71 94.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.972 0.415 . . . . 0.0 110.995 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.449 ' CG ' ' HB2' ' A' ' 33' ' ' LYS . 1.1 ttmm -67.16 -13.43 61.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.325 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.81 -7.02 25.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.711 0.291 . . . . 0.0 111.225 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.877 HD12 ' O ' ' A' ' 8' ' ' TRP . 2.6 mp -124.19 124.41 25.88 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.899 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -73.06 130.97 16.09 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.675 2.25 . . . . 0.0 112.712 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 32' ' ' PHE . 46.9 t -65.81 136.67 56.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.826 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.606 ' HB2' HD13 ' A' ' 19' ' ' ILE . 6.3 ptt180 -53.23 -22.23 6.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.667 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.6 m-80 -61.67 -57.07 13.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.939 0.4 . . . . 0.0 110.251 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mm -66.97 -28.98 44.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.883 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.417 HG22 HD12 ' A' ' 19' ' ' ILE . 2.8 m -78.83 -42.35 27.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.247 -178.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.759 HG22 ' CD2' ' A' ' 20' ' ' TYR . 2.1 mp -96.84 -54.43 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.952 0.406 . . . . 0.0 111.921 -178.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.759 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.27 -11.32 55.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.109 -178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.14 6.67 54.45 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.731 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -160.23 145.49 14.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.536 0.207 . . . . 0.0 110.467 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.468 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 27.8 t -120.86 80.39 1.63 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.84 0.353 . . . . 0.0 110.537 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -56.35 -21.77 26.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.33 -0.91 57.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.247 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -54.26 -36.35 63.5 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.808 0.337 . . . . 0.0 110.38 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -66.53 -14.91 62.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.509 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 30' ' ' CYS . 4.9 mt-10 -96.21 179.12 5.16 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.433 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.92 26.05 0.09 OUTLIER Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.535 -0.841 . . . . 0.0 113.749 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.502 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.7 t -66.31 134.08 94.6 Favored Pre-proline 0 C--O 1.231 0.124 0 CA-C-N 117.717 0.758 . . . . 0.0 110.539 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 88.9 Cg_endo -83.46 148.14 12.73 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.455 2.103 . . . . 0.0 112.627 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.75 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 25.9 m-85 108.97 154.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.1 0.96 . . . . 0.0 111.1 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.449 ' HB2' ' CG ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -87.55 96.46 10.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.129 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.468 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 2.0 m80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.631 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.692 ' CE3' HD12 ' A' ' 12' ' ' ILE . 8.8 p-90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.707 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -64.72 -36.0 82.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.075 0.464 . . . . 0.0 110.651 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.671 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -68.39 -13.89 62.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.288 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -102.3 -1.97 29.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.748 0.308 . . . . 0.0 110.852 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.692 HD12 ' CE3' ' A' ' 8' ' ' TRP . 65.1 mt -124.57 116.6 26.58 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.833 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.84 130.51 20.62 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.45 2.1 . . . . 0.0 112.596 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.4 t -66.73 137.05 56.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.852 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.421 ' HB3' HD13 ' A' ' 19' ' ' ILE . 72.1 mtt180 -52.97 -22.41 5.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.74 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.426 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.8 m-80 -63.58 -57.15 11.03 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 110.372 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.404 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.2 mm -65.52 -27.72 42.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.496 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.594 HG22 HD12 ' A' ' 19' ' ' ILE . 18.0 m -78.91 -44.78 21.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.192 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.756 HG22 ' CD1' ' A' ' 20' ' ' TYR . 2.3 mp -95.36 -54.62 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.965 0.412 . . . . 0.0 111.99 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.756 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.32 -9.98 56.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.028 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 66.83 7.48 42.67 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.279 -0.963 . . . . 0.0 111.81 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 10.2 p90 -160.35 144.17 13.96 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.47 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 35.1 t -120.81 80.26 1.61 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.777 0.323 . . . . 0.0 110.543 178.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.38 -22.76 33.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.68 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.59 -2.91 58.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.051 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -54.06 -36.08 62.73 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.885 0.374 . . . . 0.0 110.266 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -65.83 -15.79 63.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.41 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 30' ' ' CYS . 33.5 mt-10 -96.65 179.14 5.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.561 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.37 25.72 0.08 OUTLIER Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.888 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.498 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.8 t -66.34 130.31 94.21 Favored Pre-proline 0 CA--C 1.527 0.069 0 CA-C-N 117.874 0.837 . . . . 0.0 110.622 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 96.6 Cg_endo -79.87 150.73 21.17 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.32 2.013 . . . . 0.0 112.379 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.707 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.6 m-85 106.55 154.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.957 0.903 . . . . 0.0 111.105 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.671 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -87.73 96.56 10.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.228 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.47 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 1.9 m80 . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.658 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.52 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 7.6 p-90 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.852 0.358 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.733 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.87 -39.87 95.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.082 0.468 . . . . 0.0 110.96 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -67.77 -12.27 60.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.414 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -101.64 -5.01 25.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.676 0.274 . . . . 0.0 111.163 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.496 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 8.2 mt -124.32 123.72 25.88 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.829 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.08 130.72 16.96 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.496 2.131 . . . . 0.0 112.692 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.22 137.0 55.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.927 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.537 ' HB3' HD13 ' A' ' 19' ' ' ILE . 45.9 mtt85 -53.09 -22.29 5.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.806 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.443 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.6 m-80 -62.86 -57.04 12.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 110.228 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.408 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.1 mm -66.1 -27.65 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.546 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.507 HG22 HD12 ' A' ' 19' ' ' ILE . 16.7 m -78.9 -45.77 19.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.205 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.766 HG22 ' CD2' ' A' ' 20' ' ' TYR . 2.2 mp -94.11 -54.39 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.935 0.398 . . . . 0.0 111.939 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.766 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.2 -11.34 55.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.998 -178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 68.9 6.23 50.89 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.808 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -160.34 143.36 13.47 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.469 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 25.6 t -120.76 79.9 1.56 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.734 0.302 . . . . 0.0 110.5 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -56.21 -23.26 34.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.698 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.39 -1.06 52.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.0 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -53.51 -36.19 61.47 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.847 0.356 . . . . 0.0 110.393 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -68.54 -12.84 61.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.668 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 30' ' ' CYS . 7.4 mt-10 -96.94 179.04 5.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 25.49 0.09 OUTLIER Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.708 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.501 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.1 t -66.31 133.21 94.47 Favored Pre-proline 0 C--O 1.231 0.108 0 CA-C-N 117.766 0.783 . . . . 0.0 110.687 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 87.2 Cg_endo -82.84 147.51 13.46 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.404 2.069 . . . . 0.0 112.258 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.733 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.7 m-85 108.01 156.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.011 0.924 . . . . 0.0 110.969 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 6.2 tmmm? -88.52 105.48 17.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.076 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.491 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 1.6 m80 . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.569 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.862 ' O ' HD12 ' A' ' 12' ' ' ILE . 8.0 p-90 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.817 0.341 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.666 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.82 -39.54 94.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.076 0.465 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.422 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 2.2 ttmt -67.77 -13.48 62.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.293 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.94 -5.29 28.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.675 0.274 . . . . 0.0 111.122 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.862 HD12 ' O ' ' A' ' 8' ' ' TRP . 2.5 mp -124.17 117.08 27.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.707 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.0 130.49 19.14 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.568 2.179 . . . . 0.0 112.774 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.9 t -65.29 136.91 57.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.641 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.485 ' HB3' HD13 ' A' ' 19' ' ' ILE . 2.9 mtm105 -53.12 -23.18 7.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 0.0 110.629 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.429 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.4 m-80 -61.53 -55.29 32.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.939 0.4 . . . . 0.0 110.199 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.411 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.8 mm -69.29 -28.37 38.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.834 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 m -78.77 -42.21 28.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.053 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.785 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.4 mp -97.02 -54.12 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 111.872 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.785 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.5 m-85 -85.37 -12.25 52.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.001 -178.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.45 6.11 57.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.874 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -160.28 144.79 14.46 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.53 0.205 . . . . 0.0 110.475 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.477 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 41.2 t -120.99 79.88 1.57 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.813 0.34 . . . . 0.0 110.674 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -56.4 -21.37 24.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.752 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.16 -1.12 57.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.341 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -53.72 -36.81 62.66 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.856 0.36 . . . . 0.0 110.42 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -65.69 -15.39 62.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.332 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 30' ' ' CYS . 9.3 mm-40 -94.1 179.34 5.35 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.516 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.36 21.28 0.06 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.833 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.513 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.4 t -66.22 127.45 93.25 Favored Pre-proline 0 C--O 1.231 0.098 0 CA-C-N 117.901 0.85 . . . . 0.0 110.723 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 87.3 Cg_endo -82.08 152.97 16.56 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.43 2.087 . . . . 0.0 112.512 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.666 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 27.0 m-85 107.77 154.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.942 0.897 . . . . 0.0 111.128 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.422 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 17.4 tptp -85.23 96.41 9.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.262 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.477 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 3.9 m80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.681 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.651 ' CE3' HD12 ' A' ' 12' ' ' ILE . 13.0 p-90 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.012 0.434 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.747 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.32 -33.5 74.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.244 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -67.17 -19.47 65.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.356 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -98.32 -0.59 43.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.167 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.651 HD12 ' CE3' ' A' ' 8' ' ' TRP . 81.4 mt -124.36 103.79 32.15 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.057 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.59 130.5 35.67 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.428 2.085 . . . . 0.0 112.161 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.5 t -65.6 136.65 56.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.815 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.415 ' HB3' HD13 ' A' ' 19' ' ' ILE . 4.7 mtp180 -53.16 -25.6 14.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.337 . . . . 0.0 110.514 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.433 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 5.5 m120 -63.12 -53.23 56.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.31 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 34' ' ' HIS . 13.1 mm -67.15 -30.59 49.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.612 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 m -78.98 -41.46 29.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.251 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.729 HG22 ' CD2' ' A' ' 20' ' ' TYR . 1.6 mp -96.34 -54.3 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.925 0.393 . . . . 0.0 111.949 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.729 ' CD2' HG22 ' A' ' 19' ' ' ILE . 2.8 m-85 -85.24 -12.33 52.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.036 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.38 7.47 57.64 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.676 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 22' ' ' TYR . 9.0 p90 -160.29 143.87 13.86 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 120.609 0.242 . . . . 0.0 110.468 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.471 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 36.8 t -120.65 80.76 1.67 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.791 0.329 . . . . 0.0 110.27 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -22.06 27.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.103 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.76 2.13 55.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.171 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -55.0 -36.55 65.54 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.857 0.36 . . . . 0.0 110.301 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -66.54 -14.41 62.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.419 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.52 ' C ' ' H ' ' A' ' 30' ' ' CYS . 4.9 mm-40 -94.42 179.19 5.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.602 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.82 22.05 0.07 OUTLIER Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.752 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.52 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.4 t -66.38 123.74 86.29 Favored Pre-proline 0 CA--C 1.527 0.073 0 CA-C-N 117.82 0.81 . . . . 0.0 110.687 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 71.8 Cg_endo -77.62 151.7 28.88 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.195 1.93 . . . . 0.0 112.249 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.747 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 25.6 m-85 109.45 153.02 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.062 0.945 . . . . 0.0 111.049 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -86.49 96.47 10.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.247 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.471 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 3.2 m80 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.084 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.528 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.0 p-90 . . . . . 0 N--CA 1.461 0.111 0 CA-C-O 120.808 0.337 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.73 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.34 -37.73 88.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 0.0 110.842 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -67.92 -13.59 62.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.419 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.47 -3.6 28.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 111.14 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.504 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 6.7 mt -124.19 116.35 27.18 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.765 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 131.6 21.66 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.655 2.237 . . . . 0.0 112.859 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.1 t -67.12 136.81 55.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.777 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.433 ' HB3' HD13 ' A' ' 19' ' ' ILE . 10.3 mtt-85 -52.93 -25.6 12.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 0.0 110.568 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.443 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 5.1 m120 -64.36 -52.78 56.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.289 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.405 HD11 ' HB3' ' A' ' 34' ' ' HIS . 14.9 mm -67.77 -31.27 51.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.613 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.55 HG22 HD12 ' A' ' 19' ' ' ILE . 3.1 m -78.92 -40.8 31.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.426 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.55 HD12 HG22 ' A' ' 18' ' ' THR . 3.1 mp -98.43 -51.47 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.509 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.2 m-85 -85.14 -14.87 45.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.439 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.38 7.41 63.91 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.472 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 20' ' ' TYR . 12.2 p90 -160.48 144.54 13.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.443 0.297 . . . . 0.0 110.344 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.481 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 27.3 t -120.77 80.71 1.66 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.349 178.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.19 -22.7 30.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.846 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 9.27 32.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.482 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -58.79 -36.4 74.39 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.9 0.381 . . . . 0.0 110.202 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -68.65 -12.94 61.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.593 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.3 OUTLIER -93.91 179.28 5.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.33 19.53 0.05 OUTLIER Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.846 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.53 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.0 t -66.3 124.38 87.91 Favored Pre-proline 0 C--O 1.231 0.124 0 CA-C-N 117.885 0.843 . . . . 0.0 110.619 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.549 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 98.2 Cg_endo -80.0 153.6 22.26 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.357 2.038 . . . . 0.0 112.445 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.73 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.8 m-85 107.31 153.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.03 0.932 . . . . 0.0 111.0 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -84.46 96.42 9.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.359 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.482 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 4.3 m80 . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.68 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.531 ' O ' HD12 ' A' ' 12' ' ' ILE . 7.7 p-90 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.824 0.345 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.72 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -63.3 -38.59 91.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.085 0.469 . . . . 0.0 110.821 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.5 tmmt? -67.58 -13.03 61.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.45 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -102.02 -3.99 26.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.723 0.296 . . . . 0.0 111.245 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.531 HD12 ' O ' ' A' ' 8' ' ' TRP . 4.8 mt -124.29 122.37 26.02 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.871 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.79 130.68 17.24 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.64 2.227 . . . . 0.0 112.8 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.3 t -67.2 137.05 55.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.925 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.452 ' HB3' HD13 ' A' ' 19' ' ' ILE . 16.9 mtt85 -52.81 -24.85 9.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.69 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.436 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 6.1 m120 -63.41 -55.47 24.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.979 0.418 . . . . 0.0 110.325 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.411 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 10.0 mm -65.49 -29.26 46.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.6 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.1 m -78.93 -42.47 26.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.361 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.766 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.7 mp -96.17 -53.93 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.766 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.0 m-85 -85.15 -12.52 52.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.902 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.63 6.78 56.59 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.768 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -160.26 142.01 12.67 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.464 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 35.0 t -120.77 79.11 1.45 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.672 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.0 tptt -56.74 -20.43 22.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.827 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -85.19 -2.74 58.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.337 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 34' ' ' HIS . 14.8 tt0 -53.9 -36.42 62.68 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.778 0.323 . . . . 0.0 110.381 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.54 -15.79 63.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.051 0.453 . . . . 0.0 110.273 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' A' ' 30' ' ' CYS . 10.2 mt-10 -95.13 179.14 5.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.479 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.12 23.96 0.08 OUTLIER Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.889 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.506 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.6 t -66.27 132.6 94.44 Favored Pre-proline 0 C--O 1.231 0.128 0 CA-C-N 117.868 0.834 . . . . 0.0 110.718 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 86.3 Cg_endo -83.41 149.31 13.09 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.41 2.073 . . . . 0.0 112.451 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.72 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.3 m-85 107.99 155.18 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.989 0.916 . . . . 0.0 111.0 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 12.6 tptt -87.54 97.6 10.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.391 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.464 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 1.4 m80 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.531 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.552 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 16.9 p-90 . . . . . 0 N--CA 1.46 0.058 0 CA-C-O 121.033 0.444 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.729 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.43 -34.37 76.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.194 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.5 ttmt -67.32 -17.64 64.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.394 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.39 -1.04 39.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.613 0.244 . . . . 0.0 111.287 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.521 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 8.3 mt -124.33 105.53 30.99 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.686 0.279 . . . . 0.0 111.168 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.74 130.58 33.74 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.573 2.182 . . . . 0.0 112.439 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.9 t -67.69 136.96 55.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.836 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.594 ' HB3' HD13 ' A' ' 19' ' ' ILE . 10.7 mtm180 -53.04 -23.29 7.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.774 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.419 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.1 m-80 -61.11 -54.96 38.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.081 0.467 . . . . 0.0 110.116 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.439 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.1 mm -69.25 -28.5 38.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.881 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 m -78.86 -41.36 30.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.021 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.772 HG22 ' CD2' ' A' ' 20' ' ' TYR . 1.8 mp -97.06 -54.6 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.915 0.388 . . . . 0.0 111.738 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.772 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.25 -13.08 50.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.963 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 71.86 5.43 61.26 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.746 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -160.27 142.98 13.34 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.617 0.246 . . . . 0.0 110.53 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.481 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 37.5 t -120.82 79.53 1.51 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.459 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.42 -22.04 29.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.717 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.52 -1.66 56.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.401 ' CG ' ' HB2' ' A' ' 34' ' ' HIS . 14.2 tt0 -54.06 -35.55 62.15 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 120.727 0.299 . . . . 0.0 110.389 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.92 -15.95 63.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.421 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.52 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -95.19 179.35 5.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.561 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.48 21.11 0.05 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.653 -0.785 . . . . 0.0 114.133 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.52 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.8 t -66.2 124.25 87.46 Favored Pre-proline 0 C--O 1.231 0.111 0 CA-C-N 117.976 0.888 . . . . 0.0 110.598 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 86.3 Cg_endo -78.89 151.1 24.12 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.302 2.001 . . . . 0.0 112.471 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.729 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.0 m-85 108.46 154.82 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.041 0.936 . . . . 0.0 111.034 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 15.9 tptt -86.0 99.55 11.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.293 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.481 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 3.0 m80 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.731 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.614 ' CE3' HD12 ' A' ' 12' ' ' ILE . 7.2 p-90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.864 0.364 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.762 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.8 -38.0 88.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.04 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.44 ' CG ' ' HB2' ' A' ' 33' ' ' LYS . 1.8 ttmt -67.24 -14.99 63.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.348 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -100.33 -3.47 31.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.646 0.26 . . . . 0.0 111.134 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.614 HD12 ' CE3' ' A' ' 8' ' ' TRP . 55.5 mt -124.3 126.69 25.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.11 132.31 13.86 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.633 2.222 . . . . 0.0 112.907 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.0 t -70.65 136.85 49.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.641 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.6 ' HB3' HD13 ' A' ' 19' ' ' ILE . 16.3 mtp85 -53.21 -22.56 6.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.0 110.835 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.5 m-80 -61.68 -55.74 27.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.016 0.436 . . . . 0.0 110.185 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.41 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.9 mm -68.44 -28.82 41.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.836 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.5 m -78.64 -42.58 28.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.178 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.772 HG22 ' CD2' ' A' ' 20' ' ' TYR . 1.7 mp -96.57 -54.31 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.41 . . . . 0.0 111.863 -178.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.772 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.28 -12.06 53.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.063 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.93 6.31 55.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.163 -1.017 . . . . 0.0 111.759 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -160.18 146.6 15.72 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.48 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 21.8 t -120.8 81.05 1.71 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.575 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.3 -22.37 29.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.667 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.88 2.04 54.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.016 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -55.05 -35.16 64.19 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.806 0.336 . . . . 0.0 110.427 179.818 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -11.09 60.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.718 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.512 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -97.26 179.04 5.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.665 179.402 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.45 23.28 0.08 OUTLIER Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.81 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.512 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.5 t -66.36 131.35 94.26 Favored Pre-proline 0 C--O 1.23 0.054 0 CA-C-N 117.75 0.775 . . . . 0.0 110.714 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.556 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 94.8 Cg_endo -81.52 148.9 16.39 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.398 2.065 . . . . 0.0 112.25 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.762 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 25.5 m-85 109.16 154.77 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.062 0.945 . . . . 0.0 111.056 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HB2' ' CG ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -87.18 98.79 11.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.269 179.637 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.489 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 2.1 m80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.633 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.889 0.376 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -104.2 -30.87 9.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.926 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.18 123.42 32.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.934 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.28 107.6 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.45 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 2.3 t30 -73.76 138.28 76.87 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.179 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -42.8 -25.08 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.523 2.149 . . . . 0.0 112.864 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -58.71 -23.89 60.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.283 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.534 ' O ' HD12 ' A' ' 12' ' ' ILE . 7.7 p-90 -76.05 -52.07 10.95 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.789 0.328 . . . . 0.0 111.109 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.715 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.33 -38.06 89.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.051 0.453 . . . . 0.0 110.875 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -67.76 -13.73 62.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.358 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.06 -3.91 28.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.698 0.285 . . . . 0.0 111.14 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 8' ' ' TRP . 4.8 mt -124.29 116.19 27.08 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.741 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 131.74 21.81 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.573 2.182 . . . . 0.0 112.787 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.37 136.86 55.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.735 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 mtt85 -52.92 -25.95 13.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.34 . . . . 0.0 110.576 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.403 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 5.7 m120 -63.53 -52.94 59.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.366 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 34' ' ' HIS . 13.7 mm -67.26 -31.12 51.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.632 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -79.01 -40.81 30.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.324 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.702 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.9 mp -96.38 -54.6 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.702 ' CD1' HG22 ' A' ' 19' ' ' ILE . 2.7 m-85 -85.24 -12.21 53.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.038 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 68.4 8.34 55.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.529 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.427 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 10.1 p90 -160.27 143.9 13.92 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.7 t -120.71 80.93 1.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.57 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -22.23 30.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.921 0.391 . . . . 0.0 110.525 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.9 -3.38 58.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.952 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.424 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -53.34 -36.88 61.8 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.805 0.336 . . . . 0.0 110.4 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -65.94 -15.47 63.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.494 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 30' ' ' CYS . 48.5 mt-10 -95.9 179.17 5.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.558 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.45 24.32 0.08 OUTLIER Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.727 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.502 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.9 t -66.34 127.31 93.22 Favored Pre-proline 0 C--O 1.231 0.088 0 CA-C-N 117.819 0.809 . . . . 0.0 110.597 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 92.1 Cg_endo -80.96 152.43 18.93 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.352 2.035 . . . . 0.0 112.541 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.715 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.2 m-85 107.5 154.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.965 0.906 . . . . 0.0 111.066 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -84.45 96.54 9.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.419 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.45 ' HB3' HD11 ' A' ' 17' ' ' ILE . 4.7 m80 -90.07 79.02 6.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.703 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -95.43 110.71 22.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.863 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -118.82 31.73 6.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -117.29 -60.22 1.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.4 m -83.67 86.25 7.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -67.88 111.58 4.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.53 173.68 11.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.075 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.838 0.351 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.4 -70.68 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.06 113.18 10.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.86 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.547 ' H ' HD12 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -124.77 111.6 28.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.026 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.433 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -76.07 136.15 69.71 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.278 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -42.72 -24.98 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.695 2.263 . . . . 0.0 113.009 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.2 p30 -64.1 -16.17 61.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.428 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.611 ' O ' HD12 ' A' ' 12' ' ' ILE . 8.0 p-90 -78.9 -51.95 8.96 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.848 0.356 . . . . 0.0 111.057 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.72 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.06 -38.43 91.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.023 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.415 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -67.59 -13.04 61.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.399 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -101.65 -4.09 27.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.756 0.312 . . . . 0.0 111.25 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 8' ' ' TRP . 3.9 mt -124.35 107.86 29.68 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.942 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.6 130.63 32.3 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.497 2.131 . . . . 0.0 112.386 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.2 t -66.46 136.77 56.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.8 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.44 ' HB3' HD13 ' A' ' 19' ' ' ILE . 13.9 mtt85 -53.15 -24.14 9.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.71 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.432 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.1 m-80 -60.48 -52.95 63.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.113 0.482 . . . . 0.0 110.094 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.433 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.2 mm -71.34 -29.75 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.015 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.599 HG22 HD12 ' A' ' 19' ' ' ILE . 1.6 m -78.72 -38.32 39.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.007 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.717 HG22 ' CD1' ' A' ' 20' ' ' TYR . 2.9 mp -99.3 -54.73 6.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.934 0.397 . . . . 0.0 111.709 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.717 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.6 m-85 -85.48 -13.62 48.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.946 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 72.5 5.65 64.02 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.659 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.427 ' CD1' ' HG3' ' A' ' 24' ' ' LYS . 14.2 p90 -160.26 143.97 13.97 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.482 0.182 . . . . 0.0 110.513 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.1 t -120.82 79.39 1.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.49 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.427 ' HG3' ' CD1' ' A' ' 22' ' ' TYR . 45.5 mttm -56.37 -21.7 26.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.838 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.59 1.96 52.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.187 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -55.49 -37.15 67.45 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.773 0.321 . . . . 0.0 110.274 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -15.86 63.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.372 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.532 ' C ' ' H ' ' A' ' 30' ' ' CYS . 1.5 mt-10 -93.19 179.36 5.44 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.0 19.73 0.05 OUTLIER Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.929 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.532 ' H ' ' C ' ' A' ' 28' ' ' GLU . 2.4 t -66.2 123.59 85.7 Favored Pre-proline 0 C--O 1.232 0.138 0 CA-C-N 117.824 0.812 . . . . 0.0 110.858 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.554 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 95.1 Cg_endo -79.85 153.78 22.78 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.282 1.988 . . . . 0.0 112.331 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.72 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 27.2 m-85 107.38 155.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.985 0.914 . . . . 0.0 111.133 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.415 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 14.5 tptt -85.77 97.51 10.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.38 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.447 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 3.1 m80 -92.17 79.03 5.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.782 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.8 t -68.24 105.21 2.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.929 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -136.27 -175.16 3.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.833 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -67.67 -36.13 80.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 90.2 m 61.21 153.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.821 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 m 61.09 102.98 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.801 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.46 143.85 34.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.206 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.473 HG22 ' OXT' ' A' ' 41' ' ' THR . 6.4 m . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.933 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ptp . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.896 0.379 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -104.22 41.56 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.14 90.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.66 HG23 ' CD1' ' A' ' 8' ' ' TRP . 11.4 tt -139.17 163.08 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.024 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.57 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 5.3 m-20 -90.64 138.38 26.65 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.013 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -42.72 -27.53 0.87 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.801 2.334 . . . . 0.0 113.299 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -61.95 -16.96 55.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.73 0.3 . . . . 0.0 110.969 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.66 ' CD1' HG23 ' A' ' 4' ' ' ILE . 13.8 p-90 -70.44 -51.47 29.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.381 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.756 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.35 -34.49 76.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.181 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.6 ttmt -67.15 -17.2 64.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.477 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -100.42 -1.6 35.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.581 0.229 . . . . 0.0 111.269 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.503 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 16.6 mt -124.24 109.9 29.03 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.202 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.04 130.61 31.43 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.483 2.122 . . . . 0.0 112.216 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.3 t -68.02 137.02 54.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.881 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -52.78 -22.97 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.584 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -61.66 -57.04 13.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.041 0.448 . . . . 0.0 110.128 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.424 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.2 mm -67.66 -29.17 44.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.841 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.2 m -78.82 -41.55 29.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.197 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.76 HG22 ' CD2' ' A' ' 20' ' ' TYR . 2.2 mt -97.02 -54.54 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.925 0.393 . . . . 0.0 111.867 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.76 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.3 m-85 -85.47 -12.1 52.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.971 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.93 6.81 57.65 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.284 -0.96 . . . . 0.0 111.782 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -160.27 143.24 13.51 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.575 0.226 . . . . 0.0 110.53 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.403 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 17.6 t -120.85 80.22 1.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.565 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.22 -22.61 30.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.501 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -2.59 56.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.927 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.3 tm-20 -53.7 -34.17 57.91 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.758 0.313 . . . . 0.0 110.432 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.19 -11.86 61.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.691 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -99.11 179.05 4.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.671 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.78 25.79 0.11 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.742 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.496 ' H ' ' C ' ' A' ' 28' ' ' GLU . 6.3 t -66.33 133.03 94.42 Favored Pre-proline 0 N--CA 1.457 -0.077 0 CA-C-N 117.599 0.699 . . . . 0.0 110.714 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 95.3 Cg_endo -82.05 148.14 15.1 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.363 2.042 . . . . 0.0 112.326 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.756 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.2 m-85 108.53 154.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.951 0.901 . . . . 0.0 110.91 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 47.3 tptt -87.09 99.99 12.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.443 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.479 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 2.2 m80 -95.63 79.0 3.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.654 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.4 p -77.11 128.57 34.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.49 176.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -143.64 -48.0 0.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.17 86.1 4.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.7 -43.5 2.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.89 -46.99 5.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.104 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.846 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.89 0.376 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -125.77 -42.93 1.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.948 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -85.98 145.65 27.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.988 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.408 ' HB ' ' CD1' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -116.8 101.36 12.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.451 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 16.7 t-20 -72.03 139.16 82.27 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.213 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -42.76 -24.77 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.54 2.16 . . . . 0.0 112.856 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -61.32 -24.82 66.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.311 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.531 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.0 p-90 -71.93 -52.23 18.23 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.796 0.332 . . . . 0.0 110.97 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.71 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.23 -38.76 92.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.174 0.511 . . . . 0.0 110.893 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.439 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -68.46 -13.37 62.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.356 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.39 -3.31 31.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.781 0.324 . . . . 0.0 111.021 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.529 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 5.8 mt -124.35 109.17 29.09 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.54 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.66 130.62 23.87 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.644 2.229 . . . . 0.0 112.914 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.2 t -65.9 136.87 56.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.716 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -52.77 -25.36 11.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.837 0.351 . . . . 0.0 110.684 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -63.42 -53.43 52.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.172 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.424 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 10.9 mm -68.32 -29.31 43.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.554 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.8 m -78.95 -40.67 31.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.112 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.746 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.6 mp -96.85 -54.64 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 111.934 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.746 ' CD1' HG22 ' A' ' 19' ' ' ILE . 2.9 m-85 -85.32 -13.11 50.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.949 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.9 6.96 61.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.098 -1.048 . . . . 0.0 111.614 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.42 ' CE1' ' HG3' ' A' ' 24' ' ' LYS . 9.2 p90 -160.19 143.3 13.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.599 0.238 . . . . 0.0 110.45 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.0 t -120.67 80.55 1.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.387 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.42 ' HG3' ' CE1' ' A' ' 22' ' ' TYR . 5.8 mtmm -56.22 -22.11 27.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.771 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.75 10.17 27.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -59.12 -34.52 72.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.876 0.369 . . . . 0.0 110.124 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -69.48 -12.64 61.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.565 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.526 ' C ' ' H ' ' A' ' 30' ' ' CYS . 2.0 mt-10 -94.12 179.39 5.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.69 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.74 14.47 0.02 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.746 -0.74 . . . . 0.0 114.109 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.526 ' H ' ' C ' ' A' ' 28' ' ' GLU . 1.5 t -66.26 114.51 17.24 Favored Pre-proline 0 C--O 1.23 0.075 0 CA-C-N 118.028 0.914 . . . . 0.0 110.632 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 74.1 Cg_endo -75.67 158.65 39.48 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.279 1.986 . . . . 0.0 112.158 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.71 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 28.0 m-85 105.68 154.28 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.95 0.9 . . . . 0.0 111.06 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 23.6 tptp -82.13 96.33 7.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.609 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.441 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 9.0 m80 -89.25 79.3 7.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.827 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.95 160.65 17.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -98.12 33.28 2.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -143.14 -171.83 3.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.4 m -130.83 125.57 34.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 t -123.22 -43.69 2.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.16 140.43 49.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.153 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mtt . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.742 0.306 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -120.52 -41.13 2.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.34 101.7 9.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.655 HG23 ' CD1' ' A' ' 8' ' ' TRP . 14.8 tt -152.69 163.78 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.988 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.571 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 8.5 p30 -93.19 137.43 23.62 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.683 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -42.3 -28.2 0.88 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.112 2.542 . . . . 0.0 113.069 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -60.38 -19.12 54.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.935 0.397 . . . . 0.0 110.564 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.655 ' CD1' HG23 ' A' ' 4' ' ' ILE . 15.7 p-90 -65.34 -51.21 62.09 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.349 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.747 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.17 -35.12 77.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.135 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.2 ttmt -67.32 -18.74 65.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.214 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.69 -2.02 42.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.133 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.591 HD12 ' CE3' ' A' ' 8' ' ' TRP . 53.6 mt -124.2 126.37 25.56 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.94 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.39 130.58 13.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.526 2.151 . . . . 0.0 112.511 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t -67.18 136.84 55.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.782 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.487 ' HB3' HD13 ' A' ' 19' ' ' ILE . 21.3 mtp85 -52.81 -25.43 11.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.935 0.398 . . . . 0.0 110.5 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.447 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 5.0 m120 -63.71 -55.22 24.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.413 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 mm -64.87 -30.47 50.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.603 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.0 m -78.93 -43.27 25.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.561 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.725 HG22 ' CD2' ' A' ' 20' ' ' TYR . 2.1 mp -95.39 -53.42 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.725 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.0 m-85 -85.19 -12.08 53.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.944 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.96 7.82 51.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.203 -0.998 . . . . 0.0 111.657 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.411 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 10.2 p90 -160.3 143.12 13.39 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.5 t -120.7 80.15 1.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.698 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -56.4 -22.06 29.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.585 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -83.51 -5.37 59.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.076 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.4 ' CG ' ' HB2' ' A' ' 34' ' ' HIS . 22.0 tt0 -53.61 -36.24 61.78 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 120.812 0.339 . . . . 0.0 110.383 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -15.79 63.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.294 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.478 ' C ' ' H ' ' A' ' 30' ' ' CYS . 70.0 mt-10 -97.75 179.04 4.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.457 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.92 28.73 0.11 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.746 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.478 ' H ' ' C ' ' A' ' 28' ' ' GLU . 6.1 t -66.43 134.09 94.48 Favored Pre-proline 0 CA--C 1.528 0.097 0 CA-C-N 117.764 0.782 . . . . 0.0 110.628 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 89.5 Cg_endo -82.37 147.86 14.42 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.258 1.972 . . . . 0.0 112.338 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.747 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.5 m-85 107.81 155.61 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.978 0.911 . . . . 0.0 111.035 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -88.02 100.57 13.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.468 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.483 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 1.0 OUTLIER -98.26 78.85 2.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.338 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.3 m -123.28 156.0 36.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.138 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 59.98 161.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.934 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -118.19 92.09 3.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.21 32.49 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.845 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.93 122.94 4.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.899 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.83 -48.16 4.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.094 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.889 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.757 0.313 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -165.96 -43.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 109.07 17.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.762 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.638 HG23 ' CD1' ' A' ' 8' ' ' TRP . 14.3 tt -132.78 163.75 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.968 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.565 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 1.6 m-20 -91.86 137.53 25.32 Favored Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.941 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -42.62 -27.86 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.929 2.419 . . . . 0.0 113.284 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -64.44 -14.68 58.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.717 0.294 . . . . 0.0 110.967 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.638 ' CD1' HG23 ' A' ' 4' ' ' ILE . 14.3 p-90 -68.95 -51.27 41.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.0 0.428 . . . . 0.0 111.441 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.762 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.34 -33.48 74.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.323 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -67.5 -17.88 64.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.457 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.39 -1.03 39.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.192 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.525 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 9.4 mt -124.34 103.64 32.32 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.075 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.89 130.58 35.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.479 2.119 . . . . 0.0 112.366 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.7 t -65.48 136.73 56.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.881 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.574 ' HB3' HD12 ' A' ' 19' ' ' ILE . 36.1 mtt180 -52.88 -25.61 12.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.613 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -63.78 -52.98 57.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.121 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' A' ' 34' ' ' HIS . 14.5 mm -67.01 -31.23 52.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.522 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.4 m -78.97 -39.99 32.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.334 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.721 HG22 ' CD2' ' A' ' 20' ' ' TYR . 4.1 mt -96.69 -54.68 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.721 ' CD2' HG22 ' A' ' 19' ' ' ILE . 2.6 m-85 -85.47 -12.56 51.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.996 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.18 7.11 59.29 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.596 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.405 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 11.7 p90 -160.19 143.25 13.64 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.61 0.243 . . . . 0.0 110.57 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.6 t -120.86 80.2 1.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.805 0.336 . . . . 0.0 110.281 178.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.2 -23.21 34.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.775 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 3.82 45.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.487 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -55.23 -36.15 65.69 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.818 0.342 . . . . 0.0 110.384 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -68.11 -13.2 62.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.407 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' A' ' 30' ' ' CYS . 3.7 mm-40 -94.38 179.14 5.39 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.592 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.09 20.24 0.06 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.798 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.525 ' H ' ' C ' ' A' ' 28' ' ' GLU . 2.6 t -66.32 121.17 75.42 Favored Pre-proline 0 C--O 1.231 0.086 0 CA-C-N 117.747 0.774 . . . . 0.0 110.769 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 72.6 Cg_endo -77.72 153.28 29.78 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.293 1.995 . . . . 0.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.762 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 25.9 m-85 108.33 153.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.006 0.923 . . . . 0.0 111.104 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -85.1 96.66 9.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.339 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.487 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 3.8 m80 -89.56 79.03 6.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.672 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.1 p -72.33 159.6 33.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -118.31 42.51 2.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -107.9 142.26 38.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.24 160.35 40.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.839 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.9 101.1 9.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.6 157.53 24.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.135 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.7 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.951 179.892 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.824 0.345 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -126.96 68.93 1.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -73.1 95.25 2.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.82 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.654 HG23 ' CD1' ' A' ' 8' ' ' TRP . 9.5 tt -105.66 161.59 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.606 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 4.7 t-20 -90.75 136.71 27.55 Favored Pre-proline 0 N--CA 1.461 0.116 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.771 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -42.04 -25.99 0.45 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.087 2.525 . . . . 0.0 113.115 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.54 -18.34 51.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.769 0.318 . . . . 0.0 110.686 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.654 ' CD1' HG23 ' A' ' 4' ' ' ILE . 16.3 p-90 -71.13 -51.64 23.87 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.232 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.779 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.79 -34.97 78.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.202 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -67.39 -13.73 62.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.549 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -105.88 0.85 26.27 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.42 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.506 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 11.7 mt -124.48 110.77 28.21 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 120.682 0.277 . . . . 0.0 111.121 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.03 130.67 33.51 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.562 2.174 . . . . 0.0 112.376 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.1 t -72.61 136.68 45.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.939 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.627 ' HB2' HD13 ' A' ' 19' ' ' ILE . 27.4 ptt180 -53.47 -21.5 6.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.07 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.439 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.0 OUTLIER -61.65 -57.24 12.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.056 0.455 . . . . 0.0 110.513 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.666 HD11 ' HB3' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -71.25 -25.83 25.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.773 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.414 ' HB ' ' HA ' ' A' ' 15' ' ' ARG . 2.0 m -78.87 -42.88 26.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.536 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.77 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.5 mp -96.44 -53.03 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 111.786 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.77 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.6 m-85 -85.28 -15.08 44.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.937 -178.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 72.85 5.5 64.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.81 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -160.33 142.36 12.82 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.1 t -120.85 78.6 1.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.603 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.4 -22.63 32.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.576 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.8 -2.14 53.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.112 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.521 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.7 tm-20 -53.54 -35.78 61.1 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.799 0.333 . . . . 0.0 110.449 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -68.51 -13.03 62.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.771 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.49 ' C ' ' H ' ' A' ' 30' ' ' CYS . 9.6 mp0 -98.4 179.06 4.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.689 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.23 27.47 0.1 OUTLIER Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.765 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.49 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.7 t -66.45 134.88 94.56 Favored Pre-proline 0 C--O 1.231 0.083 0 CA-C-N 117.752 0.776 . . . . 0.0 110.6 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.554 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 88.5 Cg_endo -82.4 146.31 13.77 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.35 2.034 . . . . 0.0 112.083 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.779 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 27.6 m-85 106.56 157.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.839 0.856 . . . . 0.0 111.004 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -88.47 105.78 17.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.599 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.666 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -105.13 79.08 1.45 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.561 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -110.89 145.32 38.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -170.59 1.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.833 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -85.2 103.27 14.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.5 m -84.85 89.33 7.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.26 -48.17 2.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.27 32.21 3.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.081 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.948 179.982 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ptp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.849 0.357 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -175.56 -40.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.2 pttm -99.01 116.53 31.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.943 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.575 ' H ' HD12 ' A' ' 4' ' ' ILE . 0.4 OUTLIER -127.99 101.9 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.031 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -76.77 142.61 70.08 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.229 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -42.93 -24.55 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.557 2.171 . . . . 0.0 112.981 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -65.56 -22.44 66.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.523 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.671 ' CE3' HD12 ' A' ' 12' ' ' ILE . 7.4 p-90 -68.19 -52.17 37.38 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.798 0.333 . . . . 0.0 110.997 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.699 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.54 -38.44 91.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.046 0.45 . . . . 0.0 110.709 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -68.12 -14.2 62.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.31 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.24 -3.42 31.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.728 0.299 . . . . 0.0 110.968 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.671 HD12 ' CE3' ' A' ' 8' ' ' TRP . 63.8 mt -124.36 113.51 27.66 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.786 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.95 130.64 22.11 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.54 2.16 . . . . 0.0 112.756 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.3 t -67.81 136.93 54.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.662 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.446 ' HB2' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -53.04 -22.8 6.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.786 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.44 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.3 m-80 -61.71 -57.03 13.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.032 0.444 . . . . 0.0 110.117 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.425 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.3 mm -66.73 -28.3 42.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.741 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -78.9 -43.06 25.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.227 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.786 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.4 mp -95.99 -54.08 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.863 0.363 . . . . 0.0 111.844 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.786 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.3 m-85 -85.17 -12.65 52.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.904 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.88 5.44 57.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.804 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -160.29 143.32 13.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 32.2 t -120.78 79.7 1.53 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.824 0.345 . . . . 0.0 110.647 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -56.34 -22.6 31.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.455 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.36 -1.47 53.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.064 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 1.3 tm-20 -52.95 -37.75 61.35 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.857 0.361 . . . . 0.0 110.485 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.51 -13.59 61.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.625 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 30' ' ' CYS . 12.7 mt-10 -95.07 179.19 5.3 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.655 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.87 19.55 0.06 OUTLIER Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.776 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.523 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.0 t -66.28 124.22 87.45 Favored Pre-proline 0 C--O 1.232 0.133 0 CA-C-N 117.9 0.85 . . . . 0.0 110.823 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 88.5 Cg_endo -79.36 154.64 24.7 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.311 2.008 . . . . 0.0 112.295 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.699 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.4 m-85 106.89 153.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.988 0.915 . . . . 0.0 111.029 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 11.3 tptt -84.28 96.34 8.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.242 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.451 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 5.3 m80 -89.86 79.08 6.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.688 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.9 p -89.05 100.6 13.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.46 -27.92 9.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -56.98 101.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.94 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.0 m -163.88 78.94 0.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.2 t -62.75 152.86 34.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 59.78 81.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.099 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mtp . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.858 0.361 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -108.75 27.4 9.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.38 112.99 2.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.65 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.596 HG23 ' CD1' ' A' ' 8' ' ' TRP . 8.2 tp -152.62 154.57 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.226 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.646 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 1.5 m-20 -91.17 145.04 30.8 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.628 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -41.79 -23.73 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.185 2.59 . . . . 0.0 113.229 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.39 -21.74 26.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.666 0.269 . . . . 0.0 110.738 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.646 ' HD1' ' O ' ' A' ' 5' ' ' ASN . 18.3 p-90 -77.63 -49.76 13.9 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.035 0.445 . . . . 0.0 111.268 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.748 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.15 -35.09 77.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.216 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.439 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -67.11 -18.46 65.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -96.01 -5.02 42.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.653 0.263 . . . . 0.0 111.242 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.474 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 6.3 mt -124.26 126.31 25.55 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.47 130.65 13.0 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.583 2.189 . . . . 0.0 112.725 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.422 ' HA ' ' CD1' ' A' ' 32' ' ' PHE . 49.7 t -63.36 136.79 57.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.791 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.2 mtp85 -53.02 -25.85 13.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.914 0.387 . . . . 0.0 110.287 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.45 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 3.7 m120 -64.66 -52.92 54.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.328 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 23' ' ' CYS . 17.3 mm -67.21 -30.7 50.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.618 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 m -78.97 -44.92 21.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.379 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.529 HG22 ' CD1' ' A' ' 20' ' ' TYR . 2.0 mp -95.59 -49.79 12.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.529 ' CD1' HG22 ' A' ' 19' ' ' ILE . 4.3 m-85 -85.06 -15.47 43.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.523 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.62 7.21 60.76 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.345 -0.931 . . . . 0.0 111.481 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -160.56 143.72 13.36 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 122.39 0.276 . . . . 0.0 110.501 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.406 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 30.4 t -120.99 80.48 1.64 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.754 0.311 . . . . 0.0 110.266 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.19 -22.77 31.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.821 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.02 4.18 49.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.1 tm-20 -55.92 -32.5 63.84 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.852 0.358 . . . . 0.0 110.191 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -71.55 -11.04 60.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.615 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 30' ' ' CYS . 2.6 mt-10 -98.53 179.06 4.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.773 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.06 24.59 0.09 OUTLIER Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.859 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.501 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.5 t -66.41 132.11 94.28 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 117.763 0.781 . . . . 0.0 110.654 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 88.1 Cg_endo -82.49 148.65 14.46 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.435 2.09 . . . . 0.0 112.663 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.748 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.1 m-85 109.06 154.37 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.094 0.957 . . . . 0.0 111.091 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 2.9 tppt? -86.35 98.01 10.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.243 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.467 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 2.9 m80 -91.42 78.84 5.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.579 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -91.73 126.58 36.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.835 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -62.08 -175.77 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -108.84 -29.26 8.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.977 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.25 176.13 10.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.0 p -108.51 119.51 39.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.24 31.19 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.126 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 42.0 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.925 -179.98 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttt . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.805 0.336 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.4 -77.98 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.832 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -77.14 119.92 21.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.931 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.49 105.92 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.062 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -78.61 140.69 59.66 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.027 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.12 -24.27 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.613 2.209 . . . . 0.0 113.114 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -16.34 62.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.831 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.525 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.4 p-90 -67.25 -52.07 45.44 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.879 0.371 . . . . 0.0 110.919 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.695 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.94 -38.41 91.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.095 0.474 . . . . 0.0 110.842 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -68.07 -12.19 60.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.408 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.08 -3.5 25.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.677 0.275 . . . . 0.0 111.103 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.509 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 9.0 mt -124.19 108.15 29.91 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.143 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.86 130.55 33.38 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.411 2.074 . . . . 0.0 112.348 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.5 t -66.44 136.82 56.27 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.817 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.726 ' HB3' HD12 ' A' ' 19' ' ' ILE . 2.3 mmp_? -53.02 -23.58 7.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.803 0.335 . . . . 0.0 110.624 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.402 ' OD1' ' HA ' ' A' ' 23' ' ' CYS . 1.2 m-80 -61.06 -54.08 49.13 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 110.297 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' A' ' 23' ' ' CYS . 4.7 mm -70.99 -29.16 35.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.765 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -78.74 -38.93 37.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.944 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.748 HG22 ' CD1' ' A' ' 20' ' ' TYR . 5.9 mt -99.84 -54.7 6.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.863 0.363 . . . . 0.0 111.963 -178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.748 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.8 m-85 -85.58 -11.98 52.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.003 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.18 7.33 59.72 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.722 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -160.3 146.87 15.69 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.422 ' HB2' HD11 ' A' ' 17' ' ' ILE . 34.1 t -120.9 80.45 1.64 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.753 0.311 . . . . 0.0 110.684 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -56.37 -21.97 28.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.704 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 -2.99 58.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.067 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.7 tm-20 -53.65 -35.82 61.43 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.765 0.316 . . . . 0.0 110.365 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.11 -16.04 63.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.391 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.493 ' C ' ' H ' ' A' ' 30' ' ' CYS . 15.3 mt-10 -96.83 179.15 5.06 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.56 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 27.4 0.1 OUTLIER Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.754 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.493 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.5 t -66.51 130.07 94.14 Favored Pre-proline 0 C--O 1.231 0.129 0 CA-C-N 117.738 0.769 . . . . 0.0 110.603 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 92.8 Cg_endo -81.13 150.12 17.64 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.382 2.055 . . . . 0.0 112.42 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.695 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.6 m-85 107.51 156.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.995 0.918 . . . . 0.0 111.042 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.466 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 7.4 tptp -87.14 100.06 12.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.445 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.469 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 2.0 m80 -96.35 78.99 3.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.673 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.7 p -117.6 106.22 12.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -164.42 150.24 10.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -136.8 104.66 5.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.27 83.76 3.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.783 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.2 p -140.93 -67.69 0.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.72 173.35 11.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.97 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 mtm . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.793 0.33 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -107.76 -31.67 7.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 mttm -89.8 123.07 33.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.488 HG22 ' CG ' ' A' ' 8' ' ' TRP . 0.2 OUTLIER -144.5 102.06 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.423 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 8.1 m-20 -76.41 145.12 75.4 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.244 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -42.82 -24.76 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.526 2.15 . . . . 0.0 112.83 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.91 -26.35 67.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.321 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.881 ' O ' HD12 ' A' ' 12' ' ' ILE . 7.9 p-90 -69.54 -51.91 31.15 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.814 0.34 . . . . 0.0 110.933 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.641 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.52 -40.58 97.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.013 0.435 . . . . 0.0 110.889 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.446 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 2.7 ttmt -67.7 -13.41 62.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.24 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -99.31 -5.56 29.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.64 0.257 . . . . 0.0 111.092 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.881 HD12 ' O ' ' A' ' 8' ' ' TRP . 2.5 mp -124.24 117.0 26.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.645 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.92 130.55 19.35 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.48 2.12 . . . . 0.0 112.779 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.98 136.7 56.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.652 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.44 ' HB2' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -53.02 -21.99 5.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.752 0.31 . . . . 0.0 110.737 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -62.37 -56.75 15.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.917 0.389 . . . . 0.0 110.117 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.416 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.9 mm -67.72 -28.18 40.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.774 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 m -78.81 -42.76 26.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.167 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.785 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.6 mp -96.61 -54.22 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.357 . . . . 0.0 111.872 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.785 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.5 m-85 -85.28 -12.09 53.22 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.058 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.12 6.56 57.38 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.731 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -160.23 144.47 14.34 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.569 0.223 . . . . 0.0 110.445 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.7 t -120.82 80.74 1.67 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.754 0.311 . . . . 0.0 110.657 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -22.83 31.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.482 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -1.45 56.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.996 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 3.3 tm-20 -53.75 -35.25 61.04 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.813 0.34 . . . . 0.0 110.45 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 mtpp -68.84 -13.06 62.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.58 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 30' ' ' CYS . 16.4 mm-40 -96.53 179.17 5.09 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.655 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.2 22.51 0.08 OUTLIER Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.858 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.51 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.2 t -66.38 128.78 94.03 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 117.735 0.767 . . . . 0.0 110.636 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 90.0 Cg_endo -81.87 152.39 16.86 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.44 2.094 . . . . 0.0 112.592 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.641 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.7 m-85 107.48 154.08 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.079 0.952 . . . . 0.0 111.07 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -84.38 96.53 9.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.295 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.47 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 5.3 m80 -89.87 79.12 6.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.793 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.5 p -123.52 104.78 9.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -130.66 -48.85 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -110.24 174.65 5.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -88.58 -178.72 5.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.476 ' H ' HG22 ' A' ' 38' ' ' THR . 0.6 OUTLIER -108.39 152.58 24.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.904 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.96 164.45 30.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.88 -179.956 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.804 0.335 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -98.19 -34.78 10.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -100.75 110.04 22.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.1 105.97 11.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.035 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.442 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 6.7 t30 -74.49 139.83 75.06 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.297 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -42.69 -24.89 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.55 2.167 . . . . 0.0 112.918 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -24.09 64.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.295 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.877 ' O ' HD12 ' A' ' 12' ' ' ILE . 7.9 p-90 -73.71 -51.76 15.51 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.805 0.336 . . . . 0.0 111.133 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.75 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.45 -39.71 94.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.972 0.415 . . . . 0.0 110.995 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.449 ' CG ' ' HB2' ' A' ' 33' ' ' LYS . 1.1 ttmm -67.16 -13.43 61.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.325 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.81 -7.02 25.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.711 0.291 . . . . 0.0 111.225 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.877 HD12 ' O ' ' A' ' 8' ' ' TRP . 2.6 mp -124.19 124.41 25.88 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.899 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -73.06 130.97 16.09 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.675 2.25 . . . . 0.0 112.712 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 32' ' ' PHE . 46.9 t -65.81 136.67 56.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.826 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.606 ' HB2' HD13 ' A' ' 19' ' ' ILE . 6.3 ptt180 -53.23 -22.23 6.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.667 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.6 m-80 -61.67 -57.07 13.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.939 0.4 . . . . 0.0 110.251 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mm -66.97 -28.98 44.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.883 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.417 HG22 HD12 ' A' ' 19' ' ' ILE . 2.8 m -78.83 -42.35 27.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.247 -178.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.759 HG22 ' CD2' ' A' ' 20' ' ' TYR . 2.1 mp -96.84 -54.43 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.952 0.406 . . . . 0.0 111.921 -178.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.759 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.27 -11.32 55.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.109 -178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.14 6.67 54.45 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.731 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -160.23 145.49 14.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.536 0.207 . . . . 0.0 110.467 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.8 t -120.86 80.39 1.63 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.84 0.353 . . . . 0.0 110.537 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -56.35 -21.77 26.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.33 -0.91 57.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.247 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -54.26 -36.35 63.5 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.808 0.337 . . . . 0.0 110.38 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -66.53 -14.91 62.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.509 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 30' ' ' CYS . 4.9 mt-10 -96.21 179.12 5.16 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.433 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.92 26.05 0.09 OUTLIER Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.535 -0.841 . . . . 0.0 113.749 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.502 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.7 t -66.31 134.08 94.6 Favored Pre-proline 0 C--O 1.231 0.124 0 CA-C-N 117.717 0.758 . . . . 0.0 110.539 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 88.9 Cg_endo -83.46 148.14 12.73 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.455 2.103 . . . . 0.0 112.627 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.75 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 25.9 m-85 108.97 154.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.1 0.96 . . . . 0.0 111.1 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.449 ' HB2' ' CG ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -87.55 96.46 10.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.129 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.459 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 2.0 m80 -90.9 78.91 5.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.631 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -89.19 100.96 13.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.68 88.2 3.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -108.15 111.07 22.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.952 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.58 96.31 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.942 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.89 37.59 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.915 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.19 31.58 4.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.129 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.908 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.803 0.335 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -110.69 -48.71 3.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.827 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -93.36 96.13 9.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.719 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -120.74 106.29 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.969 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.401 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -79.29 147.53 68.97 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.207 179.417 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -42.88 -24.18 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.604 2.203 . . . . 0.0 112.862 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.25 -27.01 69.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.441 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.692 ' CE3' HD12 ' A' ' 12' ' ' ILE . 8.8 p-90 -64.77 -52.04 59.03 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.707 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -64.72 -36.0 82.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.075 0.464 . . . . 0.0 110.651 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.671 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -68.39 -13.89 62.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.288 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -102.3 -1.97 29.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.748 0.308 . . . . 0.0 110.852 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.692 HD12 ' CE3' ' A' ' 8' ' ' TRP . 65.1 mt -124.57 116.6 26.58 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.833 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.84 130.51 20.62 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.45 2.1 . . . . 0.0 112.596 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.4 t -66.73 137.05 56.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.852 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.421 ' HB3' HD13 ' A' ' 19' ' ' ILE . 72.1 mtt180 -52.97 -22.41 5.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.74 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.426 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.8 m-80 -63.58 -57.15 11.03 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 110.372 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.404 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.2 mm -65.52 -27.72 42.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.496 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.594 HG22 HD12 ' A' ' 19' ' ' ILE . 18.0 m -78.91 -44.78 21.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.192 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.756 HG22 ' CD1' ' A' ' 20' ' ' TYR . 2.3 mp -95.36 -54.62 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.965 0.412 . . . . 0.0 111.99 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.756 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.32 -9.98 56.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.028 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 66.83 7.48 42.67 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.279 -0.963 . . . . 0.0 111.81 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 10.2 p90 -160.35 144.17 13.96 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.1 t -120.81 80.26 1.61 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.777 0.323 . . . . 0.0 110.543 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.38 -22.76 33.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.68 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.59 -2.91 58.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.051 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -54.06 -36.08 62.73 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.885 0.374 . . . . 0.0 110.266 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -65.83 -15.79 63.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.41 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 30' ' ' CYS . 33.5 mt-10 -96.65 179.14 5.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.561 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.37 25.72 0.08 OUTLIER Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.888 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.498 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.8 t -66.34 130.31 94.21 Favored Pre-proline 0 CA--C 1.527 0.069 0 CA-C-N 117.874 0.837 . . . . 0.0 110.622 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 96.6 Cg_endo -79.87 150.73 21.17 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.32 2.013 . . . . 0.0 112.379 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.707 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.6 m-85 106.55 154.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.957 0.903 . . . . 0.0 111.105 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.671 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -87.73 96.56 10.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.228 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.459 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 1.9 m80 -91.29 79.19 5.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.658 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.0 m -59.55 156.23 13.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.913 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.95 102.98 4.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.935 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -62.75 -31.71 72.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.827 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.11 86.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -110.18 -54.21 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.946 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.92 -70.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.069 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.926 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.76 0.314 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -142.19 -46.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.872 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.57 127.4 41.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.783 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.578 ' H ' HD12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -120.9 113.35 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.033 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.24 144.31 50.17 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.288 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -42.99 -24.99 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.607 2.205 . . . . 0.0 112.948 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -66.18 -20.04 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.567 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.52 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 7.6 p-90 -67.92 -52.05 40.77 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.852 0.358 . . . . 0.0 111.035 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.733 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.87 -39.87 95.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.082 0.468 . . . . 0.0 110.96 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -67.77 -12.27 60.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.414 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -101.64 -5.01 25.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.676 0.274 . . . . 0.0 111.163 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.496 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 8.2 mt -124.32 123.72 25.88 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.829 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.08 130.72 16.96 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.496 2.131 . . . . 0.0 112.692 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.22 137.0 55.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.927 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.537 ' HB3' HD13 ' A' ' 19' ' ' ILE . 45.9 mtt85 -53.09 -22.29 5.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.806 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.443 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.6 m-80 -62.86 -57.04 12.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 110.228 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.408 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.1 mm -66.1 -27.65 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.546 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.507 HG22 HD12 ' A' ' 19' ' ' ILE . 16.7 m -78.9 -45.77 19.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.205 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.766 HG22 ' CD2' ' A' ' 20' ' ' TYR . 2.2 mp -94.11 -54.39 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.935 0.398 . . . . 0.0 111.939 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.766 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.2 -11.34 55.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.998 -178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 68.9 6.23 50.89 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.808 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -160.34 143.36 13.47 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.6 t -120.76 79.9 1.56 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.734 0.302 . . . . 0.0 110.5 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -56.21 -23.26 34.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.698 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.39 -1.06 52.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.0 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -53.51 -36.19 61.47 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.847 0.356 . . . . 0.0 110.393 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -68.54 -12.84 61.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.668 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 30' ' ' CYS . 7.4 mt-10 -96.94 179.04 5.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 25.49 0.09 OUTLIER Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.708 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.501 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.1 t -66.31 133.21 94.47 Favored Pre-proline 0 C--O 1.231 0.108 0 CA-C-N 117.766 0.783 . . . . 0.0 110.687 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 87.2 Cg_endo -82.84 147.51 13.46 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.404 2.069 . . . . 0.0 112.258 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.733 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.7 m-85 108.01 156.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.011 0.924 . . . . 0.0 110.969 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 6.2 tmmm? -88.52 105.48 17.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.076 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.491 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 1.6 m80 -101.63 78.81 1.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.569 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.5 p -59.76 134.25 56.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -97.08 110.77 23.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.6 t30 62.39 121.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.028 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 m -109.91 150.14 28.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.8 p -122.03 -43.38 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.81 120.2 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.949 179.984 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttm . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.831 0.348 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -63.19 -39.06 93.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -84.47 108.09 17.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.727 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.51 120.94 57.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.186 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -80.74 139.52 50.57 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.998 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -42.98 -24.81 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.503 2.135 . . . . 0.0 113.013 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.65 -20.77 66.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.599 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.862 ' O ' HD12 ' A' ' 12' ' ' ILE . 8.0 p-90 -66.34 -51.91 52.42 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.817 0.341 . . . . 0.0 110.996 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.666 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.82 -39.54 94.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.076 0.465 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.422 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 2.2 ttmt -67.77 -13.48 62.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.293 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.94 -5.29 28.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.675 0.274 . . . . 0.0 111.122 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.862 HD12 ' O ' ' A' ' 8' ' ' TRP . 2.5 mp -124.17 117.08 27.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.707 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.0 130.49 19.14 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.568 2.179 . . . . 0.0 112.774 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.9 t -65.29 136.91 57.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.641 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.485 ' HB3' HD13 ' A' ' 19' ' ' ILE . 2.9 mtm105 -53.12 -23.18 7.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 0.0 110.629 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.429 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.4 m-80 -61.53 -55.29 32.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.939 0.4 . . . . 0.0 110.199 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.411 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.8 mm -69.29 -28.37 38.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.834 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 m -78.77 -42.21 28.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.053 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.785 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.4 mp -97.02 -54.12 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 111.872 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.785 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.5 m-85 -85.37 -12.25 52.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.001 -178.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.45 6.11 57.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.874 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -160.28 144.79 14.46 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.53 0.205 . . . . 0.0 110.475 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.2 t -120.99 79.88 1.57 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.813 0.34 . . . . 0.0 110.674 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -56.4 -21.37 24.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.752 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.16 -1.12 57.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.341 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -53.72 -36.81 62.66 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.856 0.36 . . . . 0.0 110.42 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -65.69 -15.39 62.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.332 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 30' ' ' CYS . 9.3 mm-40 -94.1 179.34 5.35 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.516 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.36 21.28 0.06 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.833 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.513 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.4 t -66.22 127.45 93.25 Favored Pre-proline 0 C--O 1.231 0.098 0 CA-C-N 117.901 0.85 . . . . 0.0 110.723 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 87.3 Cg_endo -82.08 152.97 16.56 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.43 2.087 . . . . 0.0 112.512 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.666 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 27.0 m-85 107.77 154.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.942 0.897 . . . . 0.0 111.128 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.422 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 17.4 tptp -85.23 96.41 9.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.262 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.444 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 3.9 m80 -89.82 79.08 6.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.681 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.71 145.54 29.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.25 152.67 32.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.951 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.57 115.72 4.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 t -112.92 154.88 25.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.983 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 2.2 m -63.63 -19.09 64.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.147 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 39' ' ' THR . . . 67.84 95.22 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.872 0.368 . . . . 0.0 111.134 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.3 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.87 -179.969 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mtm . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.828 0.347 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -137.81 -47.58 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.29 124.94 49.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.658 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.597 HG23 ' CD1' ' A' ' 8' ' ' TRP . 7.9 tp -123.12 154.54 28.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.16 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.604 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 12.4 t30 -87.98 141.78 31.65 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.928 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -42.49 -25.73 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.738 2.292 . . . . 0.0 113.247 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -58.35 -20.41 43.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.793 0.33 . . . . 0.0 110.765 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.651 ' CE3' HD12 ' A' ' 12' ' ' ILE . 13.0 p-90 -74.29 -51.11 16.21 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.012 0.434 . . . . 0.0 111.295 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.747 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.32 -33.5 74.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.244 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -67.17 -19.47 65.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.356 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -98.32 -0.59 43.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.167 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.651 HD12 ' CE3' ' A' ' 8' ' ' TRP . 81.4 mt -124.36 103.79 32.15 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.057 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.59 130.5 35.67 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.428 2.085 . . . . 0.0 112.161 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.5 t -65.6 136.65 56.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.815 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.415 ' HB3' HD13 ' A' ' 19' ' ' ILE . 4.7 mtp180 -53.16 -25.6 14.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.337 . . . . 0.0 110.514 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.433 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 5.5 m120 -63.12 -53.23 56.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.31 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 34' ' ' HIS . 13.1 mm -67.15 -30.59 49.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.612 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 m -78.98 -41.46 29.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.251 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.729 HG22 ' CD2' ' A' ' 20' ' ' TYR . 1.6 mp -96.34 -54.3 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.925 0.393 . . . . 0.0 111.949 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.729 ' CD2' HG22 ' A' ' 19' ' ' ILE . 2.8 m-85 -85.24 -12.33 52.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.036 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.38 7.47 57.64 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.676 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 22' ' ' TYR . 9.0 p90 -160.29 143.87 13.86 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 120.609 0.242 . . . . 0.0 110.468 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.8 t -120.65 80.76 1.67 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.791 0.329 . . . . 0.0 110.27 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -22.06 27.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.103 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.76 2.13 55.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.171 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -55.0 -36.55 65.54 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.857 0.36 . . . . 0.0 110.301 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -66.54 -14.41 62.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.419 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.52 ' C ' ' H ' ' A' ' 30' ' ' CYS . 4.9 mm-40 -94.42 179.19 5.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.602 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.82 22.05 0.07 OUTLIER Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.752 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.52 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.4 t -66.38 123.74 86.29 Favored Pre-proline 0 CA--C 1.527 0.073 0 CA-C-N 117.82 0.81 . . . . 0.0 110.687 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 71.8 Cg_endo -77.62 151.7 28.88 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.195 1.93 . . . . 0.0 112.249 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.747 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 25.6 m-85 109.45 153.02 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.062 0.945 . . . . 0.0 111.049 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -86.49 96.47 10.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.247 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.463 ' HB3' HD11 ' A' ' 17' ' ' ILE . 3.2 m80 -89.94 79.16 6.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.084 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.4 p -112.89 119.39 37.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.773 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -94.51 -56.94 2.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.3 58.98 0.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.9 m -123.68 33.03 5.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 t -157.38 145.96 19.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.09 167.86 10.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.7 p . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.895 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 mtp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.849 0.357 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -64.73 -31.02 72.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -99.55 100.63 11.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.551 ' H ' HD12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -136.42 106.73 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.69 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.459 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 83.0 m-20 -72.89 138.72 79.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.385 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -42.68 -24.69 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.522 2.148 . . . . 0.0 112.887 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -57.92 -23.44 53.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.214 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.528 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.0 p-90 -78.87 -51.99 8.93 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 120.808 0.337 . . . . 0.0 110.951 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.73 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.34 -37.73 88.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 0.0 110.842 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -67.92 -13.59 62.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.419 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.47 -3.6 28.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 111.14 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.504 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 6.7 mt -124.19 116.35 27.18 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.765 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 131.6 21.66 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.655 2.237 . . . . 0.0 112.859 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.1 t -67.12 136.81 55.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.777 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.433 ' HB3' HD13 ' A' ' 19' ' ' ILE . 10.3 mtt-85 -52.93 -25.6 12.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 0.0 110.568 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.443 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 5.1 m120 -64.36 -52.78 56.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.289 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.405 HD11 ' HB3' ' A' ' 34' ' ' HIS . 14.9 mm -67.77 -31.27 51.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.613 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.55 HG22 HD12 ' A' ' 19' ' ' ILE . 3.1 m -78.92 -40.8 31.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.426 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.55 HD12 HG22 ' A' ' 18' ' ' THR . 3.1 mp -98.43 -51.47 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.509 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.2 m-85 -85.14 -14.87 45.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.439 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.38 7.41 63.91 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.472 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 20' ' ' TYR . 12.2 p90 -160.48 144.54 13.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.443 0.297 . . . . 0.0 110.344 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.3 t -120.77 80.71 1.66 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.349 178.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.19 -22.7 30.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.846 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 9.27 32.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.482 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -58.79 -36.4 74.39 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.9 0.381 . . . . 0.0 110.202 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -68.65 -12.94 61.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.593 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.3 OUTLIER -93.91 179.28 5.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.33 19.53 0.05 OUTLIER Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.846 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.53 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.0 t -66.3 124.38 87.91 Favored Pre-proline 0 C--O 1.231 0.124 0 CA-C-N 117.885 0.843 . . . . 0.0 110.619 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.549 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 98.2 Cg_endo -80.0 153.6 22.26 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.357 2.038 . . . . 0.0 112.445 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.73 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.8 m-85 107.31 153.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.03 0.932 . . . . 0.0 111.0 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -84.46 96.42 9.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.359 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.482 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 4.3 m80 -90.11 79.07 6.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.68 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -74.84 159.19 32.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.868 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 t0 61.43 162.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.39 154.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.33 -67.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.828 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.68 103.18 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.43 -173.28 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.026 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.887 -179.983 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 mtm . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.781 0.324 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -176.72 -39.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.43 94.46 7.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.603 ' H ' HD12 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -131.87 118.57 38.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.976 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -78.19 136.24 61.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.232 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -42.83 -24.93 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.627 2.218 . . . . 0.0 113.018 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -67.35 -14.63 63.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.717 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.531 ' O ' HD12 ' A' ' 12' ' ' ILE . 7.7 p-90 -75.57 -52.06 11.47 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.824 0.345 . . . . 0.0 111.151 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.72 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -63.3 -38.59 91.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.085 0.469 . . . . 0.0 110.821 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.5 tmmt? -67.58 -13.03 61.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.45 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -102.02 -3.99 26.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.723 0.296 . . . . 0.0 111.245 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.531 HD12 ' O ' ' A' ' 8' ' ' TRP . 4.8 mt -124.29 122.37 26.02 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.871 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.79 130.68 17.24 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.64 2.227 . . . . 0.0 112.8 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.3 t -67.2 137.05 55.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.925 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.452 ' HB3' HD13 ' A' ' 19' ' ' ILE . 16.9 mtt85 -52.81 -24.85 9.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.69 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.436 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 6.1 m120 -63.41 -55.47 24.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.979 0.418 . . . . 0.0 110.325 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.411 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 10.0 mm -65.49 -29.26 46.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.6 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.1 m -78.93 -42.47 26.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.361 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.766 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.7 mp -96.17 -53.93 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.766 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.0 m-85 -85.15 -12.52 52.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.902 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.63 6.78 56.59 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.768 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -160.26 142.01 12.67 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.0 t -120.77 79.11 1.45 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.672 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.0 tptt -56.74 -20.43 22.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.827 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -85.19 -2.74 58.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.337 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 34' ' ' HIS . 14.8 tt0 -53.9 -36.42 62.68 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.778 0.323 . . . . 0.0 110.381 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.54 -15.79 63.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.051 0.453 . . . . 0.0 110.273 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' A' ' 30' ' ' CYS . 10.2 mt-10 -95.13 179.14 5.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.479 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.12 23.96 0.08 OUTLIER Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.889 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.506 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.6 t -66.27 132.6 94.44 Favored Pre-proline 0 C--O 1.231 0.128 0 CA-C-N 117.868 0.834 . . . . 0.0 110.718 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 86.3 Cg_endo -83.41 149.31 13.09 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.41 2.073 . . . . 0.0 112.451 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.72 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.3 m-85 107.99 155.18 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.989 0.916 . . . . 0.0 111.0 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 12.6 tptt -87.54 97.6 10.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.391 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.464 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 1.4 m80 -94.26 79.05 3.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.531 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 85.3 p -88.04 111.37 21.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.975 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.04 74.54 0.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -173.25 147.13 1.5 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.91 65.89 6.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.7 m -73.26 155.4 39.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.818 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.35 -47.01 7.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.085 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.906 179.954 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.811 0.338 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.54 -47.32 0.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -79.95 103.43 9.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.723 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.582 HG23 ' CD1' ' A' ' 8' ' ' TRP . 8.4 tp -139.06 154.72 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.163 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.634 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 1.2 t30 -89.65 140.59 28.12 Favored Pre-proline 0 C--N 1.333 -0.14 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.497 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -41.94 -24.48 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.094 2.529 . . . . 0.0 113.192 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -58.86 -20.31 49.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.821 0.343 . . . . 0.0 110.728 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.634 ' HD1' ' O ' ' A' ' 5' ' ' ASN . 16.9 p-90 -73.63 -51.09 17.97 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-O 121.033 0.444 . . . . 0.0 111.226 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.729 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.43 -34.37 76.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.194 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.5 ttmt -67.32 -17.64 64.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.394 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.39 -1.04 39.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.613 0.244 . . . . 0.0 111.287 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.521 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 8.3 mt -124.33 105.53 30.99 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.686 0.279 . . . . 0.0 111.168 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.74 130.58 33.74 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.573 2.182 . . . . 0.0 112.439 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.9 t -67.69 136.96 55.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.836 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.594 ' HB3' HD13 ' A' ' 19' ' ' ILE . 10.7 mtm180 -53.04 -23.29 7.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.774 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.419 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.1 m-80 -61.11 -54.96 38.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.081 0.467 . . . . 0.0 110.116 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.439 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.1 mm -69.25 -28.5 38.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.881 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 m -78.86 -41.36 30.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.021 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.772 HG22 ' CD2' ' A' ' 20' ' ' TYR . 1.8 mp -97.06 -54.6 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.915 0.388 . . . . 0.0 111.738 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.772 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.25 -13.08 50.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.963 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 71.86 5.43 61.26 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.746 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -160.27 142.98 13.34 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.617 0.246 . . . . 0.0 110.53 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 37.5 t -120.82 79.53 1.51 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.459 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.42 -22.04 29.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.717 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.52 -1.66 56.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.401 ' CG ' ' HB2' ' A' ' 34' ' ' HIS . 14.2 tt0 -54.06 -35.55 62.15 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 120.727 0.299 . . . . 0.0 110.389 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.92 -15.95 63.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.421 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.52 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -95.19 179.35 5.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.561 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.48 21.11 0.05 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.653 -0.785 . . . . 0.0 114.133 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.52 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.8 t -66.2 124.25 87.46 Favored Pre-proline 0 C--O 1.231 0.111 0 CA-C-N 117.976 0.888 . . . . 0.0 110.598 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 86.3 Cg_endo -78.89 151.1 24.12 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.302 2.001 . . . . 0.0 112.471 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.729 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.0 m-85 108.46 154.82 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.041 0.936 . . . . 0.0 111.034 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 15.9 tptt -86.0 99.55 11.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.293 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.461 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 3.0 m80 -93.96 79.07 4.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.731 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.3 151.4 26.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.903 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.03 159.4 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -126.04 -56.31 1.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.2 m -152.49 153.34 33.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.88 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.79 82.53 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.876 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.96 152.3 7.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.013 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.906 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.815 0.341 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -99.68 -35.16 9.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -89.7 118.07 29.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.59 ' H ' HD12 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -129.2 107.59 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.979 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.423 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -75.67 142.27 73.55 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.314 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -42.84 -25.28 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.58 2.187 . . . . 0.0 112.845 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -59.33 -25.56 64.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.211 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.614 ' CE3' HD12 ' A' ' 12' ' ' ILE . 7.2 p-90 -72.29 -51.86 18.9 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.864 0.364 . . . . 0.0 110.891 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.762 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.8 -38.0 88.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.04 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.44 ' CG ' ' HB2' ' A' ' 33' ' ' LYS . 1.8 ttmt -67.24 -14.99 63.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.348 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -100.33 -3.47 31.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.646 0.26 . . . . 0.0 111.134 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.614 HD12 ' CE3' ' A' ' 8' ' ' TRP . 55.5 mt -124.3 126.69 25.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.11 132.31 13.86 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.633 2.222 . . . . 0.0 112.907 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.0 t -70.65 136.85 49.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.641 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.6 ' HB3' HD13 ' A' ' 19' ' ' ILE . 16.3 mtp85 -53.21 -22.56 6.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.0 110.835 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.5 m-80 -61.68 -55.74 27.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.016 0.436 . . . . 0.0 110.185 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.41 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.9 mm -68.44 -28.82 41.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.836 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.5 m -78.64 -42.58 28.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.178 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.772 HG22 ' CD2' ' A' ' 20' ' ' TYR . 1.7 mp -96.57 -54.31 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.41 . . . . 0.0 111.863 -178.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.772 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.28 -12.06 53.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.063 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.93 6.31 55.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.163 -1.017 . . . . 0.0 111.759 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -160.18 146.6 15.72 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.405 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 21.8 t -120.8 81.05 1.71 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.575 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.3 -22.37 29.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.667 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.88 2.04 54.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.016 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -55.05 -35.16 64.19 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.806 0.336 . . . . 0.0 110.427 179.818 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -11.09 60.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.718 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.512 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -97.26 179.04 5.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.665 179.402 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.45 23.28 0.08 OUTLIER Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.81 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.512 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.5 t -66.36 131.35 94.26 Favored Pre-proline 0 C--O 1.23 0.054 0 CA-C-N 117.75 0.775 . . . . 0.0 110.714 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.556 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 94.8 Cg_endo -81.52 148.9 16.39 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.398 2.065 . . . . 0.0 112.25 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.762 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 25.5 m-85 109.16 154.77 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.062 0.945 . . . . 0.0 111.056 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HB2' ' CG ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -87.18 98.79 11.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.269 179.637 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.489 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 2.1 m80 -95.07 79.0 3.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.633 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -97.58 150.2 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.57 79.1 9.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.022 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -93.47 178.83 5.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.4 m -94.2 143.12 26.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.843 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 m -101.27 34.28 2.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.93 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.67 107.1 19.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.315 -0.85 . . . . 0.0 110.956 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.534 ' O ' HD12 ' A' ' 12' ' ' ILE . 7.7 p-90 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.789 0.328 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.715 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.33 -38.06 89.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.051 0.453 . . . . 0.0 110.875 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -67.76 -13.73 62.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.358 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.06 -3.91 28.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.698 0.285 . . . . 0.0 111.14 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 8' ' ' TRP . 4.8 mt -124.29 116.19 27.08 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.741 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 131.74 21.81 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.573 2.182 . . . . 0.0 112.787 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.37 136.86 55.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.735 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 mtt85 -52.92 -25.95 13.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.34 . . . . 0.0 110.576 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.403 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 5.7 m120 -63.53 -52.94 59.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.366 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 34' ' ' HIS . 13.7 mm -67.26 -31.12 51.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.632 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -79.01 -40.81 30.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.324 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.702 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.9 mp -96.38 -54.6 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.702 ' CD1' HG22 ' A' ' 19' ' ' ILE . 2.7 m-85 -85.24 -12.21 53.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.038 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 68.4 8.34 55.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.529 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.427 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 10.1 p90 -160.27 143.9 13.92 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.47 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 36.7 t -120.71 80.93 1.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.57 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -22.23 30.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.921 0.391 . . . . 0.0 110.525 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.9 -3.38 58.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.952 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.424 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -53.34 -36.88 61.8 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.805 0.336 . . . . 0.0 110.4 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -65.94 -15.47 63.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.494 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 30' ' ' CYS . 48.5 mt-10 -95.9 179.17 5.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.558 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.45 24.32 0.08 OUTLIER Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.727 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.502 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.9 t -66.34 127.31 93.22 Favored Pre-proline 0 C--O 1.231 0.088 0 CA-C-N 117.819 0.809 . . . . 0.0 110.597 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 92.1 Cg_endo -80.96 152.43 18.93 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.352 2.035 . . . . 0.0 112.541 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.715 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.2 m-85 107.5 154.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.965 0.906 . . . . 0.0 111.066 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -84.45 96.54 9.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.419 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.47 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 4.7 m80 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.703 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.611 ' O ' HD12 ' A' ' 12' ' ' ILE . 8.0 p-90 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.848 0.356 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.72 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.06 -38.43 91.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.023 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.415 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -67.59 -13.04 61.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.399 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -101.65 -4.09 27.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.756 0.312 . . . . 0.0 111.25 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 8' ' ' TRP . 3.9 mt -124.35 107.86 29.68 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.942 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.6 130.63 32.3 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.497 2.131 . . . . 0.0 112.386 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.2 t -66.46 136.77 56.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.8 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.44 ' HB3' HD13 ' A' ' 19' ' ' ILE . 13.9 mtt85 -53.15 -24.14 9.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.71 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.432 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.1 m-80 -60.48 -52.95 63.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.113 0.482 . . . . 0.0 110.094 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.433 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.2 mm -71.34 -29.75 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.015 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.599 HG22 HD12 ' A' ' 19' ' ' ILE . 1.6 m -78.72 -38.32 39.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.007 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.717 HG22 ' CD1' ' A' ' 20' ' ' TYR . 2.9 mp -99.3 -54.73 6.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.934 0.397 . . . . 0.0 111.709 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.717 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.6 m-85 -85.48 -13.62 48.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.946 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 72.5 5.65 64.02 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.659 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.427 ' CD1' ' HG3' ' A' ' 24' ' ' LYS . 14.2 p90 -160.26 143.97 13.97 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.482 0.182 . . . . 0.0 110.513 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.49 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 46.1 t -120.82 79.39 1.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.49 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.427 ' HG3' ' CD1' ' A' ' 22' ' ' TYR . 45.5 mttm -56.37 -21.7 26.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.838 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.59 1.96 52.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.187 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -55.49 -37.15 67.45 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.773 0.321 . . . . 0.0 110.274 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -15.86 63.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.372 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.532 ' C ' ' H ' ' A' ' 30' ' ' CYS . 1.5 mt-10 -93.19 179.36 5.44 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.0 19.73 0.05 OUTLIER Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.929 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.532 ' H ' ' C ' ' A' ' 28' ' ' GLU . 2.4 t -66.2 123.59 85.7 Favored Pre-proline 0 C--O 1.232 0.138 0 CA-C-N 117.824 0.812 . . . . 0.0 110.858 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.554 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 95.1 Cg_endo -79.85 153.78 22.78 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.282 1.988 . . . . 0.0 112.331 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.72 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 27.2 m-85 107.38 155.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.985 0.914 . . . . 0.0 111.133 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.415 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 14.5 tptt -85.77 97.51 10.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.38 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.49 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 3.1 m80 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.782 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.55 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 13.8 p-90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.912 0.387 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.756 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.35 -34.49 76.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.181 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.6 ttmt -67.15 -17.2 64.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.477 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -100.42 -1.6 35.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.581 0.229 . . . . 0.0 111.269 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.503 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 16.6 mt -124.24 109.9 29.03 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.202 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.04 130.61 31.43 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.483 2.122 . . . . 0.0 112.216 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.3 t -68.02 137.02 54.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.881 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -52.78 -22.97 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.584 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -61.66 -57.04 13.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.041 0.448 . . . . 0.0 110.128 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.424 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.2 mm -67.66 -29.17 44.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.841 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.2 m -78.82 -41.55 29.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.197 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.76 HG22 ' CD2' ' A' ' 20' ' ' TYR . 2.2 mt -97.02 -54.54 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.925 0.393 . . . . 0.0 111.867 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.76 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.3 m-85 -85.47 -12.1 52.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.971 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.93 6.81 57.65 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.284 -0.96 . . . . 0.0 111.782 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -160.27 143.24 13.51 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.575 0.226 . . . . 0.0 110.53 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.479 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 17.6 t -120.85 80.22 1.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.565 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.22 -22.61 30.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.501 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -2.59 56.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.927 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.3 tm-20 -53.7 -34.17 57.91 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.758 0.313 . . . . 0.0 110.432 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.19 -11.86 61.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.691 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -99.11 179.05 4.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.671 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.78 25.79 0.11 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.742 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.496 ' H ' ' C ' ' A' ' 28' ' ' GLU . 6.3 t -66.33 133.03 94.42 Favored Pre-proline 0 N--CA 1.457 -0.077 0 CA-C-N 117.599 0.699 . . . . 0.0 110.714 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 95.3 Cg_endo -82.05 148.14 15.1 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.363 2.042 . . . . 0.0 112.326 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.756 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.2 m-85 108.53 154.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.951 0.901 . . . . 0.0 110.91 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 47.3 tptt -87.09 99.99 12.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.443 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.479 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 2.2 m80 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.654 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.531 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.0 p-90 . . . . . 0 N--CA 1.461 0.087 0 CA-C-O 120.796 0.332 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.71 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.23 -38.76 92.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.174 0.511 . . . . 0.0 110.893 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.439 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -68.46 -13.37 62.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.356 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.39 -3.31 31.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.781 0.324 . . . . 0.0 111.021 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.529 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 5.8 mt -124.35 109.17 29.09 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.54 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.66 130.62 23.87 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.644 2.229 . . . . 0.0 112.914 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.2 t -65.9 136.87 56.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.716 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -52.77 -25.36 11.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.837 0.351 . . . . 0.0 110.684 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -63.42 -53.43 52.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.172 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.424 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 10.9 mm -68.32 -29.31 43.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.554 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.8 m -78.95 -40.67 31.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.112 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.746 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.6 mp -96.85 -54.64 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 111.934 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.746 ' CD1' HG22 ' A' ' 19' ' ' ILE . 2.9 m-85 -85.32 -13.11 50.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.949 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.9 6.96 61.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.098 -1.048 . . . . 0.0 111.614 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.42 ' CE1' ' HG3' ' A' ' 24' ' ' LYS . 9.2 p90 -160.19 143.3 13.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.599 0.238 . . . . 0.0 110.45 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.47 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 36.0 t -120.67 80.55 1.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.387 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.42 ' HG3' ' CE1' ' A' ' 22' ' ' TYR . 5.8 mtmm -56.22 -22.11 27.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.771 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.75 10.17 27.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -59.12 -34.52 72.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.876 0.369 . . . . 0.0 110.124 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -69.48 -12.64 61.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.565 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.526 ' C ' ' H ' ' A' ' 30' ' ' CYS . 2.0 mt-10 -94.12 179.39 5.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.69 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.74 14.47 0.02 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.746 -0.74 . . . . 0.0 114.109 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.526 ' H ' ' C ' ' A' ' 28' ' ' GLU . 1.5 t -66.26 114.51 17.24 Favored Pre-proline 0 C--O 1.23 0.075 0 CA-C-N 118.028 0.914 . . . . 0.0 110.632 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 74.1 Cg_endo -75.67 158.65 39.48 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.279 1.986 . . . . 0.0 112.158 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.71 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 28.0 m-85 105.68 154.28 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.95 0.9 . . . . 0.0 111.06 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 23.6 tptp -82.13 96.33 7.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.609 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.47 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 9.0 m80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.827 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.591 ' CE3' HD12 ' A' ' 12' ' ' ILE . 15.7 p-90 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.948 0.404 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.747 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.17 -35.12 77.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.135 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.2 ttmt -67.32 -18.74 65.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.214 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.69 -2.02 42.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.133 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.591 HD12 ' CE3' ' A' ' 8' ' ' TRP . 53.6 mt -124.2 126.37 25.56 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.94 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.39 130.58 13.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.526 2.151 . . . . 0.0 112.511 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.431 ' HG ' ' H ' ' A' ' 16' ' ' ASN . 45.6 t -67.18 136.84 55.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.782 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.487 ' HB3' HD13 ' A' ' 19' ' ' ILE . 21.3 mtp85 -52.81 -25.43 11.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.935 0.398 . . . . 0.0 110.5 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.447 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 5.0 m120 -63.71 -55.22 24.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.413 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 mm -64.87 -30.47 50.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.603 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.0 m -78.93 -43.27 25.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.561 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.725 HG22 ' CD2' ' A' ' 20' ' ' TYR . 2.1 mp -95.39 -53.42 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.725 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.0 m-85 -85.19 -12.08 53.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.944 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.96 7.82 51.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.203 -0.998 . . . . 0.0 111.657 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.411 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 10.2 p90 -160.3 143.12 13.39 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.46 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 34.5 t -120.7 80.15 1.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.698 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -56.4 -22.06 29.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.585 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -83.51 -5.37 59.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.076 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.4 ' CG ' ' HB2' ' A' ' 34' ' ' HIS . 22.0 tt0 -53.61 -36.24 61.78 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 120.812 0.339 . . . . 0.0 110.383 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -15.79 63.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.294 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.478 ' C ' ' H ' ' A' ' 30' ' ' CYS . 70.0 mt-10 -97.75 179.04 4.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.457 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.92 28.73 0.11 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.746 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.478 ' H ' ' C ' ' A' ' 28' ' ' GLU . 6.1 t -66.43 134.09 94.48 Favored Pre-proline 0 CA--C 1.528 0.097 0 CA-C-N 117.764 0.782 . . . . 0.0 110.628 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 89.5 Cg_endo -82.37 147.86 14.42 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.258 1.972 . . . . 0.0 112.338 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.747 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.5 m-85 107.81 155.61 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.978 0.911 . . . . 0.0 111.035 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -88.02 100.57 13.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.468 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.483 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.338 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.556 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 14.3 p-90 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.0 0.428 . . . . 0.0 111.441 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.762 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.34 -33.48 74.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.323 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -67.5 -17.88 64.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.457 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.39 -1.03 39.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.192 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.525 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 9.4 mt -124.34 103.64 32.32 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.075 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.89 130.58 35.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.479 2.119 . . . . 0.0 112.366 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.7 t -65.48 136.73 56.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.881 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.574 ' HB3' HD12 ' A' ' 19' ' ' ILE . 36.1 mtt180 -52.88 -25.61 12.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.613 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -63.78 -52.98 57.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.121 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' A' ' 34' ' ' HIS . 14.5 mm -67.01 -31.23 52.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.522 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.4 m -78.97 -39.99 32.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.334 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.721 HG22 ' CD2' ' A' ' 20' ' ' TYR . 4.1 mt -96.69 -54.68 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.721 ' CD2' HG22 ' A' ' 19' ' ' ILE . 2.6 m-85 -85.47 -12.56 51.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.996 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.18 7.11 59.29 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.596 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.405 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 11.7 p90 -160.19 143.25 13.64 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.61 0.243 . . . . 0.0 110.57 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.477 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 35.6 t -120.86 80.2 1.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.805 0.336 . . . . 0.0 110.281 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.2 -23.21 34.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.775 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 3.82 45.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.487 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -55.23 -36.15 65.69 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.818 0.342 . . . . 0.0 110.384 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -68.11 -13.2 62.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.407 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' A' ' 30' ' ' CYS . 3.7 mm-40 -94.38 179.14 5.39 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.592 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.09 20.24 0.06 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.798 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.525 ' H ' ' C ' ' A' ' 28' ' ' GLU . 2.6 t -66.32 121.17 75.42 Favored Pre-proline 0 C--O 1.231 0.086 0 CA-C-N 117.747 0.774 . . . . 0.0 110.769 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 72.6 Cg_endo -77.72 153.28 29.78 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.293 1.995 . . . . 0.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.762 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 25.9 m-85 108.33 153.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.006 0.923 . . . . 0.0 111.104 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -85.1 96.66 9.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.339 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.487 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 3.8 m80 . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.672 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.555 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 16.3 p-90 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.939 0.399 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.779 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.79 -34.97 78.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.202 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -67.39 -13.73 62.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.549 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -105.88 0.85 26.27 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.42 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.506 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 11.7 mt -124.48 110.77 28.21 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 120.682 0.277 . . . . 0.0 111.121 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.03 130.67 33.51 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.562 2.174 . . . . 0.0 112.376 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.1 t -72.61 136.68 45.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.939 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.627 ' HB2' HD13 ' A' ' 19' ' ' ILE . 27.4 ptt180 -53.47 -21.5 6.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.07 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.439 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.0 OUTLIER -61.65 -57.24 12.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.056 0.455 . . . . 0.0 110.513 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.666 HD11 ' HB3' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -71.25 -25.83 25.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.773 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.414 ' HB ' ' HA ' ' A' ' 15' ' ' ARG . 2.0 m -78.87 -42.88 26.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.536 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.77 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.5 mp -96.44 -53.03 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 111.786 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.77 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.6 m-85 -85.28 -15.08 44.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.937 -178.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 72.85 5.5 64.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.81 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -160.33 142.36 12.82 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.482 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 7.1 t -120.85 78.6 1.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.603 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.4 -22.63 32.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.576 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.8 -2.14 53.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.112 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.521 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.7 tm-20 -53.54 -35.78 61.1 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.799 0.333 . . . . 0.0 110.449 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -68.51 -13.03 62.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.771 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.49 ' C ' ' H ' ' A' ' 30' ' ' CYS . 9.6 mp0 -98.4 179.06 4.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.689 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.23 27.47 0.1 OUTLIER Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.765 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.49 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.7 t -66.45 134.88 94.56 Favored Pre-proline 0 C--O 1.231 0.083 0 CA-C-N 117.752 0.776 . . . . 0.0 110.6 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.554 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 88.5 Cg_endo -82.4 146.31 13.77 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.35 2.034 . . . . 0.0 112.083 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.779 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 27.6 m-85 106.56 157.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.839 0.856 . . . . 0.0 111.004 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -88.47 105.78 17.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.599 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.666 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.561 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.671 ' CE3' HD12 ' A' ' 12' ' ' ILE . 7.4 p-90 . . . . . 0 N--CA 1.461 0.105 0 CA-C-O 120.798 0.333 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.699 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.54 -38.44 91.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.046 0.45 . . . . 0.0 110.709 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -68.12 -14.2 62.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.31 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.24 -3.42 31.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.728 0.299 . . . . 0.0 110.968 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.671 HD12 ' CE3' ' A' ' 8' ' ' TRP . 63.8 mt -124.36 113.51 27.66 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.786 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.95 130.64 22.11 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.54 2.16 . . . . 0.0 112.756 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.3 t -67.81 136.93 54.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.662 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.446 ' HB2' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -53.04 -22.8 6.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.786 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.44 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.3 m-80 -61.71 -57.03 13.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.032 0.444 . . . . 0.0 110.117 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.425 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.3 mm -66.73 -28.3 42.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.741 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -78.9 -43.06 25.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.227 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.786 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.4 mp -95.99 -54.08 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.863 0.363 . . . . 0.0 111.844 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.786 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.3 m-85 -85.17 -12.65 52.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.904 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.88 5.44 57.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.804 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -160.29 143.32 13.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.47 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 32.2 t -120.78 79.7 1.53 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.824 0.345 . . . . 0.0 110.647 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -56.34 -22.6 31.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.455 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.36 -1.47 53.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.064 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 1.3 tm-20 -52.95 -37.75 61.35 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.857 0.361 . . . . 0.0 110.485 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.51 -13.59 61.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.625 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 30' ' ' CYS . 12.7 mt-10 -95.07 179.19 5.3 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.655 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.87 19.55 0.06 OUTLIER Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.776 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.523 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.0 t -66.28 124.22 87.45 Favored Pre-proline 0 C--O 1.232 0.133 0 CA-C-N 117.9 0.85 . . . . 0.0 110.823 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 88.5 Cg_endo -79.36 154.64 24.7 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.311 2.008 . . . . 0.0 112.295 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.699 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.4 m-85 106.89 153.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.988 0.915 . . . . 0.0 111.029 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 11.3 tptt -84.28 96.34 8.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.242 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.47 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 5.3 m80 . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.688 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.527 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 18.3 p-90 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.035 0.445 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.748 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.15 -35.09 77.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.216 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.439 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -67.11 -18.46 65.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -96.01 -5.02 42.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.653 0.263 . . . . 0.0 111.242 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.474 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 6.3 mt -124.26 126.31 25.55 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.47 130.65 13.0 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.583 2.189 . . . . 0.0 112.725 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.422 ' HA ' ' CD1' ' A' ' 32' ' ' PHE . 49.7 t -63.36 136.79 57.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.791 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.2 mtp85 -53.02 -25.85 13.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.914 0.387 . . . . 0.0 110.287 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.45 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 3.7 m120 -64.66 -52.92 54.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.328 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 23' ' ' CYS . 17.3 mm -67.21 -30.7 50.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.618 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 m -78.97 -44.92 21.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.379 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.529 HG22 ' CD1' ' A' ' 20' ' ' TYR . 2.0 mp -95.59 -49.79 12.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.529 ' CD1' HG22 ' A' ' 19' ' ' ILE . 4.3 m-85 -85.06 -15.47 43.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.523 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.62 7.21 60.76 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.345 -0.931 . . . . 0.0 111.481 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -160.56 143.72 13.36 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 122.39 0.276 . . . . 0.0 110.501 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.481 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 30.4 t -120.99 80.48 1.64 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.754 0.311 . . . . 0.0 110.266 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.19 -22.77 31.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.821 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.02 4.18 49.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.1 tm-20 -55.92 -32.5 63.84 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.852 0.358 . . . . 0.0 110.191 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -71.55 -11.04 60.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.615 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 30' ' ' CYS . 2.6 mt-10 -98.53 179.06 4.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.773 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.06 24.59 0.09 OUTLIER Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.859 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.501 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.5 t -66.41 132.11 94.28 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 117.763 0.781 . . . . 0.0 110.654 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 88.1 Cg_endo -82.49 148.65 14.46 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.435 2.09 . . . . 0.0 112.663 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.748 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.1 m-85 109.06 154.37 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.094 0.957 . . . . 0.0 111.091 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.439 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 2.9 tppt? -86.35 98.01 10.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.243 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.481 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 2.9 m80 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.579 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.525 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.4 p-90 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.879 0.371 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.695 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.94 -38.41 91.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.095 0.474 . . . . 0.0 110.842 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -68.07 -12.19 60.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.408 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.08 -3.5 25.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.677 0.275 . . . . 0.0 111.103 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.509 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 9.0 mt -124.19 108.15 29.91 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.143 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.86 130.55 33.38 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.411 2.074 . . . . 0.0 112.348 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.5 t -66.44 136.82 56.27 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.817 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.726 ' HB3' HD12 ' A' ' 19' ' ' ILE . 2.3 mmp_? -53.02 -23.58 7.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.803 0.335 . . . . 0.0 110.624 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.402 ' OD1' ' HA ' ' A' ' 23' ' ' CYS . 1.2 m-80 -61.06 -54.08 49.13 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 110.297 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' A' ' 23' ' ' CYS . 4.7 mm -70.99 -29.16 35.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.765 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -78.74 -38.93 37.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.944 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.748 HG22 ' CD1' ' A' ' 20' ' ' TYR . 5.9 mt -99.84 -54.7 6.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.863 0.363 . . . . 0.0 111.963 -178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.748 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.8 m-85 -85.58 -11.98 52.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.003 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.18 7.33 59.72 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.722 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -160.3 146.87 15.69 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.491 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 34.1 t -120.9 80.45 1.64 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.753 0.311 . . . . 0.0 110.684 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -56.37 -21.97 28.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.704 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 -2.99 58.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.067 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.7 tm-20 -53.65 -35.82 61.43 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.765 0.316 . . . . 0.0 110.365 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.11 -16.04 63.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.391 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.493 ' C ' ' H ' ' A' ' 30' ' ' CYS . 15.3 mt-10 -96.83 179.15 5.06 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.56 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 27.4 0.1 OUTLIER Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.754 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.493 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.5 t -66.51 130.07 94.14 Favored Pre-proline 0 C--O 1.231 0.129 0 CA-C-N 117.738 0.769 . . . . 0.0 110.603 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 92.8 Cg_endo -81.13 150.12 17.64 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.382 2.055 . . . . 0.0 112.42 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.695 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.6 m-85 107.51 156.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.995 0.918 . . . . 0.0 111.042 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.466 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 7.4 tptp -87.14 100.06 12.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.445 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.491 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 2.0 m80 . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.673 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.881 ' O ' HD12 ' A' ' 12' ' ' ILE . 7.9 p-90 . . . . . 0 N--CA 1.461 0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.641 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.52 -40.58 97.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.013 0.435 . . . . 0.0 110.889 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.446 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 2.7 ttmt -67.7 -13.41 62.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.24 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -99.31 -5.56 29.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.64 0.257 . . . . 0.0 111.092 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.881 HD12 ' O ' ' A' ' 8' ' ' TRP . 2.5 mp -124.24 117.0 26.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.645 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.92 130.55 19.35 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.48 2.12 . . . . 0.0 112.779 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.98 136.7 56.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.652 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.44 ' HB2' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -53.02 -21.99 5.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.752 0.31 . . . . 0.0 110.737 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -62.37 -56.75 15.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.917 0.389 . . . . 0.0 110.117 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.416 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.9 mm -67.72 -28.18 40.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.774 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 m -78.81 -42.76 26.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.167 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.785 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.6 mp -96.61 -54.22 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.357 . . . . 0.0 111.872 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.785 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.5 m-85 -85.28 -12.09 53.22 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.058 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.12 6.56 57.38 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.731 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -160.23 144.47 14.34 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.569 0.223 . . . . 0.0 110.445 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.478 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 26.7 t -120.82 80.74 1.67 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.754 0.311 . . . . 0.0 110.657 178.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -22.83 31.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.482 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -1.45 56.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.996 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 3.3 tm-20 -53.75 -35.25 61.04 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.813 0.34 . . . . 0.0 110.45 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 mtpp -68.84 -13.06 62.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.58 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 30' ' ' CYS . 16.4 mm-40 -96.53 179.17 5.09 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.655 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.2 22.51 0.08 OUTLIER Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.858 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.51 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.2 t -66.38 128.78 94.03 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 117.735 0.767 . . . . 0.0 110.636 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 90.0 Cg_endo -81.87 152.39 16.86 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.44 2.094 . . . . 0.0 112.592 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.641 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.7 m-85 107.48 154.08 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.079 0.952 . . . . 0.0 111.07 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -84.38 96.53 9.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.295 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.478 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 5.3 m80 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.793 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.877 ' O ' HD12 ' A' ' 12' ' ' ILE . 7.9 p-90 . . . . . 0 N--CA 1.461 0.088 0 CA-C-O 120.805 0.336 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.75 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.45 -39.71 94.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.972 0.415 . . . . 0.0 110.995 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.449 ' CG ' ' HB2' ' A' ' 33' ' ' LYS . 1.1 ttmm -67.16 -13.43 61.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.325 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.81 -7.02 25.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.711 0.291 . . . . 0.0 111.225 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.877 HD12 ' O ' ' A' ' 8' ' ' TRP . 2.6 mp -124.19 124.41 25.88 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.899 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -73.06 130.97 16.09 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.675 2.25 . . . . 0.0 112.712 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 32' ' ' PHE . 46.9 t -65.81 136.67 56.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.826 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.606 ' HB2' HD13 ' A' ' 19' ' ' ILE . 6.3 ptt180 -53.23 -22.23 6.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.667 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.6 m-80 -61.67 -57.07 13.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.939 0.4 . . . . 0.0 110.251 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mm -66.97 -28.98 44.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.883 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.417 HG22 HD12 ' A' ' 19' ' ' ILE . 2.8 m -78.83 -42.35 27.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.247 -178.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.759 HG22 ' CD2' ' A' ' 20' ' ' TYR . 2.1 mp -96.84 -54.43 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.952 0.406 . . . . 0.0 111.921 -178.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.759 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.27 -11.32 55.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.109 -178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.14 6.67 54.45 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.731 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -160.23 145.49 14.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.536 0.207 . . . . 0.0 110.467 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.468 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 27.8 t -120.86 80.39 1.63 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.84 0.353 . . . . 0.0 110.537 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -56.35 -21.77 26.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.33 -0.91 57.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.247 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -54.26 -36.35 63.5 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.808 0.337 . . . . 0.0 110.38 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -66.53 -14.91 62.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.509 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 30' ' ' CYS . 4.9 mt-10 -96.21 179.12 5.16 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.433 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.92 26.05 0.09 OUTLIER Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.535 -0.841 . . . . 0.0 113.749 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.502 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.7 t -66.31 134.08 94.6 Favored Pre-proline 0 C--O 1.231 0.124 0 CA-C-N 117.717 0.758 . . . . 0.0 110.539 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 88.9 Cg_endo -83.46 148.14 12.73 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.455 2.103 . . . . 0.0 112.627 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.75 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 25.9 m-85 108.97 154.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.1 0.96 . . . . 0.0 111.1 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.449 ' HB2' ' CG ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -87.55 96.46 10.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.129 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.468 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 2.0 m80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.631 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.692 ' CE3' HD12 ' A' ' 12' ' ' ILE . 8.8 p-90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.707 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -64.72 -36.0 82.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.075 0.464 . . . . 0.0 110.651 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.671 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -68.39 -13.89 62.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.288 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -102.3 -1.97 29.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.748 0.308 . . . . 0.0 110.852 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.692 HD12 ' CE3' ' A' ' 8' ' ' TRP . 65.1 mt -124.57 116.6 26.58 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.833 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.84 130.51 20.62 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.45 2.1 . . . . 0.0 112.596 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.4 t -66.73 137.05 56.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.852 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.421 ' HB3' HD13 ' A' ' 19' ' ' ILE . 72.1 mtt180 -52.97 -22.41 5.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.74 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.426 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.8 m-80 -63.58 -57.15 11.03 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 110.372 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.404 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.2 mm -65.52 -27.72 42.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.496 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.594 HG22 HD12 ' A' ' 19' ' ' ILE . 18.0 m -78.91 -44.78 21.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.192 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.756 HG22 ' CD1' ' A' ' 20' ' ' TYR . 2.3 mp -95.36 -54.62 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.965 0.412 . . . . 0.0 111.99 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.756 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.32 -9.98 56.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.028 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 66.83 7.48 42.67 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.279 -0.963 . . . . 0.0 111.81 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 10.2 p90 -160.35 144.17 13.96 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.47 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 35.1 t -120.81 80.26 1.61 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.777 0.323 . . . . 0.0 110.543 178.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.38 -22.76 33.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.68 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.59 -2.91 58.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.051 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -54.06 -36.08 62.73 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.885 0.374 . . . . 0.0 110.266 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -65.83 -15.79 63.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.41 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 30' ' ' CYS . 33.5 mt-10 -96.65 179.14 5.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.561 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.37 25.72 0.08 OUTLIER Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.888 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.498 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.8 t -66.34 130.31 94.21 Favored Pre-proline 0 CA--C 1.527 0.069 0 CA-C-N 117.874 0.837 . . . . 0.0 110.622 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 96.6 Cg_endo -79.87 150.73 21.17 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.32 2.013 . . . . 0.0 112.379 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.707 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.6 m-85 106.55 154.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.957 0.903 . . . . 0.0 111.105 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.671 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -87.73 96.56 10.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.228 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.47 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 1.9 m80 . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.658 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.52 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 7.6 p-90 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.852 0.358 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.733 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.87 -39.87 95.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.082 0.468 . . . . 0.0 110.96 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -67.77 -12.27 60.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.414 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -101.64 -5.01 25.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.676 0.274 . . . . 0.0 111.163 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.496 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 8.2 mt -124.32 123.72 25.88 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.829 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.08 130.72 16.96 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.496 2.131 . . . . 0.0 112.692 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.22 137.0 55.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.927 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.537 ' HB3' HD13 ' A' ' 19' ' ' ILE . 45.9 mtt85 -53.09 -22.29 5.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.806 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.443 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.6 m-80 -62.86 -57.04 12.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 110.228 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.408 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.1 mm -66.1 -27.65 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.546 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.507 HG22 HD12 ' A' ' 19' ' ' ILE . 16.7 m -78.9 -45.77 19.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.205 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.766 HG22 ' CD2' ' A' ' 20' ' ' TYR . 2.2 mp -94.11 -54.39 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.935 0.398 . . . . 0.0 111.939 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.766 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.2 -11.34 55.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.998 -178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 68.9 6.23 50.89 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.808 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -160.34 143.36 13.47 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.469 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 25.6 t -120.76 79.9 1.56 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.734 0.302 . . . . 0.0 110.5 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -56.21 -23.26 34.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.698 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.39 -1.06 52.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.0 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -53.51 -36.19 61.47 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.847 0.356 . . . . 0.0 110.393 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -68.54 -12.84 61.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.668 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 30' ' ' CYS . 7.4 mt-10 -96.94 179.04 5.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 25.49 0.09 OUTLIER Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.708 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.501 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.1 t -66.31 133.21 94.47 Favored Pre-proline 0 C--O 1.231 0.108 0 CA-C-N 117.766 0.783 . . . . 0.0 110.687 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 87.2 Cg_endo -82.84 147.51 13.46 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.404 2.069 . . . . 0.0 112.258 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.733 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.7 m-85 108.01 156.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.011 0.924 . . . . 0.0 110.969 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 6.2 tmmm? -88.52 105.48 17.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.076 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.491 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 1.6 m80 . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.569 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.862 ' O ' HD12 ' A' ' 12' ' ' ILE . 8.0 p-90 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.817 0.341 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.666 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.82 -39.54 94.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.076 0.465 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.422 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 2.2 ttmt -67.77 -13.48 62.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.293 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.94 -5.29 28.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.675 0.274 . . . . 0.0 111.122 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.862 HD12 ' O ' ' A' ' 8' ' ' TRP . 2.5 mp -124.17 117.08 27.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.707 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.0 130.49 19.14 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.568 2.179 . . . . 0.0 112.774 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.9 t -65.29 136.91 57.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.641 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.485 ' HB3' HD13 ' A' ' 19' ' ' ILE . 2.9 mtm105 -53.12 -23.18 7.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 0.0 110.629 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.429 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.4 m-80 -61.53 -55.29 32.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.939 0.4 . . . . 0.0 110.199 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.411 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.8 mm -69.29 -28.37 38.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.834 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 m -78.77 -42.21 28.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.053 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.785 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.4 mp -97.02 -54.12 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 111.872 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.785 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.5 m-85 -85.37 -12.25 52.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.001 -178.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.45 6.11 57.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.874 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -160.28 144.79 14.46 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.53 0.205 . . . . 0.0 110.475 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.477 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 41.2 t -120.99 79.88 1.57 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.813 0.34 . . . . 0.0 110.674 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -56.4 -21.37 24.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.752 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.16 -1.12 57.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.341 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -53.72 -36.81 62.66 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.856 0.36 . . . . 0.0 110.42 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -65.69 -15.39 62.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.332 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 30' ' ' CYS . 9.3 mm-40 -94.1 179.34 5.35 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.516 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.36 21.28 0.06 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.833 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.513 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.4 t -66.22 127.45 93.25 Favored Pre-proline 0 C--O 1.231 0.098 0 CA-C-N 117.901 0.85 . . . . 0.0 110.723 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 87.3 Cg_endo -82.08 152.97 16.56 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.43 2.087 . . . . 0.0 112.512 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.666 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 27.0 m-85 107.77 154.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.942 0.897 . . . . 0.0 111.128 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.422 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 17.4 tptp -85.23 96.41 9.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.262 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.477 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 3.9 m80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.681 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.651 ' CE3' HD12 ' A' ' 12' ' ' ILE . 13.0 p-90 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.012 0.434 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.747 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.32 -33.5 74.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.244 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -67.17 -19.47 65.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.356 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -98.32 -0.59 43.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.167 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.651 HD12 ' CE3' ' A' ' 8' ' ' TRP . 81.4 mt -124.36 103.79 32.15 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.057 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.59 130.5 35.67 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.428 2.085 . . . . 0.0 112.161 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.5 t -65.6 136.65 56.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.815 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.415 ' HB3' HD13 ' A' ' 19' ' ' ILE . 4.7 mtp180 -53.16 -25.6 14.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.337 . . . . 0.0 110.514 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.433 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 5.5 m120 -63.12 -53.23 56.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.31 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 34' ' ' HIS . 13.1 mm -67.15 -30.59 49.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.612 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 m -78.98 -41.46 29.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.251 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.729 HG22 ' CD2' ' A' ' 20' ' ' TYR . 1.6 mp -96.34 -54.3 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.925 0.393 . . . . 0.0 111.949 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.729 ' CD2' HG22 ' A' ' 19' ' ' ILE . 2.8 m-85 -85.24 -12.33 52.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.036 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.38 7.47 57.64 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.676 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 22' ' ' TYR . 9.0 p90 -160.29 143.87 13.86 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 120.609 0.242 . . . . 0.0 110.468 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.471 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 36.8 t -120.65 80.76 1.67 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.791 0.329 . . . . 0.0 110.27 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -22.06 27.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.103 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.76 2.13 55.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.171 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -55.0 -36.55 65.54 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.857 0.36 . . . . 0.0 110.301 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -66.54 -14.41 62.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.419 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.52 ' C ' ' H ' ' A' ' 30' ' ' CYS . 4.9 mm-40 -94.42 179.19 5.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.602 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.82 22.05 0.07 OUTLIER Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.752 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.52 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.4 t -66.38 123.74 86.29 Favored Pre-proline 0 CA--C 1.527 0.073 0 CA-C-N 117.82 0.81 . . . . 0.0 110.687 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 71.8 Cg_endo -77.62 151.7 28.88 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.195 1.93 . . . . 0.0 112.249 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.747 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 25.6 m-85 109.45 153.02 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.062 0.945 . . . . 0.0 111.049 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -86.49 96.47 10.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.247 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.471 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 3.2 m80 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.084 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.528 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.0 p-90 . . . . . 0 N--CA 1.461 0.111 0 CA-C-O 120.808 0.337 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.73 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.34 -37.73 88.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 0.0 110.842 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -67.92 -13.59 62.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.419 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.47 -3.6 28.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 111.14 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.504 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 6.7 mt -124.19 116.35 27.18 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.765 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 131.6 21.66 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.655 2.237 . . . . 0.0 112.859 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.1 t -67.12 136.81 55.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.777 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.433 ' HB3' HD13 ' A' ' 19' ' ' ILE . 10.3 mtt-85 -52.93 -25.6 12.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 0.0 110.568 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.443 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 5.1 m120 -64.36 -52.78 56.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.289 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.405 HD11 ' HB3' ' A' ' 34' ' ' HIS . 14.9 mm -67.77 -31.27 51.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.613 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.55 HG22 HD12 ' A' ' 19' ' ' ILE . 3.1 m -78.92 -40.8 31.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.426 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.55 HD12 HG22 ' A' ' 18' ' ' THR . 3.1 mp -98.43 -51.47 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.509 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.2 m-85 -85.14 -14.87 45.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.439 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.38 7.41 63.91 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.472 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 20' ' ' TYR . 12.2 p90 -160.48 144.54 13.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.443 0.297 . . . . 0.0 110.344 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.481 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 27.3 t -120.77 80.71 1.66 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.349 178.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.19 -22.7 30.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.846 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 9.27 32.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.482 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -58.79 -36.4 74.39 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.9 0.381 . . . . 0.0 110.202 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -68.65 -12.94 61.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.593 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.3 OUTLIER -93.91 179.28 5.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.33 19.53 0.05 OUTLIER Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.846 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.53 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.0 t -66.3 124.38 87.91 Favored Pre-proline 0 C--O 1.231 0.124 0 CA-C-N 117.885 0.843 . . . . 0.0 110.619 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.549 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 98.2 Cg_endo -80.0 153.6 22.26 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.357 2.038 . . . . 0.0 112.445 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.73 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.8 m-85 107.31 153.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.03 0.932 . . . . 0.0 111.0 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -84.46 96.42 9.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.359 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.482 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 4.3 m80 . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.68 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.531 ' O ' HD12 ' A' ' 12' ' ' ILE . 7.7 p-90 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.824 0.345 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.72 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -63.3 -38.59 91.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.085 0.469 . . . . 0.0 110.821 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.5 tmmt? -67.58 -13.03 61.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.45 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -102.02 -3.99 26.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.723 0.296 . . . . 0.0 111.245 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.531 HD12 ' O ' ' A' ' 8' ' ' TRP . 4.8 mt -124.29 122.37 26.02 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.871 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.79 130.68 17.24 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.64 2.227 . . . . 0.0 112.8 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.3 t -67.2 137.05 55.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.925 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.452 ' HB3' HD13 ' A' ' 19' ' ' ILE . 16.9 mtt85 -52.81 -24.85 9.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.69 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.436 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 6.1 m120 -63.41 -55.47 24.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.979 0.418 . . . . 0.0 110.325 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.411 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 10.0 mm -65.49 -29.26 46.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.6 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.1 m -78.93 -42.47 26.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.361 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.766 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.7 mp -96.17 -53.93 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.766 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.0 m-85 -85.15 -12.52 52.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.902 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.63 6.78 56.59 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.768 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -160.26 142.01 12.67 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.464 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 35.0 t -120.77 79.11 1.45 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.672 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.0 tptt -56.74 -20.43 22.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.827 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -85.19 -2.74 58.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.337 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 34' ' ' HIS . 14.8 tt0 -53.9 -36.42 62.68 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.778 0.323 . . . . 0.0 110.381 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.54 -15.79 63.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.051 0.453 . . . . 0.0 110.273 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' A' ' 30' ' ' CYS . 10.2 mt-10 -95.13 179.14 5.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.479 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.12 23.96 0.08 OUTLIER Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.889 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.506 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.6 t -66.27 132.6 94.44 Favored Pre-proline 0 C--O 1.231 0.128 0 CA-C-N 117.868 0.834 . . . . 0.0 110.718 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 86.3 Cg_endo -83.41 149.31 13.09 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.41 2.073 . . . . 0.0 112.451 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.72 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.3 m-85 107.99 155.18 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.989 0.916 . . . . 0.0 111.0 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 12.6 tptt -87.54 97.6 10.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.391 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.464 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 1.4 m80 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.531 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.552 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 16.9 p-90 . . . . . 0 N--CA 1.46 0.058 0 CA-C-O 121.033 0.444 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.729 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.43 -34.37 76.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.194 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.5 ttmt -67.32 -17.64 64.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.394 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.39 -1.04 39.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.613 0.244 . . . . 0.0 111.287 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.521 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 8.3 mt -124.33 105.53 30.99 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.686 0.279 . . . . 0.0 111.168 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.74 130.58 33.74 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.573 2.182 . . . . 0.0 112.439 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.9 t -67.69 136.96 55.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.836 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.594 ' HB3' HD13 ' A' ' 19' ' ' ILE . 10.7 mtm180 -53.04 -23.29 7.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.774 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.419 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.1 m-80 -61.11 -54.96 38.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.081 0.467 . . . . 0.0 110.116 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.439 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.1 mm -69.25 -28.5 38.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.881 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 m -78.86 -41.36 30.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.021 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.772 HG22 ' CD2' ' A' ' 20' ' ' TYR . 1.8 mp -97.06 -54.6 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.915 0.388 . . . . 0.0 111.738 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.772 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.25 -13.08 50.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.963 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 71.86 5.43 61.26 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.746 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -160.27 142.98 13.34 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.617 0.246 . . . . 0.0 110.53 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.481 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 37.5 t -120.82 79.53 1.51 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.459 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.42 -22.04 29.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.717 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.52 -1.66 56.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.401 ' CG ' ' HB2' ' A' ' 34' ' ' HIS . 14.2 tt0 -54.06 -35.55 62.15 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 120.727 0.299 . . . . 0.0 110.389 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.92 -15.95 63.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.421 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.52 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -95.19 179.35 5.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.561 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.48 21.11 0.05 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.653 -0.785 . . . . 0.0 114.133 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.52 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.8 t -66.2 124.25 87.46 Favored Pre-proline 0 C--O 1.231 0.111 0 CA-C-N 117.976 0.888 . . . . 0.0 110.598 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 86.3 Cg_endo -78.89 151.1 24.12 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.302 2.001 . . . . 0.0 112.471 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.729 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.0 m-85 108.46 154.82 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.041 0.936 . . . . 0.0 111.034 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 15.9 tptt -86.0 99.55 11.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.293 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.481 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 3.0 m80 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.731 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.614 ' CE3' HD12 ' A' ' 12' ' ' ILE . 7.2 p-90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.864 0.364 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.762 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.8 -38.0 88.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.04 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.44 ' CG ' ' HB2' ' A' ' 33' ' ' LYS . 1.8 ttmt -67.24 -14.99 63.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.348 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -100.33 -3.47 31.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.646 0.26 . . . . 0.0 111.134 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.614 HD12 ' CE3' ' A' ' 8' ' ' TRP . 55.5 mt -124.3 126.69 25.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.11 132.31 13.86 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.633 2.222 . . . . 0.0 112.907 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.0 t -70.65 136.85 49.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.641 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.6 ' HB3' HD13 ' A' ' 19' ' ' ILE . 16.3 mtp85 -53.21 -22.56 6.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.0 110.835 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.5 m-80 -61.68 -55.74 27.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.016 0.436 . . . . 0.0 110.185 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.41 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.9 mm -68.44 -28.82 41.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.836 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.5 m -78.64 -42.58 28.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.178 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.772 HG22 ' CD2' ' A' ' 20' ' ' TYR . 1.7 mp -96.57 -54.31 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.41 . . . . 0.0 111.863 -178.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.772 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.28 -12.06 53.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.063 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.93 6.31 55.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.163 -1.017 . . . . 0.0 111.759 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -160.18 146.6 15.72 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.48 ' SG ' ' CD2' ' A' ' 34' ' ' HIS . 21.8 t -120.8 81.05 1.71 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.575 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.3 -22.37 29.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.667 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.88 2.04 54.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.016 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -55.05 -35.16 64.19 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.806 0.336 . . . . 0.0 110.427 179.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -11.09 60.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.718 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.512 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -97.26 179.04 5.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.665 179.402 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.45 23.28 0.08 OUTLIER Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.81 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.512 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.5 t -66.36 131.35 94.26 Favored Pre-proline 0 C--O 1.23 0.054 0 CA-C-N 117.75 0.775 . . . . 0.0 110.714 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.556 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 94.8 Cg_endo -81.52 148.9 16.39 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.398 2.065 . . . . 0.0 112.25 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.762 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 25.5 m-85 109.16 154.77 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.062 0.945 . . . . 0.0 111.056 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HB2' ' CG ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -87.18 98.79 11.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.269 179.637 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.489 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 2.1 m80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.633 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.889 0.376 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -104.2 -30.87 9.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.926 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.18 123.42 32.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.934 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.28 107.6 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.45 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 2.3 t30 -73.76 138.28 76.87 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.179 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -42.8 -25.08 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.523 2.149 . . . . 0.0 112.864 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -58.71 -23.89 60.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.283 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.534 ' O ' HD12 ' A' ' 12' ' ' ILE . 7.7 p-90 -76.05 -52.07 10.95 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.789 0.328 . . . . 0.0 111.109 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.715 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.33 -38.06 89.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.051 0.453 . . . . 0.0 110.875 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -67.76 -13.73 62.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.358 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.06 -3.91 28.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.698 0.285 . . . . 0.0 111.14 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 8' ' ' TRP . 4.8 mt -124.29 116.19 27.08 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.741 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 131.74 21.81 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.573 2.182 . . . . 0.0 112.787 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.37 136.86 55.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.735 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 mtt85 -52.92 -25.95 13.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.34 . . . . 0.0 110.576 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.403 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 5.7 m120 -63.53 -52.94 59.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.366 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 34' ' ' HIS . 13.7 mm -67.26 -31.12 51.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.632 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -79.01 -40.81 30.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.324 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.702 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.9 mp -96.38 -54.6 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.702 ' CD1' HG22 ' A' ' 19' ' ' ILE . 2.7 m-85 -85.24 -12.21 53.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.038 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 68.4 8.34 55.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.529 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.427 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 10.1 p90 -160.27 143.9 13.92 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.7 t -120.71 80.93 1.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.57 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -22.23 30.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.921 0.391 . . . . 0.0 110.525 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.9 -3.38 58.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.952 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.424 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -53.34 -36.88 61.8 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.805 0.336 . . . . 0.0 110.4 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -65.94 -15.47 63.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.494 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 30' ' ' CYS . 48.5 mt-10 -95.9 179.17 5.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.558 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.45 24.32 0.08 OUTLIER Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.727 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.502 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.9 t -66.34 127.31 93.22 Favored Pre-proline 0 C--O 1.231 0.088 0 CA-C-N 117.819 0.809 . . . . 0.0 110.597 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 92.1 Cg_endo -80.96 152.43 18.93 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.352 2.035 . . . . 0.0 112.541 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.715 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.2 m-85 107.5 154.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.965 0.906 . . . . 0.0 111.066 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -84.45 96.54 9.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.419 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.45 ' HB3' HD11 ' A' ' 17' ' ' ILE . 4.7 m80 -90.07 79.02 6.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.703 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -95.43 110.71 22.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.863 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -118.82 31.73 6.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -117.29 -60.22 1.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.4 m -83.67 86.25 7.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -67.88 111.58 4.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.53 173.68 11.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.075 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.838 0.351 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.4 -70.68 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.06 113.18 10.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.86 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.547 ' H ' HD12 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -124.77 111.6 28.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.026 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.433 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -76.07 136.15 69.71 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.278 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -42.72 -24.98 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.695 2.263 . . . . 0.0 113.009 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.2 p30 -64.1 -16.17 61.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.428 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.611 ' O ' HD12 ' A' ' 12' ' ' ILE . 8.0 p-90 -78.9 -51.95 8.96 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.848 0.356 . . . . 0.0 111.057 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.72 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.06 -38.43 91.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.023 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.415 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -67.59 -13.04 61.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.399 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -101.65 -4.09 27.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.756 0.312 . . . . 0.0 111.25 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 8' ' ' TRP . 3.9 mt -124.35 107.86 29.68 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.942 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.6 130.63 32.3 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.497 2.131 . . . . 0.0 112.386 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.2 t -66.46 136.77 56.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.8 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.44 ' HB3' HD13 ' A' ' 19' ' ' ILE . 13.9 mtt85 -53.15 -24.14 9.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.71 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.432 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.1 m-80 -60.48 -52.95 63.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.113 0.482 . . . . 0.0 110.094 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.433 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.2 mm -71.34 -29.75 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.015 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.599 HG22 HD12 ' A' ' 19' ' ' ILE . 1.6 m -78.72 -38.32 39.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.007 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.717 HG22 ' CD1' ' A' ' 20' ' ' TYR . 2.9 mp -99.3 -54.73 6.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.934 0.397 . . . . 0.0 111.709 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.717 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.6 m-85 -85.48 -13.62 48.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.946 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 72.5 5.65 64.02 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.659 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.427 ' CD1' ' HG3' ' A' ' 24' ' ' LYS . 14.2 p90 -160.26 143.97 13.97 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.482 0.182 . . . . 0.0 110.513 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.1 t -120.82 79.39 1.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.49 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.427 ' HG3' ' CD1' ' A' ' 22' ' ' TYR . 45.5 mttm -56.37 -21.7 26.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.838 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.59 1.96 52.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.187 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -55.49 -37.15 67.45 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.773 0.321 . . . . 0.0 110.274 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -15.86 63.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.372 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.532 ' C ' ' H ' ' A' ' 30' ' ' CYS . 1.5 mt-10 -93.19 179.36 5.44 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.0 19.73 0.05 OUTLIER Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.929 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.532 ' H ' ' C ' ' A' ' 28' ' ' GLU . 2.4 t -66.2 123.59 85.7 Favored Pre-proline 0 C--O 1.232 0.138 0 CA-C-N 117.824 0.812 . . . . 0.0 110.858 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.554 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 95.1 Cg_endo -79.85 153.78 22.78 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.282 1.988 . . . . 0.0 112.331 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.72 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 27.2 m-85 107.38 155.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.985 0.914 . . . . 0.0 111.133 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.415 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 14.5 tptt -85.77 97.51 10.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.38 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.447 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 3.1 m80 -92.17 79.03 5.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.782 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.8 t -68.24 105.21 2.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.929 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -136.27 -175.16 3.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.833 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -67.67 -36.13 80.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 90.2 m 61.21 153.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.821 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 m 61.09 102.98 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.801 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.46 143.85 34.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.206 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.473 ' OXT' HG22 ' A' ' 41' ' ' THR . 6.4 m . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.933 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ptp . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.896 0.379 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -104.22 41.56 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.14 90.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.66 HG23 ' CD1' ' A' ' 8' ' ' TRP . 11.4 tt -139.17 163.08 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.024 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.57 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 5.3 m-20 -90.64 138.38 26.65 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.013 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -42.72 -27.53 0.87 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.801 2.334 . . . . 0.0 113.299 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -61.95 -16.96 55.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.73 0.3 . . . . 0.0 110.969 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.66 ' CD1' HG23 ' A' ' 4' ' ' ILE . 13.8 p-90 -70.44 -51.47 29.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.381 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.756 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.35 -34.49 76.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.181 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.6 ttmt -67.15 -17.2 64.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.477 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -100.42 -1.6 35.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.581 0.229 . . . . 0.0 111.269 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.503 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 16.6 mt -124.24 109.9 29.03 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.202 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.04 130.61 31.43 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.483 2.122 . . . . 0.0 112.216 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.3 t -68.02 137.02 54.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.881 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -52.78 -22.97 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.584 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -61.66 -57.04 13.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.041 0.448 . . . . 0.0 110.128 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.424 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.2 mm -67.66 -29.17 44.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.841 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.2 m -78.82 -41.55 29.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.197 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.76 HG22 ' CD2' ' A' ' 20' ' ' TYR . 2.2 mt -97.02 -54.54 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.925 0.393 . . . . 0.0 111.867 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.76 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.3 m-85 -85.47 -12.1 52.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.971 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.93 6.81 57.65 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.284 -0.96 . . . . 0.0 111.782 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -160.27 143.24 13.51 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.575 0.226 . . . . 0.0 110.53 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.403 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 17.6 t -120.85 80.22 1.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.565 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.22 -22.61 30.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.501 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -2.59 56.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.927 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.3 tm-20 -53.7 -34.17 57.91 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.758 0.313 . . . . 0.0 110.432 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.19 -11.86 61.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.691 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -99.11 179.05 4.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.671 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.78 25.79 0.11 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.742 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.496 ' H ' ' C ' ' A' ' 28' ' ' GLU . 6.3 t -66.33 133.03 94.42 Favored Pre-proline 0 N--CA 1.457 -0.077 0 CA-C-N 117.599 0.699 . . . . 0.0 110.714 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 95.3 Cg_endo -82.05 148.14 15.1 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.363 2.042 . . . . 0.0 112.326 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.756 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.2 m-85 108.53 154.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.951 0.901 . . . . 0.0 110.91 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 47.3 tptt -87.09 99.99 12.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.443 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.479 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 2.2 m80 -95.63 79.0 3.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.654 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.4 p -77.11 128.57 34.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.49 176.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -143.64 -48.0 0.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.17 86.1 4.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.7 -43.5 2.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.89 -46.99 5.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.104 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.846 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.89 0.376 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -125.77 -42.93 1.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.948 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -85.98 145.65 27.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.988 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.408 ' HB ' ' CD1' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -116.8 101.36 12.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.451 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 16.7 t-20 -72.03 139.16 82.27 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.213 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -42.76 -24.77 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.54 2.16 . . . . 0.0 112.856 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -61.32 -24.82 66.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.311 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.531 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.0 p-90 -71.93 -52.23 18.23 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.796 0.332 . . . . 0.0 110.97 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.71 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.23 -38.76 92.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.174 0.511 . . . . 0.0 110.893 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.439 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -68.46 -13.37 62.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.356 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.39 -3.31 31.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.781 0.324 . . . . 0.0 111.021 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.529 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 5.8 mt -124.35 109.17 29.09 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.54 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.66 130.62 23.87 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.644 2.229 . . . . 0.0 112.914 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.2 t -65.9 136.87 56.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.716 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -52.77 -25.36 11.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.837 0.351 . . . . 0.0 110.684 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -63.42 -53.43 52.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.172 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.424 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 10.9 mm -68.32 -29.31 43.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.554 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.8 m -78.95 -40.67 31.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.112 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.746 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.6 mp -96.85 -54.64 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 111.934 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.746 ' CD1' HG22 ' A' ' 19' ' ' ILE . 2.9 m-85 -85.32 -13.11 50.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.949 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.9 6.96 61.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.098 -1.048 . . . . 0.0 111.614 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.42 ' CE1' ' HG3' ' A' ' 24' ' ' LYS . 9.2 p90 -160.19 143.3 13.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.599 0.238 . . . . 0.0 110.45 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.0 t -120.67 80.55 1.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.387 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.42 ' HG3' ' CE1' ' A' ' 22' ' ' TYR . 5.8 mtmm -56.22 -22.11 27.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.771 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.75 10.17 27.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -59.12 -34.52 72.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.876 0.369 . . . . 0.0 110.124 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -69.48 -12.64 61.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.565 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.526 ' C ' ' H ' ' A' ' 30' ' ' CYS . 2.0 mt-10 -94.12 179.39 5.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.69 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.74 14.47 0.02 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.746 -0.74 . . . . 0.0 114.109 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.526 ' H ' ' C ' ' A' ' 28' ' ' GLU . 1.5 t -66.26 114.51 17.24 Favored Pre-proline 0 C--O 1.23 0.075 0 CA-C-N 118.028 0.914 . . . . 0.0 110.632 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 74.1 Cg_endo -75.67 158.65 39.48 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.279 1.986 . . . . 0.0 112.158 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.71 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 28.0 m-85 105.68 154.28 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.95 0.9 . . . . 0.0 111.06 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 23.6 tptp -82.13 96.33 7.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.609 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.441 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 9.0 m80 -89.25 79.3 7.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.827 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.95 160.65 17.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -98.12 33.28 2.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -143.14 -171.83 3.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.4 m -130.83 125.57 34.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 t -123.22 -43.69 2.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.16 140.43 49.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.153 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mtt . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.742 0.306 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -120.52 -41.13 2.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.34 101.7 9.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.655 HG23 ' CD1' ' A' ' 8' ' ' TRP . 14.8 tt -152.69 163.78 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.988 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.571 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -93.19 137.43 23.62 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.683 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -42.3 -28.2 0.88 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.112 2.542 . . . . 0.0 113.069 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -60.38 -19.12 54.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.935 0.397 . . . . 0.0 110.564 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.655 ' CD1' HG23 ' A' ' 4' ' ' ILE . 15.7 p-90 -65.34 -51.21 62.09 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.349 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.747 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.17 -35.12 77.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.135 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.2 ttmt -67.32 -18.74 65.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.214 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.69 -2.02 42.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.133 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.591 HD12 ' CE3' ' A' ' 8' ' ' TRP . 53.6 mt -124.2 126.37 25.56 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.94 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.39 130.58 13.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.526 2.151 . . . . 0.0 112.511 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t -67.18 136.84 55.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.782 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.487 ' HB3' HD13 ' A' ' 19' ' ' ILE . 21.3 mtp85 -52.81 -25.43 11.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.935 0.398 . . . . 0.0 110.5 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.447 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 5.0 m120 -63.71 -55.22 24.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.413 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 mm -64.87 -30.47 50.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.603 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.0 m -78.93 -43.27 25.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.561 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.725 HG22 ' CD2' ' A' ' 20' ' ' TYR . 2.1 mp -95.39 -53.42 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.725 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.0 m-85 -85.19 -12.08 53.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.944 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.96 7.82 51.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.203 -0.998 . . . . 0.0 111.657 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.411 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 10.2 p90 -160.3 143.12 13.39 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.5 t -120.7 80.15 1.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.698 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -56.4 -22.06 29.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.585 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -83.51 -5.37 59.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.076 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.4 ' CG ' ' HB2' ' A' ' 34' ' ' HIS . 22.0 tt0 -53.61 -36.24 61.78 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 120.812 0.339 . . . . 0.0 110.383 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -15.79 63.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.294 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.478 ' C ' ' H ' ' A' ' 30' ' ' CYS . 70.0 mt-10 -97.75 179.04 4.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.457 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.92 28.73 0.11 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.746 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.478 ' H ' ' C ' ' A' ' 28' ' ' GLU . 6.1 t -66.43 134.09 94.48 Favored Pre-proline 0 CA--C 1.528 0.097 0 CA-C-N 117.764 0.782 . . . . 0.0 110.628 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 89.5 Cg_endo -82.37 147.86 14.42 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.258 1.972 . . . . 0.0 112.338 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.747 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.5 m-85 107.81 155.61 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.978 0.911 . . . . 0.0 111.035 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -88.02 100.57 13.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.468 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.483 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 1.0 OUTLIER -98.26 78.85 2.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.338 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.3 m -123.28 156.0 36.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.138 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 59.98 161.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.934 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -118.19 92.09 3.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.21 32.49 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.845 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.93 122.94 4.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.899 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.83 -48.16 4.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.094 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.889 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.757 0.313 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -165.96 -43.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 109.07 17.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.762 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.638 HG23 ' CD1' ' A' ' 8' ' ' TRP . 14.3 tt -132.78 163.75 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.968 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.565 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 1.6 m-20 -91.86 137.53 25.32 Favored Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.941 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -42.62 -27.86 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.929 2.419 . . . . 0.0 113.284 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -64.44 -14.68 58.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.717 0.294 . . . . 0.0 110.967 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.638 ' CD1' HG23 ' A' ' 4' ' ' ILE . 14.3 p-90 -68.95 -51.27 41.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.0 0.428 . . . . 0.0 111.441 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.762 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.34 -33.48 74.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.323 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -67.5 -17.88 64.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.457 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.39 -1.03 39.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.192 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.525 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 9.4 mt -124.34 103.64 32.32 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.075 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.89 130.58 35.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.479 2.119 . . . . 0.0 112.366 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.7 t -65.48 136.73 56.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.881 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.574 ' HB3' HD12 ' A' ' 19' ' ' ILE . 36.1 mtt180 -52.88 -25.61 12.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.613 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -63.78 -52.98 57.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.121 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' A' ' 34' ' ' HIS . 14.5 mm -67.01 -31.23 52.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.522 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.4 m -78.97 -39.99 32.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.334 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.721 HG22 ' CD2' ' A' ' 20' ' ' TYR . 4.1 mt -96.69 -54.68 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.721 ' CD2' HG22 ' A' ' 19' ' ' ILE . 2.6 m-85 -85.47 -12.56 51.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.996 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.18 7.11 59.29 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.596 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.405 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 11.7 p90 -160.19 143.25 13.64 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.61 0.243 . . . . 0.0 110.57 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.6 t -120.86 80.2 1.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.805 0.336 . . . . 0.0 110.281 178.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.2 -23.21 34.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.775 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 3.82 45.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.487 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -55.23 -36.15 65.69 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.818 0.342 . . . . 0.0 110.384 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -68.11 -13.2 62.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.407 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' A' ' 30' ' ' CYS . 3.7 mm-40 -94.38 179.14 5.39 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.592 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.09 20.24 0.06 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.798 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.525 ' H ' ' C ' ' A' ' 28' ' ' GLU . 2.6 t -66.32 121.17 75.42 Favored Pre-proline 0 C--O 1.231 0.086 0 CA-C-N 117.747 0.774 . . . . 0.0 110.769 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 72.6 Cg_endo -77.72 153.28 29.78 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.293 1.995 . . . . 0.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.762 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 25.9 m-85 108.33 153.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.006 0.923 . . . . 0.0 111.104 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -85.1 96.66 9.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.339 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.487 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 3.8 m80 -89.56 79.03 6.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.672 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.1 p -72.33 159.6 33.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -118.31 42.51 2.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -107.9 142.26 38.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.24 160.35 40.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.839 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.9 101.1 9.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.6 157.53 24.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.135 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.7 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.951 179.892 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.824 0.345 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -126.96 68.93 1.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -73.1 95.25 2.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.82 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.654 HG23 ' CD1' ' A' ' 8' ' ' TRP . 9.5 tt -105.66 161.59 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.606 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 4.7 t-20 -90.75 136.71 27.55 Favored Pre-proline 0 N--CA 1.461 0.116 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.771 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -42.04 -25.99 0.45 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.087 2.525 . . . . 0.0 113.115 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.54 -18.34 51.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.769 0.318 . . . . 0.0 110.686 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.654 ' CD1' HG23 ' A' ' 4' ' ' ILE . 16.3 p-90 -71.13 -51.64 23.87 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.232 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.779 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.79 -34.97 78.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.202 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -67.39 -13.73 62.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.549 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -105.88 0.85 26.27 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.42 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.506 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 11.7 mt -124.48 110.77 28.21 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 120.682 0.277 . . . . 0.0 111.121 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.03 130.67 33.51 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.562 2.174 . . . . 0.0 112.376 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.1 t -72.61 136.68 45.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.939 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.627 ' HB2' HD13 ' A' ' 19' ' ' ILE . 27.4 ptt180 -53.47 -21.5 6.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.07 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.439 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.0 OUTLIER -61.65 -57.24 12.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.056 0.455 . . . . 0.0 110.513 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.666 HD11 ' HB3' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -71.25 -25.83 25.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.773 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.414 ' HB ' ' HA ' ' A' ' 15' ' ' ARG . 2.0 m -78.87 -42.88 26.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.536 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.77 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.5 mp -96.44 -53.03 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 111.786 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.77 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.6 m-85 -85.28 -15.08 44.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.937 -178.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 72.85 5.5 64.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.81 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -160.33 142.36 12.82 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.1 t -120.85 78.6 1.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.603 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.4 -22.63 32.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.576 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.8 -2.14 53.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.112 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.521 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.7 tm-20 -53.54 -35.78 61.1 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.799 0.333 . . . . 0.0 110.449 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -68.51 -13.03 62.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.771 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.49 ' C ' ' H ' ' A' ' 30' ' ' CYS . 9.6 mp0 -98.4 179.06 4.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.689 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.23 27.47 0.1 OUTLIER Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.765 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.49 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.7 t -66.45 134.88 94.56 Favored Pre-proline 0 C--O 1.231 0.083 0 CA-C-N 117.752 0.776 . . . . 0.0 110.6 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.554 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 88.5 Cg_endo -82.4 146.31 13.77 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.35 2.034 . . . . 0.0 112.083 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.779 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 27.6 m-85 106.56 157.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.839 0.856 . . . . 0.0 111.004 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -88.47 105.78 17.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.599 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.666 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -105.13 79.08 1.45 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.561 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -110.89 145.32 38.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -170.59 1.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.833 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -85.2 103.27 14.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.5 m -84.85 89.33 7.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.26 -48.17 2.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.27 32.21 3.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.081 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.948 179.982 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ptp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.849 0.357 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -175.56 -40.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.2 pttm -99.01 116.53 31.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.943 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.575 ' H ' HD12 ' A' ' 4' ' ' ILE . 0.4 OUTLIER -127.99 101.9 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.031 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -76.77 142.61 70.08 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.229 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -42.93 -24.55 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.557 2.171 . . . . 0.0 112.981 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -65.56 -22.44 66.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.523 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.671 ' CE3' HD12 ' A' ' 12' ' ' ILE . 7.4 p-90 -68.19 -52.17 37.38 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.798 0.333 . . . . 0.0 110.997 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.699 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.54 -38.44 91.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.046 0.45 . . . . 0.0 110.709 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -68.12 -14.2 62.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.31 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.24 -3.42 31.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.728 0.299 . . . . 0.0 110.968 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.671 HD12 ' CE3' ' A' ' 8' ' ' TRP . 63.8 mt -124.36 113.51 27.66 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.786 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.95 130.64 22.11 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.54 2.16 . . . . 0.0 112.756 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.3 t -67.81 136.93 54.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.662 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.446 ' HB2' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -53.04 -22.8 6.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.786 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.44 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.3 m-80 -61.71 -57.03 13.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.032 0.444 . . . . 0.0 110.117 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.425 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.3 mm -66.73 -28.3 42.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.741 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -78.9 -43.06 25.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.227 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.786 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.4 mp -95.99 -54.08 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.863 0.363 . . . . 0.0 111.844 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.786 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.3 m-85 -85.17 -12.65 52.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.904 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.88 5.44 57.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.804 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -160.29 143.32 13.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 32.2 t -120.78 79.7 1.53 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.824 0.345 . . . . 0.0 110.647 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -56.34 -22.6 31.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.455 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.36 -1.47 53.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.064 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 1.3 tm-20 -52.95 -37.75 61.35 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.857 0.361 . . . . 0.0 110.485 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.51 -13.59 61.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.625 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 30' ' ' CYS . 12.7 mt-10 -95.07 179.19 5.3 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.655 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.87 19.55 0.06 OUTLIER Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.776 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.523 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.0 t -66.28 124.22 87.45 Favored Pre-proline 0 C--O 1.232 0.133 0 CA-C-N 117.9 0.85 . . . . 0.0 110.823 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 88.5 Cg_endo -79.36 154.64 24.7 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.311 2.008 . . . . 0.0 112.295 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.699 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.4 m-85 106.89 153.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.988 0.915 . . . . 0.0 111.029 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 11.3 tptt -84.28 96.34 8.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.242 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.451 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 5.3 m80 -89.86 79.08 6.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.688 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.9 p -89.05 100.6 13.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.46 -27.92 9.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -56.98 101.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.94 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.0 m -163.88 78.94 0.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.2 t -62.75 152.86 34.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 59.78 81.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.099 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mtp . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.858 0.361 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -108.75 27.4 9.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.38 112.99 2.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.65 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.596 HG23 ' CD1' ' A' ' 8' ' ' TRP . 8.2 tp -152.62 154.57 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.226 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.646 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 1.5 m-20 -91.17 145.04 30.8 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.628 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -41.79 -23.73 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.185 2.59 . . . . 0.0 113.229 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.39 -21.74 26.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.666 0.269 . . . . 0.0 110.738 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.646 ' HD1' ' O ' ' A' ' 5' ' ' ASN . 18.3 p-90 -77.63 -49.76 13.9 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.035 0.445 . . . . 0.0 111.268 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.748 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.15 -35.09 77.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.216 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.439 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -67.11 -18.46 65.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -96.01 -5.02 42.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.653 0.263 . . . . 0.0 111.242 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.474 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 6.3 mt -124.26 126.31 25.55 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.47 130.65 13.0 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.583 2.189 . . . . 0.0 112.725 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.422 ' HA ' ' CD1' ' A' ' 32' ' ' PHE . 49.7 t -63.36 136.79 57.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.791 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.2 mtp85 -53.02 -25.85 13.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.914 0.387 . . . . 0.0 110.287 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.45 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 3.7 m120 -64.66 -52.92 54.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.328 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 23' ' ' CYS . 17.3 mm -67.21 -30.7 50.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.618 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 m -78.97 -44.92 21.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.379 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.529 HG22 ' CD1' ' A' ' 20' ' ' TYR . 2.0 mp -95.59 -49.79 12.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.529 ' CD1' HG22 ' A' ' 19' ' ' ILE . 4.3 m-85 -85.06 -15.47 43.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.523 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.62 7.21 60.76 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.345 -0.931 . . . . 0.0 111.481 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -160.56 143.72 13.36 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 122.39 0.276 . . . . 0.0 110.501 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.406 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 30.4 t -120.99 80.48 1.64 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.754 0.311 . . . . 0.0 110.266 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.19 -22.77 31.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.821 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.02 4.18 49.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.1 tm-20 -55.92 -32.5 63.84 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.852 0.358 . . . . 0.0 110.191 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -71.55 -11.04 60.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.615 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 30' ' ' CYS . 2.6 mt-10 -98.53 179.06 4.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.773 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.06 24.59 0.09 OUTLIER Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.859 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.501 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.5 t -66.41 132.11 94.28 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 117.763 0.781 . . . . 0.0 110.654 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 88.1 Cg_endo -82.49 148.65 14.46 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.435 2.09 . . . . 0.0 112.663 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.748 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.1 m-85 109.06 154.37 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.094 0.957 . . . . 0.0 111.091 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 2.9 tppt? -86.35 98.01 10.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.243 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.467 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 2.9 m80 -91.42 78.84 5.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.579 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -91.73 126.58 36.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.835 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -62.08 -175.77 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -108.84 -29.26 8.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.977 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.25 176.13 10.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.0 p -108.51 119.51 39.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.24 31.19 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.126 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 42.0 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.925 -179.98 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttt . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.805 0.336 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.4 -77.98 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.832 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -77.14 119.92 21.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.931 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.49 105.92 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.062 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -78.61 140.69 59.66 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.027 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.12 -24.27 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.613 2.209 . . . . 0.0 113.114 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -16.34 62.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.831 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.525 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.4 p-90 -67.25 -52.07 45.44 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.879 0.371 . . . . 0.0 110.919 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.695 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.94 -38.41 91.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.095 0.474 . . . . 0.0 110.842 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -68.07 -12.19 60.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.408 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.08 -3.5 25.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.677 0.275 . . . . 0.0 111.103 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.509 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 9.0 mt -124.19 108.15 29.91 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.143 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.86 130.55 33.38 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.411 2.074 . . . . 0.0 112.348 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.5 t -66.44 136.82 56.27 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.817 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.726 ' HB3' HD12 ' A' ' 19' ' ' ILE . 2.3 mmp_? -53.02 -23.58 7.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.803 0.335 . . . . 0.0 110.624 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.402 ' OD1' ' HA ' ' A' ' 23' ' ' CYS . 1.2 m-80 -61.06 -54.08 49.13 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 110.297 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' A' ' 23' ' ' CYS . 4.7 mm -70.99 -29.16 35.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.765 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -78.74 -38.93 37.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.944 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.748 HG22 ' CD1' ' A' ' 20' ' ' TYR . 5.9 mt -99.84 -54.7 6.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.863 0.363 . . . . 0.0 111.963 -178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.748 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.8 m-85 -85.58 -11.98 52.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.003 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.18 7.33 59.72 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.722 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -160.3 146.87 15.69 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.422 ' HB2' HD11 ' A' ' 17' ' ' ILE . 34.1 t -120.9 80.45 1.64 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.753 0.311 . . . . 0.0 110.684 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -56.37 -21.97 28.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.704 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 -2.99 58.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.067 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 2.7 tm-20 -53.65 -35.82 61.43 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.765 0.316 . . . . 0.0 110.365 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.11 -16.04 63.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.391 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.493 ' C ' ' H ' ' A' ' 30' ' ' CYS . 15.3 mt-10 -96.83 179.15 5.06 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.56 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 27.4 0.1 OUTLIER Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.754 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.493 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.5 t -66.51 130.07 94.14 Favored Pre-proline 0 C--O 1.231 0.129 0 CA-C-N 117.738 0.769 . . . . 0.0 110.603 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 92.8 Cg_endo -81.13 150.12 17.64 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.382 2.055 . . . . 0.0 112.42 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.695 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.6 m-85 107.51 156.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.995 0.918 . . . . 0.0 111.042 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.466 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 7.4 tptp -87.14 100.06 12.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.445 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.469 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 2.0 m80 -96.35 78.99 3.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.673 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.7 p -117.6 106.22 12.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -164.42 150.24 10.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -136.8 104.66 5.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.27 83.76 3.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.783 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.2 p -140.93 -67.69 0.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.72 173.35 11.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.97 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 mtm . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.793 0.33 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -107.76 -31.67 7.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 mttm -89.8 123.07 33.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.488 HG22 ' CG ' ' A' ' 8' ' ' TRP . 0.2 OUTLIER -144.5 102.06 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.423 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 8.1 m-20 -76.41 145.12 75.4 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.244 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -42.82 -24.76 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.526 2.15 . . . . 0.0 112.83 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.91 -26.35 67.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.321 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.881 ' O ' HD12 ' A' ' 12' ' ' ILE . 7.9 p-90 -69.54 -51.91 31.15 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.814 0.34 . . . . 0.0 110.933 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.641 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.52 -40.58 97.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.013 0.435 . . . . 0.0 110.889 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.446 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 2.7 ttmt -67.7 -13.41 62.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.24 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -99.31 -5.56 29.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.64 0.257 . . . . 0.0 111.092 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.881 HD12 ' O ' ' A' ' 8' ' ' TRP . 2.5 mp -124.24 117.0 26.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.645 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.92 130.55 19.35 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.48 2.12 . . . . 0.0 112.779 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.98 136.7 56.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.652 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.44 ' HB2' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -53.02 -21.99 5.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.752 0.31 . . . . 0.0 110.737 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -62.37 -56.75 15.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.917 0.389 . . . . 0.0 110.117 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.416 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.9 mm -67.72 -28.18 40.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.774 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 m -78.81 -42.76 26.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.167 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.785 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.6 mp -96.61 -54.22 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.357 . . . . 0.0 111.872 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.785 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.5 m-85 -85.28 -12.09 53.22 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.058 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.12 6.56 57.38 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.731 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -160.23 144.47 14.34 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.569 0.223 . . . . 0.0 110.445 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.7 t -120.82 80.74 1.67 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.754 0.311 . . . . 0.0 110.657 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -22.83 31.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.482 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -1.45 56.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.996 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 3.3 tm-20 -53.75 -35.25 61.04 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.813 0.34 . . . . 0.0 110.45 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 mtpp -68.84 -13.06 62.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.58 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 30' ' ' CYS . 16.4 mm-40 -96.53 179.17 5.09 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.655 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.2 22.51 0.08 OUTLIER Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.858 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.51 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.2 t -66.38 128.78 94.03 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 117.735 0.767 . . . . 0.0 110.636 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 90.0 Cg_endo -81.87 152.39 16.86 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.44 2.094 . . . . 0.0 112.592 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.641 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.7 m-85 107.48 154.08 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.079 0.952 . . . . 0.0 111.07 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -84.38 96.53 9.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.295 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.47 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 5.3 m80 -89.87 79.12 6.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.793 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.5 p -123.52 104.78 9.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -130.66 -48.85 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -110.24 174.65 5.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -88.58 -178.72 5.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.476 ' H ' HG22 ' A' ' 38' ' ' THR . 0.6 OUTLIER -108.39 152.58 24.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.904 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.96 164.45 30.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.88 -179.956 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.804 0.335 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -98.19 -34.78 10.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -100.75 110.04 22.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.1 105.97 11.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.035 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.442 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 6.7 t30 -74.49 139.83 75.06 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.297 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -42.69 -24.89 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.55 2.167 . . . . 0.0 112.918 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -24.09 64.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.295 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.877 ' O ' HD12 ' A' ' 12' ' ' ILE . 7.9 p-90 -73.71 -51.76 15.51 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.805 0.336 . . . . 0.0 111.133 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.75 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.45 -39.71 94.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.972 0.415 . . . . 0.0 110.995 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.449 ' CG ' ' HB2' ' A' ' 33' ' ' LYS . 1.1 ttmm -67.16 -13.43 61.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.325 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.81 -7.02 25.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.711 0.291 . . . . 0.0 111.225 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.877 HD12 ' O ' ' A' ' 8' ' ' TRP . 2.6 mp -124.19 124.41 25.88 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.899 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -73.06 130.97 16.09 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.675 2.25 . . . . 0.0 112.712 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 32' ' ' PHE . 46.9 t -65.81 136.67 56.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.826 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.606 ' HB2' HD13 ' A' ' 19' ' ' ILE . 6.3 ptt180 -53.23 -22.23 6.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.667 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.6 m-80 -61.67 -57.07 13.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.939 0.4 . . . . 0.0 110.251 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mm -66.97 -28.98 44.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.883 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.417 HG22 HD12 ' A' ' 19' ' ' ILE . 2.8 m -78.83 -42.35 27.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.247 -178.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.759 HG22 ' CD2' ' A' ' 20' ' ' TYR . 2.1 mp -96.84 -54.43 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.952 0.406 . . . . 0.0 111.921 -178.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.759 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.27 -11.32 55.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.109 -178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.14 6.67 54.45 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.731 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -160.23 145.49 14.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.536 0.207 . . . . 0.0 110.467 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.8 t -120.86 80.39 1.63 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.84 0.353 . . . . 0.0 110.537 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -56.35 -21.77 26.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.33 -0.91 57.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.247 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -54.26 -36.35 63.5 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.808 0.337 . . . . 0.0 110.38 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -66.53 -14.91 62.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.509 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 30' ' ' CYS . 4.9 mt-10 -96.21 179.12 5.16 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.433 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.92 26.05 0.09 OUTLIER Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.535 -0.841 . . . . 0.0 113.749 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.502 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.7 t -66.31 134.08 94.6 Favored Pre-proline 0 C--O 1.231 0.124 0 CA-C-N 117.717 0.758 . . . . 0.0 110.539 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 88.9 Cg_endo -83.46 148.14 12.73 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.455 2.103 . . . . 0.0 112.627 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.75 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 25.9 m-85 108.97 154.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.1 0.96 . . . . 0.0 111.1 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.449 ' HB2' ' CG ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -87.55 96.46 10.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.129 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.459 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 2.0 m80 -90.9 78.91 5.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.631 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -89.19 100.96 13.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.68 88.2 3.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -108.15 111.07 22.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.952 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.58 96.31 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.942 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.89 37.59 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.915 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.19 31.58 4.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.129 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.908 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.803 0.335 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -110.69 -48.71 3.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.827 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -93.36 96.13 9.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.719 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -120.74 106.29 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.969 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.401 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -79.29 147.53 68.97 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.207 179.417 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -42.88 -24.18 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.604 2.203 . . . . 0.0 112.862 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.25 -27.01 69.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.441 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.692 ' CE3' HD12 ' A' ' 12' ' ' ILE . 8.8 p-90 -64.77 -52.04 59.03 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.707 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -64.72 -36.0 82.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.075 0.464 . . . . 0.0 110.651 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.671 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -68.39 -13.89 62.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.288 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -102.3 -1.97 29.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.748 0.308 . . . . 0.0 110.852 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.692 HD12 ' CE3' ' A' ' 8' ' ' TRP . 65.1 mt -124.57 116.6 26.58 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.833 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.84 130.51 20.62 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.45 2.1 . . . . 0.0 112.596 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.4 t -66.73 137.05 56.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.852 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.421 ' HB3' HD13 ' A' ' 19' ' ' ILE . 72.1 mtt180 -52.97 -22.41 5.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.74 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.426 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.8 m-80 -63.58 -57.15 11.03 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 110.372 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.404 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.2 mm -65.52 -27.72 42.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.496 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.594 HG22 HD12 ' A' ' 19' ' ' ILE . 18.0 m -78.91 -44.78 21.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.192 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.756 HG22 ' CD1' ' A' ' 20' ' ' TYR . 2.3 mp -95.36 -54.62 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.965 0.412 . . . . 0.0 111.99 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.756 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.32 -9.98 56.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.028 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 66.83 7.48 42.67 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.279 -0.963 . . . . 0.0 111.81 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CD2' ' C ' ' A' ' 22' ' ' TYR . 10.2 p90 -160.35 144.17 13.96 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.1 t -120.81 80.26 1.61 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.777 0.323 . . . . 0.0 110.543 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.38 -22.76 33.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.68 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.59 -2.91 58.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.051 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -54.06 -36.08 62.73 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.885 0.374 . . . . 0.0 110.266 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -65.83 -15.79 63.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.41 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 30' ' ' CYS . 33.5 mt-10 -96.65 179.14 5.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.561 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.37 25.72 0.08 OUTLIER Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.888 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.498 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.8 t -66.34 130.31 94.21 Favored Pre-proline 0 CA--C 1.527 0.069 0 CA-C-N 117.874 0.837 . . . . 0.0 110.622 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 96.6 Cg_endo -79.87 150.73 21.17 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.32 2.013 . . . . 0.0 112.379 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.707 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.6 m-85 106.55 154.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.957 0.903 . . . . 0.0 111.105 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.671 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -87.73 96.56 10.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.228 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.459 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 1.9 m80 -91.29 79.19 5.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.658 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.0 m -59.55 156.23 13.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.913 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.95 102.98 4.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.935 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -62.75 -31.71 72.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.827 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.11 86.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -110.18 -54.21 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.946 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.92 -70.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.069 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.926 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.76 0.314 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -142.19 -46.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.872 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.57 127.4 41.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.783 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.578 ' H ' HD12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -120.9 113.35 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.033 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.24 144.31 50.17 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.288 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -42.99 -24.99 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.607 2.205 . . . . 0.0 112.948 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -66.18 -20.04 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.567 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.52 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 7.6 p-90 -67.92 -52.05 40.77 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.852 0.358 . . . . 0.0 111.035 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.733 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.87 -39.87 95.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.082 0.468 . . . . 0.0 110.96 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -67.77 -12.27 60.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.414 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -101.64 -5.01 25.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.676 0.274 . . . . 0.0 111.163 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.496 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 8.2 mt -124.32 123.72 25.88 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.829 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.08 130.72 16.96 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.496 2.131 . . . . 0.0 112.692 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.22 137.0 55.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.927 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.537 ' HB3' HD13 ' A' ' 19' ' ' ILE . 45.9 mtt85 -53.09 -22.29 5.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.806 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.443 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.6 m-80 -62.86 -57.04 12.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 110.228 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.408 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.1 mm -66.1 -27.65 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.546 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.507 HG22 HD12 ' A' ' 19' ' ' ILE . 16.7 m -78.9 -45.77 19.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.205 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.766 HG22 ' CD2' ' A' ' 20' ' ' TYR . 2.2 mp -94.11 -54.39 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.935 0.398 . . . . 0.0 111.939 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.766 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.2 -11.34 55.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.998 -178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 68.9 6.23 50.89 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.808 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -160.34 143.36 13.47 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.6 t -120.76 79.9 1.56 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.734 0.302 . . . . 0.0 110.5 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -56.21 -23.26 34.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.698 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.39 -1.06 52.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.0 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -53.51 -36.19 61.47 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.847 0.356 . . . . 0.0 110.393 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -68.54 -12.84 61.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.668 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 30' ' ' CYS . 7.4 mt-10 -96.94 179.04 5.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 25.49 0.09 OUTLIER Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.708 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.501 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.1 t -66.31 133.21 94.47 Favored Pre-proline 0 C--O 1.231 0.108 0 CA-C-N 117.766 0.783 . . . . 0.0 110.687 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 87.2 Cg_endo -82.84 147.51 13.46 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.404 2.069 . . . . 0.0 112.258 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.733 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.7 m-85 108.01 156.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.011 0.924 . . . . 0.0 110.969 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 6.2 tmmm? -88.52 105.48 17.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.076 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.491 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 1.6 m80 -101.63 78.81 1.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.569 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.5 p -59.76 134.25 56.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -97.08 110.77 23.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.6 t30 62.39 121.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.028 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 m -109.91 150.14 28.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.8 p -122.03 -43.38 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.81 120.2 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.949 179.984 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttm . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.831 0.348 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -63.19 -39.06 93.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -84.47 108.09 17.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.727 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.51 120.94 57.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.186 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -80.74 139.52 50.57 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.998 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -42.98 -24.81 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.503 2.135 . . . . 0.0 113.013 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.65 -20.77 66.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.599 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.862 ' O ' HD12 ' A' ' 12' ' ' ILE . 8.0 p-90 -66.34 -51.91 52.42 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.817 0.341 . . . . 0.0 110.996 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.666 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.82 -39.54 94.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.076 0.465 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.422 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . 2.2 ttmt -67.77 -13.48 62.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.293 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.94 -5.29 28.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.675 0.274 . . . . 0.0 111.122 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.862 HD12 ' O ' ' A' ' 8' ' ' TRP . 2.5 mp -124.17 117.08 27.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.707 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.0 130.49 19.14 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.568 2.179 . . . . 0.0 112.774 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.9 t -65.29 136.91 57.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.641 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.485 ' HB3' HD13 ' A' ' 19' ' ' ILE . 2.9 mtm105 -53.12 -23.18 7.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 0.0 110.629 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.429 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 1.4 m-80 -61.53 -55.29 32.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.939 0.4 . . . . 0.0 110.199 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.411 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.8 mm -69.29 -28.37 38.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.834 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 m -78.77 -42.21 28.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.053 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.785 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.4 mp -97.02 -54.12 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 111.872 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.785 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.5 m-85 -85.37 -12.25 52.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.001 -178.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 70.45 6.11 57.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.874 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -160.28 144.79 14.46 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.53 0.205 . . . . 0.0 110.475 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.2 t -120.99 79.88 1.57 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.813 0.34 . . . . 0.0 110.674 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -56.4 -21.37 24.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.752 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.16 -1.12 57.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.341 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -53.72 -36.81 62.66 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.856 0.36 . . . . 0.0 110.42 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -65.69 -15.39 62.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.332 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 30' ' ' CYS . 9.3 mm-40 -94.1 179.34 5.35 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.516 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.36 21.28 0.06 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.833 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.513 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.4 t -66.22 127.45 93.25 Favored Pre-proline 0 C--O 1.231 0.098 0 CA-C-N 117.901 0.85 . . . . 0.0 110.723 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 87.3 Cg_endo -82.08 152.97 16.56 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.43 2.087 . . . . 0.0 112.512 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.666 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 27.0 m-85 107.77 154.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.942 0.897 . . . . 0.0 111.128 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.422 ' CB ' ' HA ' ' A' ' 10' ' ' LYS . 17.4 tptp -85.23 96.41 9.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.262 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.444 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 3.9 m80 -89.82 79.08 6.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.681 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.71 145.54 29.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.25 152.67 32.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.951 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.57 115.72 4.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 t -112.92 154.88 25.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.983 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 2.2 m -63.63 -19.09 64.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.147 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 39' ' ' THR . . . 67.84 95.22 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.872 0.368 . . . . 0.0 111.134 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.3 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.87 -179.969 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mtm . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.828 0.347 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -137.81 -47.58 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.29 124.94 49.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.658 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.597 HG23 ' CD1' ' A' ' 8' ' ' TRP . 7.9 tp -123.12 154.54 28.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.16 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.604 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 2.6 t-20 -87.98 141.78 31.65 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.928 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -42.49 -25.73 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.738 2.292 . . . . 0.0 113.247 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -58.35 -20.41 43.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.793 0.33 . . . . 0.0 110.765 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.651 ' CE3' HD12 ' A' ' 12' ' ' ILE . 13.0 p-90 -74.29 -51.11 16.21 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.012 0.434 . . . . 0.0 111.295 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.747 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.32 -33.5 74.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.244 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -67.17 -19.47 65.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.356 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -98.32 -0.59 43.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.167 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.651 HD12 ' CE3' ' A' ' 8' ' ' TRP . 81.4 mt -124.36 103.79 32.15 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.057 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.59 130.5 35.67 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.428 2.085 . . . . 0.0 112.161 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.5 t -65.6 136.65 56.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.815 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.415 ' HB3' HD13 ' A' ' 19' ' ' ILE . 4.7 mtp180 -53.16 -25.6 14.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.337 . . . . 0.0 110.514 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.433 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 5.5 m120 -63.12 -53.23 56.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.31 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 34' ' ' HIS . 13.1 mm -67.15 -30.59 49.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.612 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 m -78.98 -41.46 29.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.251 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.729 HG22 ' CD2' ' A' ' 20' ' ' TYR . 1.6 mp -96.34 -54.3 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.925 0.393 . . . . 0.0 111.949 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.729 ' CD2' HG22 ' A' ' 19' ' ' ILE . 2.8 m-85 -85.24 -12.33 52.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.036 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.38 7.47 57.64 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.676 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 22' ' ' TYR . 9.0 p90 -160.29 143.87 13.86 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 120.609 0.242 . . . . 0.0 110.468 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.8 t -120.65 80.76 1.67 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.791 0.329 . . . . 0.0 110.27 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -22.06 27.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.103 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.76 2.13 55.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.171 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -55.0 -36.55 65.54 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.857 0.36 . . . . 0.0 110.301 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -66.54 -14.41 62.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.419 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.52 ' C ' ' H ' ' A' ' 30' ' ' CYS . 4.9 mm-40 -94.42 179.19 5.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.602 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.82 22.05 0.07 OUTLIER Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.752 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.52 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.4 t -66.38 123.74 86.29 Favored Pre-proline 0 CA--C 1.527 0.073 0 CA-C-N 117.82 0.81 . . . . 0.0 110.687 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 71.8 Cg_endo -77.62 151.7 28.88 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.195 1.93 . . . . 0.0 112.249 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.747 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 25.6 m-85 109.45 153.02 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.062 0.945 . . . . 0.0 111.049 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -86.49 96.47 10.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.247 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.463 ' HB3' HD11 ' A' ' 17' ' ' ILE . 3.2 m80 -89.94 79.16 6.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.084 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.4 p -112.89 119.39 37.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.773 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -94.51 -56.94 2.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -152.3 58.98 0.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.9 m -123.68 33.03 5.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 t -157.38 145.96 19.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.09 167.86 10.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.7 p . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.895 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 mtp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.849 0.357 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -64.73 -31.02 72.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -99.55 100.63 11.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.551 ' H ' HD12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -136.42 106.73 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.69 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.459 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 83.0 m-20 -72.89 138.72 79.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.385 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -42.68 -24.69 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.522 2.148 . . . . 0.0 112.887 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -57.92 -23.44 53.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.214 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.528 ' CG ' ' N ' ' A' ' 9' ' ' ALA . 8.0 p-90 -78.87 -51.99 8.93 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 120.808 0.337 . . . . 0.0 110.951 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.73 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -63.34 -37.73 88.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 0.0 110.842 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -67.92 -13.59 62.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.419 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.47 -3.6 28.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 111.14 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.504 ' HB ' ' CE2' ' A' ' 32' ' ' PHE . 6.7 mt -124.19 116.35 27.18 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.765 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 131.6 21.66 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.655 2.237 . . . . 0.0 112.859 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.1 t -67.12 136.81 55.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.777 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.433 ' HB3' HD13 ' A' ' 19' ' ' ILE . 10.3 mtt-85 -52.93 -25.6 12.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 0.0 110.568 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.443 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 5.1 m120 -64.36 -52.78 56.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.289 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.405 HD11 ' HB3' ' A' ' 34' ' ' HIS . 14.9 mm -67.77 -31.27 51.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.613 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.55 HG22 HD12 ' A' ' 19' ' ' ILE . 3.1 m -78.92 -40.8 31.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.426 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.55 HD12 HG22 ' A' ' 18' ' ' THR . 3.1 mp -98.43 -51.47 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.509 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.2 m-85 -85.14 -14.87 45.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.439 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.38 7.41 63.91 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.472 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 20' ' ' TYR . 12.2 p90 -160.48 144.54 13.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.443 0.297 . . . . 0.0 110.344 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.3 t -120.77 80.71 1.66 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.349 178.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.19 -22.7 30.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.846 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 9.27 32.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.482 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -58.79 -36.4 74.39 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.9 0.381 . . . . 0.0 110.202 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -68.65 -12.94 61.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.593 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.3 OUTLIER -93.91 179.28 5.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.33 19.53 0.05 OUTLIER Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.846 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.53 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.0 t -66.3 124.38 87.91 Favored Pre-proline 0 C--O 1.231 0.124 0 CA-C-N 117.885 0.843 . . . . 0.0 110.619 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.549 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 98.2 Cg_endo -80.0 153.6 22.26 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.357 2.038 . . . . 0.0 112.445 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.73 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.8 m-85 107.31 153.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.03 0.932 . . . . 0.0 111.0 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -84.46 96.42 9.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.359 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.482 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 4.3 m80 -90.11 79.07 6.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.68 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -74.84 159.19 32.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.868 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 t0 61.43 162.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.39 154.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.33 -67.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.828 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.68 103.18 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.43 -173.28 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.026 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.887 -179.983 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 mtm . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.781 0.324 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -176.72 -39.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.43 94.46 7.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.603 ' H ' HD12 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -131.87 118.57 38.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.976 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -78.19 136.24 61.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.232 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -42.83 -24.93 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.627 2.218 . . . . 0.0 113.018 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -67.35 -14.63 63.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.717 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.531 ' O ' HD12 ' A' ' 12' ' ' ILE . 7.7 p-90 -75.57 -52.06 11.47 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.824 0.345 . . . . 0.0 111.151 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.72 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -63.3 -38.59 91.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.085 0.469 . . . . 0.0 110.821 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.5 tmmt? -67.58 -13.03 61.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.45 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -102.02 -3.99 26.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.723 0.296 . . . . 0.0 111.245 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.531 HD12 ' O ' ' A' ' 8' ' ' TRP . 4.8 mt -124.29 122.37 26.02 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.871 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.79 130.68 17.24 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.64 2.227 . . . . 0.0 112.8 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.3 t -67.2 137.05 55.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.925 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.452 ' HB3' HD13 ' A' ' 19' ' ' ILE . 16.9 mtt85 -52.81 -24.85 9.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.69 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.436 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 6.1 m120 -63.41 -55.47 24.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.979 0.418 . . . . 0.0 110.325 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.411 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 10.0 mm -65.49 -29.26 46.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.6 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.1 m -78.93 -42.47 26.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.361 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.766 HG22 ' CD1' ' A' ' 20' ' ' TYR . 1.7 mp -96.17 -53.93 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.766 ' CD1' HG22 ' A' ' 19' ' ' ILE . 3.0 m-85 -85.15 -12.52 52.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.902 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.63 6.78 56.59 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.768 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -160.26 142.01 12.67 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.0 t -120.77 79.11 1.45 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.672 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.0 tptt -56.74 -20.43 22.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.827 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -85.19 -2.74 58.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.337 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 34' ' ' HIS . 14.8 tt0 -53.9 -36.42 62.68 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.778 0.323 . . . . 0.0 110.381 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.54 -15.79 63.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.051 0.453 . . . . 0.0 110.273 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' A' ' 30' ' ' CYS . 10.2 mt-10 -95.13 179.14 5.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.479 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.12 23.96 0.08 OUTLIER Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.889 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.506 ' H ' ' C ' ' A' ' 28' ' ' GLU . 4.6 t -66.27 132.6 94.44 Favored Pre-proline 0 C--O 1.231 0.128 0 CA-C-N 117.868 0.834 . . . . 0.0 110.718 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 86.3 Cg_endo -83.41 149.31 13.09 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.41 2.073 . . . . 0.0 112.451 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.72 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 26.3 m-85 107.99 155.18 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.989 0.916 . . . . 0.0 111.0 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 12.6 tptt -87.54 97.6 10.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.391 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.464 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 1.4 m80 -94.26 79.05 3.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.531 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 85.3 p -88.04 111.37 21.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.975 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.04 74.54 0.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -173.25 147.13 1.5 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.91 65.89 6.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.7 m -73.26 155.4 39.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.818 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.35 -47.01 7.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.085 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.906 179.954 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.811 0.338 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.54 -47.32 0.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -79.95 103.43 9.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.723 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.582 HG23 ' CD1' ' A' ' 8' ' ' TRP . 8.4 tp -139.06 154.72 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.163 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.634 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 1.2 t30 -89.65 140.59 28.12 Favored Pre-proline 0 C--N 1.333 -0.14 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.497 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -41.94 -24.48 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.094 2.529 . . . . 0.0 113.192 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -58.86 -20.31 49.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.821 0.343 . . . . 0.0 110.728 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.634 ' HD1' ' O ' ' A' ' 5' ' ' ASN . 16.9 p-90 -73.63 -51.09 17.97 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-O 121.033 0.444 . . . . 0.0 111.226 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.729 ' HB1' ' HA ' ' A' ' 32' ' ' PHE . . . -62.43 -34.37 76.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.194 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 1.5 ttmt -67.32 -17.64 64.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.394 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.39 -1.04 39.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.613 0.244 . . . . 0.0 111.287 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.521 ' HB ' ' CE1' ' A' ' 32' ' ' PHE . 8.3 mt -124.33 105.53 30.99 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.686 0.279 . . . . 0.0 111.168 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.74 130.58 33.74 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.573 2.182 . . . . 0.0 112.439 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.9 t -67.69 136.96 55.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.836 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.594 ' HB3' HD13 ' A' ' 19' ' ' ILE . 10.7 mtm180 -53.04 -23.29 7.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.774 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.419 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.1 m-80 -61.11 -54.96 38.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.081 0.467 . . . . 0.0 110.116 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.439 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 5.1 mm -69.25 -28.5 38.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.881 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 m -78.86 -41.36 30.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.021 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.772 HG22 ' CD2' ' A' ' 20' ' ' TYR . 1.8 mp -97.06 -54.6 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.915 0.388 . . . . 0.0 111.738 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.772 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.25 -13.08 50.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.963 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 71.86 5.43 61.26 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.746 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -160.27 142.98 13.34 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.617 0.246 . . . . 0.0 110.53 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 37.5 t -120.82 79.53 1.51 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.459 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.42 -22.04 29.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.717 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.52 -1.66 56.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.401 ' CG ' ' HB2' ' A' ' 34' ' ' HIS . 14.2 tt0 -54.06 -35.55 62.15 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 120.727 0.299 . . . . 0.0 110.389 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.92 -15.95 63.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.421 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.52 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -95.19 179.35 5.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.561 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.48 21.11 0.05 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.653 -0.785 . . . . 0.0 114.133 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.52 ' H ' ' C ' ' A' ' 28' ' ' GLU . 3.8 t -66.2 124.25 87.46 Favored Pre-proline 0 C--O 1.231 0.111 0 CA-C-N 117.976 0.888 . . . . 0.0 110.598 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 86.3 Cg_endo -78.89 151.1 24.12 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.302 2.001 . . . . 0.0 112.471 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.729 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 26.0 m-85 108.46 154.82 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.041 0.936 . . . . 0.0 111.034 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 15.9 tptt -86.0 99.55 11.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.293 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.461 ' CE1' ' O ' ' A' ' 32' ' ' PHE . 3.0 m80 -93.96 79.07 4.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.731 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.3 151.4 26.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.903 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.03 159.4 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -126.04 -56.31 1.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.2 m -152.49 153.34 33.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.88 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.79 82.53 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.876 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.96 152.3 7.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.013 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.906 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.815 0.341 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -99.68 -35.16 9.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -89.7 118.07 29.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.59 ' H ' HD12 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -129.2 107.59 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.979 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.423 ' O ' ' HD1' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -75.67 142.27 73.55 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.314 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -42.84 -25.28 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.58 2.187 . . . . 0.0 112.845 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -59.33 -25.56 64.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.211 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.614 ' CE3' HD12 ' A' ' 12' ' ' ILE . 7.2 p-90 -72.29 -51.86 18.9 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.864 0.364 . . . . 0.0 110.891 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.762 ' HB1' ' N ' ' A' ' 32' ' ' PHE . . . -62.8 -38.0 88.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.04 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.44 ' CG ' ' HB2' ' A' ' 33' ' ' LYS . 1.8 ttmt -67.24 -14.99 63.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.348 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -100.33 -3.47 31.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.646 0.26 . . . . 0.0 111.134 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.614 HD12 ' CE3' ' A' ' 8' ' ' TRP . 55.5 mt -124.3 126.69 25.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.11 132.31 13.86 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.633 2.222 . . . . 0.0 112.907 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.0 t -70.65 136.85 49.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.641 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.6 ' HB3' HD13 ' A' ' 19' ' ' ILE . 16.3 mtp85 -53.21 -22.56 6.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.0 110.835 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.5 m-80 -61.68 -55.74 27.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.016 0.436 . . . . 0.0 110.185 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.41 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 4.9 mm -68.44 -28.82 41.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.836 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.5 m -78.64 -42.58 28.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.178 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.772 HG22 ' CD2' ' A' ' 20' ' ' TYR . 1.7 mp -96.57 -54.31 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.41 . . . . 0.0 111.863 -178.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.772 ' CD2' HG22 ' A' ' 19' ' ' ILE . 3.4 m-85 -85.28 -12.06 53.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.063 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 17' ' ' ILE . . . 69.93 6.31 55.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.163 -1.017 . . . . 0.0 111.759 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -160.18 146.6 15.72 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.405 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 21.8 t -120.8 81.05 1.71 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.575 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.3 -22.37 29.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.667 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.88 2.04 54.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.016 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -55.05 -35.16 64.19 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.806 0.336 . . . . 0.0 110.427 179.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -11.09 60.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.718 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.512 ' C ' ' H ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -97.26 179.04 5.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.665 179.402 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.45 23.28 0.08 OUTLIER Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.81 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.512 ' H ' ' C ' ' A' ' 28' ' ' GLU . 5.5 t -66.36 131.35 94.26 Favored Pre-proline 0 C--O 1.23 0.054 0 CA-C-N 117.75 0.775 . . . . 0.0 110.714 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.556 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 94.8 Cg_endo -81.52 148.9 16.39 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.398 2.065 . . . . 0.0 112.25 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.762 ' N ' ' HB1' ' A' ' 9' ' ' ALA . 25.5 m-85 109.16 154.77 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.062 0.945 . . . . 0.0 111.056 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HB2' ' CG ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -87.18 98.79 11.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.269 179.637 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.489 ' HB2' ' HG3' ' A' ' 26' ' ' GLU . 2.1 m80 -95.07 79.0 3.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.633 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -97.58 150.2 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.57 79.1 9.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.022 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -93.47 178.83 5.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.4 m -94.2 143.12 26.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.843 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 m -101.27 34.28 2.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.93 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.67 107.1 19.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.315 -0.85 . . . . 0.0 110.956 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_